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CHAPTER 1. INTRODUCTION 
The objective of defining nutrient requirements of pigs is to enable swine producers 
to develop dietary regimens which allow for the most biologically and economically efficient 
production of pork products demanded by consumers. In order to define these nutrient 
requirements, the biological nutrient demands of pigs must be determined under defined 
genetic and environmental (i.e., ambient temperature, stocking density, and level of immune 
system activation) conditions. 
Currently, little information is available on the interaction between level of immune 
system activation and the nutrient requirements of pigs. Therefore, nutrient requirements 
of pigs are determined without regard to level of immune system activation. However, it 
has been determined in chickens (Klasing et al., 1987) and rats (Yang et al., 1983) that 
activation of the immune system results in decreased rates of body protein accretion and 
reduced levels of voluntary food intake. These changes in the animals' metabolic processes 
likely alter the animals' nutrient requirements. 
In conventional rearing schemes, pigs commonly are exposed to pathogenic and non­
pathogenic activators of the immune system. These activators include bacteria, viruses, cold 
stress, and environmental and dietary contaminants (i.e., endotoxin, molds). For example, 
a majority of the swine herds in the United States experience some level of exposure to 
pathogenic antigens. In a 1991, 99% of the herds and 70% of the pigs evaluated possessed 
gross lesions indicative of mycoplasma induced respiratory disease (National Hog Farmer, 
1991). Similarly, 46.8% of the herds monitored by the National Animal Health Monitoring 
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Service (NAHMS) had sows which tested positive for Transmissible Gastroenteritis and 
51.5% of the herds had sows which tested positive for Swine Influenza Virus (National 
Swine Survey, 1992). However, management technologies are increasingly being employed 
that reduce or minimize the exposure of pigs to antigens. These technologies include all in -
all out pig flow, multiple-site production, medicated early weaning, and depopulation-
repopulation procedures. Consequently, the degree of exposure to antigens and the 
associated levels of immune system activation differ substantially among herds or groups 
of pigs. 
The impact of level of immune system activation on tissue growth and nutrient 
utilization and thus nutrient requirements in pigs is not known. Therefore, it was the 
objective of this dissertation research to evaluate the impact of level of immune system 
activation on the rate, efficiency, and composition of body growth, the utilization of 
nutrients for these processes, and dietary lysine required for these processes in pigs fed from 
6 to 114 kg. 
Dissertation Organization 
The dissertation is divided into a literamre review, two papers, and a General 
Summary. The papers were prepared in a style appropriate for submission to the Journal 
of Animal Science. N.H. Williams is the senior author on both papers. 
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CHAPTER 2. LITERATURE REVIEW 
Animal Growth and Development 
Introduction 
Animal growth is a highly integrated process that involves a myriad of regulated 
biologic processes. In quantitative terms, growth is the increase in living substance and 
includes one or more of the following processes: cell multiplication, cell enlargement and 
incorporation of nutrients taken from the environment. Animal development is the 
qualitative aspect of growth. It is tissue differentiation and morphogenesis that results in 
the organization of various cells into organs and tissues. The organization of these various 
organs and tissue results in the development of the body as a whole. An understanding of 
these growth and development processes is essential in defining the impact of environmental 
factors (i.e. immune system activation, nutritional regimen) on nutritional needs for growth. 
Therefore, the following sections will discuss the basic processes of muscle, adipose and 
bone growth and utilizing these concepts, the developmental patterns of muscle, adipose, 
bone, and immune tissues will be discussed. 
Growth of skeletal muscle 
Skeletal muscle growth is the result of two highly regulated processes: hyperplasia, 
the increase in muscle cell number; and hypertrophy the increase in muscle cell size. 
Hyperplasia occurs during fetal growth during which time myogenesis, the formation of 
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muscle fibers from mononucleated cells, occurs. Myogenesis can be divided into four 
periods as reviewed by Stockdale and Miller (1987): 1) formation of myotubes in myotomes 
of the somites; 2) primary fiber formation during embryogenesis; 3) secondary fiber 
formation during late embryogenesis throughout fetal growth and; 4) fiber formation during 
late fetal growth. The formation of skeletal muscle fibers involves commitment of 
mesodermal precursor cells to muscle cell lineages. The commitment of these precursors 
to muscle cell lineages results in the expression of the muscle cell phenotype (Grant and 
Helferich, 1991). During myogenesis there is incomplete fusion of myotubes and the 
resulting myogenic cells that remain are termed myoblasts. Satellite cells are formed when 
myoblasts become encapsulated under the basal lamina secreted by the myofiber (Campion, 
1984). 
Most mammals are born with a full complement of skeletal muscle fibers although 
some animals may show a small (< 20%) increase in fiber number post-nataily 
(Montgomery, 1962). Studies with pigs indicate that total numbers of muscle fibers does 
not change post natally (Strickland et al., 1975). 
The number of skeletal muscle nuclei is directly related to myofiber size and nuclei 
number within the myofiber may ultimately limit the amount of protein in muscle fibers 
(Allen, 1979). Because nuclei contained within the myofiber are incapable of mitosis 
(Campion, 1984), a prerequisite for postnatal skeletal muscle growth is an increase in the 
number of muscle nuclei (DNA). Satellite cells are capable of proliferation, DNA 
synthesis, and fusion into myofibers (Moss and Lebloud. 1971) and are thought to be the 
primary source of nuclei for postnatal fiber growth (Campion, 1984). It is estimated that 
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95% of nuclei present in mature muscle fibers are derived from satellite cells (Allen, 1979). 
Satellite cell proliferation continues for a finite time as part of normal growth processes; it 
ceases abruptly and this coincides with the point that lipid deposition in muscle starts 
(Trenkle et al., 1978). 
During postnatal growth, muscle fibers differentiate into one of three fiber types 
(slow oxidative, fast glycolytic and fast oxidative) distinguished by contraction speeds of the 
muscle and preferred metabolic fuel (Ashmore et al., 1972). These fiber types are 
distinguished histochemically by properties of their myosin ATPase and by presence and/or 
absence of mitochondrial oxidative enzymes. The first fibers which form in the fetus 
contain slow myosins, irrespective of eventual muscle type (Narusawa et al., 1987). Both 
genetic (Rahelic and Puac, 1981) and environmental factors (i.e. temperature, exogenous 
growth promotes such as porcine somatotropin and beta-adrenergic agonists) influence the 
proportion of fast glycolytic to slow oxidative fibers within muscles, which in turn 
influences the animal's response to energy source and post-mortem muscle functionality 
(Stahly et al., 1995). 
In contrast to hyperplasia which occurs primarily pre natally; muscle hypertrophy 
can occur throughout all stages of development. Muscle fibers increase in both diameter 
and in length (Burleigh, 1974). The increase in cross-sectional area of muscle is largely a 
result of the increase in the number of myofibrils which occupy approximately 85 % of the 
volume of myofibers (Goldspink, 1970). Myofibrils increase in number by the longitudinal 
splitting of larger diameter myofibrils to give rise to two smaller diameter myofibrils 
(Goldspink, 1970). The increase in length of myofibers during postnatal growth occurs by 
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the insertion of intact sarcomeres, the repeating structural unit of the myofiber, into 
myofibrils at the tendon end of muscles (Goldspink, 1970). Longitudinal growth of muscle 
is believed to follow the longiuidinal growth of bones (Swatland, 1984). 
Muscle cell hypertrophy is the result of protein accretion and the rate of protein 
accretion is determined by the net difference between rates of protein synthesis and protein 
degradation. Because the majority of muscle cell proteins are myofibrilliar proteins, the 
synthesis of myofibrillar proteins closely parallels accretion of total skeletal muscle proteins 
during postnatal growth (Dickerson and Widdowson, 1960). Myofibrilliar protein synthesis 
seems to be controlled by two factors: 1) the number of ribosomes available for protein 
synthesis; and 2) the rate and efficiency of ribosomes (i.e. the rate of protein synthesis per 
unit of ribosome in the tissue (Pain, 1986). Total muscle RNA concentration, an 
approximation of ribosomal number, is highly correlated with protein synthesis rate (Young 
et al., 1990). Both ribosomal number and ribosomal efficiency are subject to nutritional and 
hormonal regulation, and these relationships will be discussed in latter sections. 
Skeletal muscle protein degradation involves various enzymes found in several 
compartments within the cell which are subject to hormonal regulation. As reviewed by 
Goll et al. (1989), protein degradation can be divided into three distinct systems: 1) 
lysosomal; 2) ubiquitin tagged; and 3) the calpain/calpastatin system. Lysosomal protein 
degradation involves mostly sarcoplasmic proteins and occurs for endocytozed proteins. It 
accounts for 20 % of protein degradation and is not subject to intense regulation because 
once proteins are in lysosomes, they are degraded. The ubiquitin system is an ATP 
requiring process which eliminates proteins which have errors in translation. It accounts 
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for approximately 10 % of protein degradation. The majority of protein degradation is 
under control of the Ca dependent proteases, calpain and calpastatin. These enzymes are 
active at various concentrations of Ca. Calpastatin inhibits the calpains at low levels of Ca. 
The calpains become active at higher physiologic concentrations of Ca and degrade 
myofibrillar proteins. 
The coordinated activities of protein synthesis and degradation allow protein 
accretion to occur. Rates of protein synthesis seem to be the main determinant of protein 
accretion in muscle although during stress or immune system activation, protein degradation 
can be the major determinant (Garlick, 1980). 
Growth of adipose tissue 
In contrast to skeletal muscle, both hyperplasia and hypertrophy of adipose tissue 
occurs during postnatal growth; however, little information ia available on the embryonic 
origin of adipose tissue or the embryonic development of the tissue. Cells which have been 
proposed as precursors for adipocytes include mesenchyme cells, endothelial cells, vascular 
cells and macrophages (Hausman et al., 1980). During fetal development, it seems that 
adipocytes differentiate and begin to accumulate lipid (Mersmann, 1990). The accumulation 
of lipid results in the fusion of multiple lipid droplets to form very large central lipid 
droplets; however, the pig has only small amounts of fat accumulation before birth 
(Mersmann, 1990). Thus, most adipocyte hyperplasia occurs post natally. 
Postnatally, both hyperplasia and hypertrophy of adipocytes occur in pigs. The 
mechanism associated with the differentiation of preadipocytes into adipocytes is not fully 
known; however, it has been demonstrated that insulin, prostaglandins, (Novakofski, 1987) 
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and somatotropin (Morikawa et al., 1984) stimulate in vitro differentiation. 
Hyperplastic growth of adipose tissue is dependent on stage of maturity and depot 
location. In general, hyperplasia occurs rapidly during the suckling phase, undergoes a 
quiescent phase and then occurs rapidly during the fattening phase (Anderson and Kauffman, 
1973). The number of adipocytes in subcutaneous depots increases approximately eight-fold 
in pigs between 8 and 73 kg (Hood and Allen, 1977). Hyperplasia also seems to be depot 
dependent, as Lee and Kauffman (1974) observed a six to eight-fold increase in the number 
of intramuscular adipocytes in the semitendinosus, while only a two-fold to three-fold 
increase in the trapezius as the pig grew from 3 to 110 kg body weight. 
Adipose tissue hypertrophy rates are also dependent on stage of maturity and depot 
location. Similar to adipose hyperplasia, adipose hypertrophy seems to occur rapidly during 
the nursing phase, undergoes a period of quiescence, and then occurs rapidly during the 
fattening phase (Anderson and Kauffman, 1973). Adipocyte volume increases 
approximately ten-fold between 8 and 105 kg (Anderson and Kauffman, 1973). Rates of 
hypertrophy seem to be dependent on depot location and the hierarchy of hypertrophy seems 
to be omental > perirenal > subcutaneous > intermuscular > intramuscular (Lee and 
Kauffman, 1974). 
The sources of fatty acids for adipose hypertrophy are derived from circulating 
triacylglycerols and de novo fatty acid synthesis. The enzyme lipoprotein lipase catalyzes 
the hydrolysis of the circulating triacylgylceride yielding a monoacylglyceride and two fatty 
acids which are translocated to the plasma membrane. Because pigs are normally fed low 
fat diets, de novo fatty acid synthesis is the primary source of fatty acids for adipose tissue 
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synthesis and the enzymes regulating de novo fatty acid synthesis are the major sites of 
control for lipogenesis of the pig (Mersmann, 1986). Acetyl-CoA carboxylase is the major 
site of enzyme regulation of lipogenesis in the pig. This enzyme catalyzes the conversion 
of acetyl coA to malonyl coA, the first committed step in fatty acid production. This 
enzyme is under allosteric control and is activated by citrate and inhibited by long chain 
fatty acyl coA's (Hardie, 1989). This enzyme also is under hormonal control, as 
catecholamines (Lee and Kim, 1979) inhibit the enzyme and decrease lipogenic flux (Hardie, 
1989). Somatotropin also inhibits lipogenesis, possibly by inhibiting the synthesis of a 
protein required for mediation of the insulin induced activation of the enzyme (Vernon et 
al., 1991). Lipolysis, the hydrolysis of triacylgylcerol, is catalyzed by hormone sensitive 
lipase. This enzyme is also under strict hormonal control, as catecholamines (Mersmann, 
1987) increase lipolytic activity through increasing cAMP concentrations in adipose cells, 
whereas insulin decreases cAMP concentration and in turn decreases lipolytic activity 
(Vernon et al., 1991). 
Bone tissue growth 
Bone serves two important functions within the body: 1) provide structural integrity 
to the animal 2) serve as a reservoir for Ca and P for mineral homeostasis. 
Bone consists of inorganic salts imbedded in organic fibers of collagen. The crystal 
is equivalent to hydroxyapatite, Ca,o(P04)6(OH)2 with some additions of carbonate, citrate, 
fluoride, magnesium and sodium (Thomson and Loveridge, 1991). As reviewed by 
Thomson and Loveridge (1991), bone begins as mesenchymal condensations within the 
limbus of the developing embryo. These mesenchymal condensations differentiate into 
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chondrocytes which proliferate and secrete collagen. During the secretion of the collagen, 
there is permeation of the cartilage which results in the differentiation of osteoblasts from 
the chondrocytes. The osteoblasts in turn secrete a thin layer of bone and alkaline 
phosphates which calcifies the bone. Once the primary bone is established, the bone is 
penetrated by osteoclasts from the periosteum which erode the internal cartilage and 
establish the primary bone. After the primary bone is established, growth occurs at the 
epiphyseal growth plate. At the growth plate, chondrocytes secrete an extracellular matrix 
which is the frame work for bone growth. Osteoblasts then form mineralized canilage 
projecting around the extracellular matrix and crystal growth then occurs. 
Once bone growth is complete, there is constant remodeling of bone in order to 
replace old matrix to prevent accumulation of micro-damaged or stress fractured bone and 
to allow for maintenance of Ca and P homeostasis. This remodeling is the result of a 
coordinated effort between osteoblasts and osteoclasts and is under strict hormonal growth. 
Osteoblasts are cells rich in glycogen and alkaline phosphatase which synthesize bone 
and play a role in the regulation of osteoclastic bone resorption (Chambers and Fuller, 
1985). Osteoblasts synthesize and secrete a bone matrix of unmineralized bone onto existing 
connective tissue surfaces (Owen, 1963). This matrix is termed osteoid and consists 
primarily of highly cross-linked collagen. Osteoblasts also aid in tone resorption by 
signalling mature osteoclasts to increase bone resorption in response to local and systemic 
factors by the production of mediators such as osteocalcin and polypeptide growth factors 
such as IGF-II (Hauschka et a!., 1986; Thomson et al., 1986) which initiate bone resorption 
or by the production of matrix degrading enzymes as osteoclasts can only attack mineralized 
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bones (Chambers el al., 1984). Osteoclasts are multinucleated cells involved in bone 
resorption of both the mineralized and organic phases of bone. Bone mineral is dissolved 
by ions secreted by osteoclasts and the organic matrix is degraded by lysosomal enzymes 
(Chambers et al., 1984). 
Bone remodeling is under strict hormonal control, mainly via parathyroid hormone 
(PTH), 1,25 hydroxycholecaliceferol (1,25(0H)203) and calcitonin. Both PTH and 
1.25(0H)203 are released in response to hypocalcemia and increase bone resorption via 
increased activity of the osteoclasts. Osteoclasts do not have receptors for either hormone 
and the response is believed to be mediated by the production of osteoclast stimulating 
factors by the osteoblasts (McSheehy and Chambers, 1986; Bradbeer et al., 1988). 
Calcitonin is released in response to hypercalcemia and it decreases bone resorption via 
direct action on the osteoclasts (Thomson and Loveridge, 1991). Cytokines (IL-1, TNF) 
have been demonstrated to promote bone resorption in response to local and systemic factors 
and may play a role in local control of bone growth (Bertolini et al., 1986). 
Animal development 
Animal development is the organization of various organs and tissues resulting in the 
development of the body as a whole. Development may be considered from three aspects 
: 1) an increase in body mass with time; 2) changes in form of composition resulting from 
differential growth rates of component parts (i.e. muscle, adipose and bone); and 3) changes 
in form of component parts resulting from differential growth rates of specific component 
groups (i.e. specific muscle or fat depots). 
The increase in body mass with time can be divided into time sequences such as birth 
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to weaning, weaning to slaughter, and slaughter weight to manirity. Live weight and empty 
body weight normally increase linearly from birth to slaughter weight. Robinson (1974) 
reported the results of several growth studies which demonstrated that live weight in pigs 
increased linearly up to 130 kg (210 days of age). Shields et al. (1983) demonstrated that 
liveweight and empty body weight increased linearly up to 145 kg. From normal slaughter 
weights to maturity, this relationship is less clear because there are few experiments in 
which pigs have been grown to maturity. Whittemore et al. (1988) fed Large White X 
Landrace pigs to 198 kg (330 days) and determined that the change in live weight over time 
was best described by the Gompertz Function. This function shows a linear increase in 
body weight, then a plateau followed by a slight linear decrease to maturity. This 
relationship is consistent with the findings of Black (1988). 
Change in form of composition over time (body weight) has been demonstrated by 
several researchers through serial slaughter experiments. The sequential development of 
bone, muscle and fat was established by McMeekan (1940). Research by Clausen (1953) 
indicated that pigs reach a point of maximum deposition of lean by 60 to 75 kg bodyweight 
but this research is not thought to be indicative of the modern pig. Doorenbal (1971, 
1972,1975) evaluated the development of pigs from 10 to 132 kg. Pigs were creep fed from 
day 10 to weaning (42 days) followed by ad-libitum feeding to slaughter. Body protein as 
a percentage of the carcass decreased from 16 percent in the 10 kg pig to 13 percent in the 
130 kg pig. Both daily fat and protein accretion increased in an almost linear fashion; 
however, daily fat accretion increased at a faster rate than protein accretion, thus the 
fat/protein ratio increased as live weight increased. 
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Shields et al. (1983) evaluated the development of crossbred (Hampshire. Yorkshire 
and Duroc) barrows and gilts from birth (1.5 kg) to 145 kg. The weights of the chemical 
components water, protein, ash and fat increased in a quadratic fashion as live weight 
increased. Both water and protein increased in linear fashion in the early stages of growth 
but during the latter stages of growth they increased in a declining manner. Fat deposition 
increased in a curvilinear fashion at a greater rate than protein and water during the latter 
stages of growth. Thus water and fat were deposited inversely to one another during the 
later stages of growth. These relationships are consistent with the findings of Schmidt et 
al. (1973) which described the fattening process as essentially one of replacing water by fat. 
Ash increases quadratically as body weight increases and follows a similar pattern as protein 
and water. The percentage composition of protein and water in the pigs' body decreased 
from 15.1 % and 71.6 %, respectively at 6.4 kg (weaning) to 12.61 and 42.28 %, 
respectively at 145 kg liveweight. Fat content increased from 1.73 % at birth to 41.0 % 
at 145 kg. These data are consistent with the findings of Doorenbal (1971, 1972), Schmidt 
et al. (1973) and Tess et al. (1986). 
In addition to the differential patterns of nutrient accretion, patterns of differential 
growth for individual component tissues (i.e. muscle, adipose, bone) have been established. 
McMeekan (1940) established the theory that tissues develop in an anterior to posterior 
pattern in all three dimensions - length, depth and breadth. 
These developmental patterns are most likely related to functional demands placed 
on tissues during development and thus tissues involved in mobility and support develop 
early during postnatal growth but have relatively low growth patterns after this. These 
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observations are supported by research findings of several workers (McMeekan, 1940; 
Kempster and Evans, 1979; and Lawrie et al., 1963). 
McMeekan (1940) demonstrated that muscles of the head and neck were the earliest 
maturing (lowest proportional increase in muscle weight postnatally compared with muscle 
weight at birth) with muscles of the loin being intermediate to muscles in the shoulder and 
ham. He also demonstrated that muscles in the limbs grew in a distal to proximal manner 
i.e. muscles in the foot were earlier maturing than muscles in the shoulder with these 
muscles being intermediate in development to muscles in the arm. These findings are 
supported by the findings of Kempster and Evans (1979) who demonstrated that muscles in 
the loin and back had the lowest growth coefficients during postnatal growth with muscles 
in the ham being intermediate and muscles in the belly being the latest. 
Differential patterns of fat deposition can be considered from two aspects 1) specific 
depot deposition (i.e. peritoneal vs intermuscular vs subcutaneous); and 2) anatomical 
deposition. In general, the literature suggests that in pigs fat is deposited in the following 
fashion; intermuscular > peritoneal > subcutaneous, although Kempster and Evans (1979) 
reported that in pigs serially slaughtered at three body weights, intermuscular (seam) fat was 
the first fat depot followed by peritoneal and subcutaneous (peripheral layer) fat. These 
findings are supported by Braude and Townsend (1963) and Lav/rie et al. (1963). 
McMeekan (1940) suggested that subcutaneous fat was earlier maturing than intermuscular 
fat, but his findings may be related to his definitions of fat depots as he considered fat 
depots in the shoulder and ham which did not serve functional roles as subcutaneous 
whereas later authors considered these depots as intermuscular fat. There also seems to be 
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differential patterns of intermuscular and subcutaneous fat deposition. Kempster and Evans 
(1979) demonstrated that postnatal intermuscular fat growth was lowest in the ham and 
highest in the muscles of the loin and back (dorsal portion of the ham and posterior portion 
of the loin) and that postnatal subcutaneous fat growth was lowest in the back and loin and 
highest in the shoulder and ham. This work is supported by that of McMeekan (1940) 
which demonstrated that fat was deposited in the shoulder first with the ham and back being 
intermediate and the work of Braude and Townsend (1963) which demonstrated that fat was 
deposited last in the back compared with the ham and shoulder. 
Bone development follows a similar pattern to muscle deposition. McMeekan (1940) 
demonstrated that bones of the skull and lower jaw were the earliest developing with bones 
of the loin being intermediate and bones in the limbs developing in a distal to proximal 
fashion with bones of the upper rump being the latest maturing. Individual bone growth 
also seems to occur in a differential fashion with length predominating over thickness during 
the early phases of growth and the ossification and thickening of the bone predominating in 
latter stages of development (Cuthbertson and Pomeroy, 1962). 
Development of the immune system 
In addition to the basic understanding of muscle, adipose and bone growth, it is 
necessary to discuss the basic components of the immune systems and the developmental 
patterns of the immune system in order to understand the relationship between immune 
system activity and tissue growth. 
Organs of the immune system are divided into primary and secondary lymphatic 
organs (Cooper et al., 1968). The primary lymphatic organs (bone marrow, thymus gland) 
are where immature lymphocytes differentiate into antigen-sensitive, mature B and T cells 
and the secondary lymphatic organs (lymph nodes, spleen, adenoids, tonsils, Peyer's patches 
of the small intestine, and appendix) are areas where lymphocytes encounter and bind 
antigens and where upon they proliferate and differentiate into mature antigen-specific 
effector cells (Cooper et al., 1968). Red bone marrow is the major source of lymphocytes 
which originate from stem cells (Weiss, 1977). Progenitor lymphocytes from bone marrow 
migrate to the thymus where they mature into viable lymphocytes which are capable of self 
recognition (Weiss, 1977). Only 5% of cells that are delivered to the thymus are released 
into the general circulation. Once in the general circulation, these lymphocytes migrate to 
the secondary lumphoid organs where they encounter trapped antigens and mount an 
immune response. 
It seems that the organs of the immune system are fully developed by the last two-
thirds of gestation and that neonates are capable of independent cellular and humoral 
immune competence (Adinolfi, 1969). However, the functional capability of the immune 
system in the neonatal pig is not fully developed as witnessed by their weak response to 
antigen and low phagocytic and bactericidal activity of phagocytes (Adinolfi, 1969). In 
pigs, independent humoral immunity is not achieved until approximately 42 days, at which 
time immunoglobulin M (IgM) levels can be detected (Wilson, 1974). Before this, neonatal 
pigs receive humoral protection from passive immune transfer of IgG's from sow colostrum 
(Wilson, 1974). Neonatal pigs have normal numbers of lymphocytes by 1 day of age, but 
maximal cellular immunity (as demonstrated by mitogen induced blastogenesis) is not 
achieved until 28 day of age (Becker and Misfeldt, 1993). Expression of surface cell 
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receptors (CD2. CD4, CDS) are not present at one day of age. but are present by 18 day 
of age (Becker and Misfeldt, 1993). 
In summary, it seems that neonatal pigs have functional immune system organs at 
binh; however, peak cellular immunity is not reached until approximately day 28 of life and 
peak humoral immunity does not occur until day 42 of life. 
Nutrient (Energy and Amino Acid) Needs for Growing Pigs 
Nutrient requirements of pigs are the sum of nutrient needs for maintenance and 
growth processes. Biologic (genetic, gender) factors determine the maximal rates at which 
these processes can occur and environmental factors (i.e. ambient temperature, social stress, 
and potentially level of immune system activation) determine the degree to which these 
processes are expressed. The dietary nutrients required by pigs for a specific set of biologic 
and environmental conditions depend primarily on the intake of nutrients relative to the 
animal's maintenance needs, the digestibility of the dietary nutrients, and the efficiency of 
use of digested nutrients for metabolic processes. 
The two common approaches for quantifying nutrient needs are: 1) factorial method 
in which daily nutrient requirements are estimated as sum of requirements for specific 
biological processes (i.e. maintenance and growth) and; 2) empirical method in which 
requirements are determined by feeding graded levels of a particular nutrient and the 
requirement is estimated to be the point where a response (i.e. maximal) of a specific 
response criterion is achieved. The empirical method is limited in two aspects: 1) difficulty 
in determining requirement and; 2) limitations in scope. Because the response to a 
particular nutrient may diminish as nutrient intakes approach the requirement, it is difficult 
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to access where maximal or optimal response occurs. The major limitation to this approach, 
however, is that requirements determined utilizing this technique are limited to the particular 
condition (i.e. genetic strain, body weight range, environmental conditions) in which they 
are determined. Any changes in the biologic or environmental condition reduces the validity 
of the requirements. Therefore, because the focus of the proposed research is on a potential 
environmental modifier of tissue accretion and/or efficiency of nutrient utilization, the 
sections on nutritional needs will focus on the factorial approach. 
Energy utilization by the growing pig 
A discussion of energy requirements requires an understanding of energy utilization 
by the pig. As reviewed by Seerley and Ewan (1983), the gross energy (GE) of a substance 
is the amount of energy released when an organic substance is completely oxidized to 
carbon dioxide and water. Energy intake (EI) is the amount of feed consumed x GE content 
of the feed. Digestible energy (DE) is the GE consumed minus the energy lost in feces. 
Because not all energy in feces is food energy the term Apparent DE is used. Metabolizable 
energy is DE minus energy lost in urine and gaseous. Gaseous losses normally are less than 
2% of GE intake and thus are frequently not accounted for in ME evaluations. ME 
decreases if a poor quality protein diet is fed or with excess protein feeding due to increased 
energy loss in urine associated with nitrogen excretion (NRC, 1988). The proportion of ME 
released during nutrient fermentation, digestion, metabolism and excretion is called heat 
increment (HI). The remaining portion of ME is referred to as net energy (NE) and can 
be partitioned into NE for maintenance (NEm) and NE for production (NEp). NEm is the 
portion of NE expended to sustain life processes of an animal and the expenditure of energy 
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associated with minimal movement for food and water consumption. NEp is the portion of 
NE retained as part of the body or voided as a useful product or work. In growing animals, 
NEp is equivalent to the energy content of tissue gain. Because of the difficulty associated 
with obtaining NE values for feedstuffs, ME is the most common system for expressing 
energy requirements in the U.S. although accurate NE values are becoming more readily 
available (Noblet et al., 1994). 
An animal's maintenance requirement is dependent on its body mass and 
composition, activity level, and environmental (i.e. effective ambient temperature, health 
status) surroundings. ARC (1981) developed the following equation for 5 to 90 kg pigs in 
thermoneutral environments based on a series of studies; ME for maintenance = 719 kj/kg 
BW ®/day or 110 kcal ME/kg BW^Vday when converted to the interspecies coefficient of 
.75 for metabolic body size (Kleiber, 1975). This equation fails to allow for the known 
increase in maintenance requirements in pigs containing higher proportions of body protein 
because of either gender (Fuller, 1980) or genetic strain (Sharma et al., 1971). Whittemore 
(1983) developed the equation of MEm =.44PB^^ Mcal/day where Pg is protein in the body 
in order to account for increasing maintenance requirements associated with increased 
protein mass. Black et al (1986) further manipulated this equation to account for an 
increase in protein mrnover associated with increased rates of body growth (McCracken and 
McAllister, 1984) to yield the equation; MEm = .339 PB ™ + .00067GB (kcal/day) where Pg 
is protein in the body and Gg is the rate of body weight change (g/days). The use of these 
latter equations is difficult because of the need to estimate protein content in the body. 
Energy needs for maintenance also have been demonstrated to be influenced by 
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environmental factors. Recombinant porcine somatotropin has been reported to increase 
maintenance needs by 10% due in part to increased liver and kidney weight and increased 
oxidative activities of these tissues (Noblet and Dubois., 1992). Additionally, activation of 
the immune system increases metabolic activity. An increase in body temperature of 1" C 
results in an increase in metabolic rate of 10 to 15% in adult humans (Beisel, 1977). In 
rodents, infusions of IL-1 results in a similar increase in resting metabolic activity 
(Dascombe et al., 1991). Increased maintenance needs also occur when animals are 
subjected to environmental conditions outside thermoneutrality as resting expenditure of 
energy must be increased to either dissipate heat or provide heat for maintaining body 
temperature. 
Energy consumed over maintenance is expended for the synthesis, accretion and 
mrnover of body stores. Each gram of protein and fat contains 5.76 and 9.5 kcal of energy, 
respectively (ARC, 1981). Because of additional biochemical reactions, 10.5 kcal ME/g 
and 12.8 kcal ME/g are required for the deposition of protein and fat, respectively for 
growing pigs weighing less than 90 kg (ARC, 1981). These values correspond to an 
efficiency of utilization of energy (ME) for protein synthesis (kp) of .56 and an efficiency 
of utilization of energy (ME) for fat synthesis (kf) of .74 (ARC, 1981). The lower 
efficiency of protein deposition is in part due to the energy cost of protein turnover 
associated with protein growth (Millward et al., 1976) and the energy cost of increased 
active transport of sodium and potassium associated with protein accretion (Reeds et al., 
1985). These efficiencies compare with more recently reported values of .67 and .64 for 
protein synthesis and .85 and .81 for fat synthesis, respectively (Noblet and Dubois, 1989; 
Noblet et al., 1992). Whittemore and Fawcett (1976) proposed that Kp declines with age 
due to proportional increases in protein turnover associated with increased protein mass. 
Nutritional factors can influence the efficiency of protein and fat deposition. As reviewed 
by Stahly (1984), the partial energetic efficiency of protein deposition is not altered by 
dietary energy source except when diets with greater than 18% neutral detergent fibers are 
fed. The efficiency of fat accretion is influenced by energy source as increasing fat in the 
diets increase K, and increasing fiber in the diets decreases K,. 
Lysine utilization by the growing pig 
The growing pig requires dietary amino acids for maintenance to replace obligatory 
amino acid loss in the urine and the integument. Lysine needs for maintenance have been 
based on body protein mass (Whittemore, 1983) and body weight independent of protein 
content (Fuller et al., 1987). Stahly (1990) estimated maintenance needs for lysine to be 
42 mg/Kg body weight (BW)^^ based on the relationship of .0035 to .004 of body protein 
mass being replaced daily (Whittemore, 1983) and 2.5% of this protein being represented 
by lysine (Fuller et al., 1989). Estimates of maintenance lysine needs based on body weight 
range from 25 mg/kg BW^ (Baker et al., 1966) and 36 mg/kg BW^^ (Fuller et al., 1989). 
This compares with ARC (1981) estimates of obligatory N loss of .15 g N/kg BW "'^ and 
37.5 mg lysine/kg BW "'^ assuming 2.5% of N loss is represented by lysine. 
Lysine needs for protein accretion are related to the animals capacity for lean 
deposition. Estimates of lysine needs for protein accretion require an understanding of the 
grams of lysine required to deposit protein, an estimation of the lysine content of the 
proteinaceous tissue and in turn, an estimation of the efficiency of lysine utilization. Several 
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groups have investigated the digestible lysine needed to deposit body protein. Fuller et al. 
(1989) determined that 1 g of digestible lysine supported 14.7 g of protein growth in 60 kg 
Large White gilts. Campbell and Travemer (1988) reported that 1 g of digestible lysine 
supported 5.0 and 7.5 g of body protein deposition of 20 kg barrows and boars from an 
improved genetic strain. Batterham et al. (1990) reported that 11.0 and 11.2 g of protein 
deposition was supported in boars and gilts, respectively by 1 g of digestible lysine whereas 
Chiba et al. (1991) reported that 6.1 g of protein deposition was supported by 1 g of 
digestible lysine in 20 to 50 kg barrows. The differences in reported literamre values for 
the grams of lysine required to deposit a gram of protein are in part due to differences in 
experimental techniques utilized to predict protein accretion. For example, values 
determined from protein accretion rates based on nitrogen balance (i.e. Fuller et al., 1989) 
would normally be higher than those derived from carcass analysis (i.e. Campbell and 
Traverner, 1988a; Batterham et al., 1990) because nitrogen balance tends to overestimate 
nitrogen retention when compared to carcass analysis because of errors associated with the 
N balance technique (McLaughlan an Campbell, 1969). The average of the estimated 
efficiencies of lysine to protein is 9.2 g of body protein deposited for each gram of 
digestible lysine intake or approximately .108 grams of digestible lysine required to deposit 
a gram of protein. Several groups have reported the lysine content of body protein of pigs 
and there is a wide range of reported values. Values reported include: 6.2% Chung and 
Baker, (1992); 6.2 and 7.3% Hahn and Baker, (1995); 7.0% Stahly, (1990); 7.1 
(Kyriazakias et al., 1993); 6.5% (Campbell et al., 1988b); 6.8% (Aumaitre and Duee, 
1974); and 7.0% (ARC, 1981). Lysine content in body protein may be influenced by 
somatotropin treatment as Krick et al (1993) reported that the lysine content of empty body 
protein in pST treated pigs was 7.5% compared with 6.7% for controls. The nutritional 
adequacy of the diet may also influence lysine concentration in protein. Gahl et al. (1994) 
reported that lysine in empty body protein increased as lysine went from deficient to 
adequate levels. Using an average literature estimate of 6.83% lysine in a unit of body 
protein the efficiency of digestible lysine utilization for lysine deposition is 63.2%. 
Literamre estimates of lysine utilization range from 51 % (Krick et al., 1993) to 90% (Gahl 
et al., 1994) with intermediate values of 65% (Stahly, 1990); 65% (Reeds and Fiorotto, 
1985); and 75% (Batterham et al., 1990) reported. Because lysine is normally the first 
limiting amino acid in corn/soybean meal based pig diets, much of the research to determine 
amino acid needs for growth has been focused on lysine. Although requirements for growth 
for amino acids other than lysine have been evaluated, much of the focus of research has 
been to evaluate how well mixtures of proteins meet amino acid requirements. A protein 
that contains a perfect balance of amino acids, both among the essential amino acids and 
between essential and nonessential amino acids has been defined as an ideal protein (ARC, 
1981). Various ideal ratios have been established by different groups based on factorial and 
empirical techniques and the composition of pig tissues. Table 1 outlines the ideal pattern 
of amino acids relative to lysine as proposed by various groups. 
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Table 1. Estimates of the composition of Ideal Protein for growing pigs" 
Amino ARC Wang and 
Acid (1981) Fuller(1989) 
Chung and 
Baker^ (1992) 
Hahn and 
Baker(1995) 
Thr 
Trp 
Val 
Arg 
His 
Iso 
Leu 
Lys 
Met+Cys 
Phe+Tyr 
55 
100 
100 
50 
96 
60 
15 
70 
60 
110 
100 
63 
120 
72 
18 
75 
42 
32 
60 
100 
100 
60 
95 
65 
18 
68 
65 
70 
20 
Ess: 
Noness'' 
45:65 
"Proportions of amino acids relative to lysine. 
''Ratio of total essential to nonessential amino acids. 
Differences in proposed ideal amino ratios arise in part from differential optimal 
patterns for maintenance and protein accretion (Fuller et al., 1989). As feed intakes are 
reduced closer to maintenance, the proportion of methionine + cystine and tryptophan is 
increased relative to lysine, compared to situations where feed intake and growth rates are 
high (Fuller et al., 1989). As pigs approach market weight, feed intake relative to 
maintenance is reduced; thus the optimal ratio of threonine, tryptophan and methionine + 
cystine relative to lysine is greater than that of lighter weight pigs (Hahn and Baker 1995, 
Chung and Baker, 1992). 
Another potential modifier of the "ideal" ratio of amino ratios is the alterations in 
metabolic activity associated with activation of the immune system. These alterations will 
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be discussed in greater detail in latter sections. But in brief activation of the immune 
system results in the mobilization of body tissue stores, greater production of acute phase 
proteins in the liver, reductions in voluntary feed intake, and reductions in skeletal muscle 
tissue accretion rates (Klasing, 1988). These responses may alter the "ideal" amino acid 
pattern due to the need for a differential pattern of amino acid needs for the synthesis of 
acute phase proteins compared with that needed for the synthesis of muscle and maintenance 
proteins for muscle and decreased rates of feed intake relative to maintenance. As discussed 
previously, decreased rates of growth and feed intake relative to maintenance increases the 
need for methionine and cysteine (Fuller et al., 1989). Also, as reviewed by Reeds et al. 
(1994), the optimal profile of cysteine, tryptophan and phenylalanine would be potentially 
increased relative to lysine because of the relatively high demand of these amino acid for 
acute phase protein synthesis compared with what is mobilized by the body. Hunter and 
Grimble, (1994) found that supplementation of low protein diets with either cysteine or 
methionine increased liver acute phase protein production. 
In addition to the metabolic alterations on the ideal amino acid profile, 
immunological activity may alter the ideal ratio. In chicks, it has been demonstrated that 
the methionine needs to optimize immune function were greater than those required to 
optimize body growth rate and efficiency (Tsiagbue et al., 1987). The increased methionine 
need may be related to the inability of lymphocytes to produce methionine from its' 
precursors homocysteine and choline (Hall et al., 1992). Additionally, Tsiagube et al. 
(1987b) demonstrated that choline and/or cysteine spared methionine for growth hut not for 
optimal immune function. 
Overview of the Immune System 
In order to understand the relationship between the immune system and metabolic 
activities in the animal, it is necessary to have a basic understanding of the concepts of 
immunology. The following section is a brief overview of cells of the immune system, and 
steps involved in cytokine release. 
Cells of the immune system 
Several white blood cells (leukocytes) play a role in the immune response. These 
leukocytes are grouped according to their characters and functions they serve. These groups 
include lymphocytes, antigen presenting cells, and granulocytes. Table 2 shows the normal 
distribution of these cells. 
Table 2. Normal blood leukocyte counts." 
Cell type 
% of total 
leukocytes 
% of leukocyte 
subsets 
Leukocytes 
Lymphocytes 
(% of lymhocytes) 
20-40 100 
T-cells 
B-cells 
Null cells 
75 
20 
5 
100 Antigen Presenting Cells 
{% of antigen presenting cells) 
1-6 
Monocytes/Macrophages 
Dendritic cells 
90 
10 
100 Granulocytes 
(% of granulocytes 
50-70 
Neutrophils 
Eosinophils 
95 
5 
"Tonegawa, 1985. 
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Lymphocytes are leukocytes which mature in lymphoid tissue and are mediators of 
the immune response. They account for the immunological characteristics of diversity, 
memory, and self recognition. Lymphocytes are divided into T-cells, B-cells, and Null cells 
(i.e. natural killer cells) based on their function and cell surface proteins. T-lymphocytes 
differentiate in bone marrow and manire in the thymus. T-cells express surface cell 
antigens which differentiate them from other lymphocytes and determine their specific 
function. All T-cells express T-cell receptors but express different cluster of determination 
(CD) antigens. T-cells which express CD4 antigens are referred to as T-helper cells. T-
helper cells only recognize antigen associated with class II major histocompatabilty complex 
(MHC) molecules (Dembie et al., 1986). T-cells which express CDg antigens are referred 
to as T-suppressor, cytotoxic cells and only recognize antigen associated with class I MHC 
molecules. MHC molecules play a role in recognition of self and non-self. T-helper cells 
respond to antigen presented by antigen presenting cells of the immune system and secrete 
cytokines which potentiate the immune response (Tonegawa, 1985). T-suppressor, cytotoxic 
cells play a dual role in that they aid in cytotoxic activities and also in suppression of the 
immune system (Batchelor et al., 1989). A more detailed discussion of CD antigens will 
follow and is included in the section on methods to assess immune status. 
B-cells derive their name from their site of mamration in poultry (Bursa of Fabricus). 
Mature B cells are distinguished from other lymphocytes by their immunoglobulin receptor 
for antigen. B-cells which have not encountered antigens are referred to as naive B-cells 
and are smaller than mature B-cells. Upon encountering an antigen, in conjunction with T-
lymphocytes and cytokines, naive B-cells differentiate to produce plasma B-cells and 
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memory B-cells (Gray, 1993). Plasma B-cells actively secrete immunoglobulins specific to 
the antigen, whereas memory B-cells are involved in the secondary response to antigen. 
Null cells are lymphocytes which do not process receptors for antigens and as such 
lack the attributes of specificity and memory. Of the null cells, natural killer cells (NKC) 
make up the largest majority. NKC can play a cytotoxic role against tumor cells and virus 
infected cells (Tonegawa, 1985). 
Antigen presenting cells are a class of cells which aid in the presentation of antigen 
to effector cells of the immune system (T-cells) and release compounds which mediate both 
immunologic and metabolic activities (monokines or cytokines). 
Mononuclear cells make up the biggest percentage of antigen presenting cells 
(Tonegawa, 1985). Mononuclear cells consist of monocytes in circulating blood and 
macrophages once they pass into tissues. Once monocytes pass into tissues, they become 
enlarged and gain the ability to secrete soluble factors known as cytokines. Macrophages 
express MHC II molecules and present antigens to T-helper cells. They are also capable 
of phagocytosis of antigens, dead host cells and cellular debris. Macrophages also release 
monokines which are involved in a wide range of activities that will be more fully discussed 
in latter sections. 
Dendritic cells make up a smaller percentage of antigen presenting cells and are 
found in nonlymphoid and lymphoid organs, blood and lymph (Tonegawa, 1985). They are 
characterized by long membrane processes, giving them the resemblance of nerve cells. 
They express MHC II molecules and play an important role in presenting antigens to T-
cells. 
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Granulocytes are a group of leukocytes characterized by their granular appearing 
cytoplasm and they play a role in the inflammatory response (Tonegawa, 1985). 
Neutrophils make up the largest percentage of the granulocytes and they are capable of 
phagocytosis (Tonegawa, 1985). Furthermore, they are important in the inflammatory 
response as they are the first cells to arrive at a site of inflammation. Eosinophils make up 
a small portion of the granulocytes present. They are also capable of phagocytosis and are 
important in parasitic infection. Basophils are found in relatively small numbers and are 
not capable of phagocytosis. However, basophils play a role in the allergic response as they 
release histamine. 
Steps involved in cytokine production 
Cytokines are produced in order to elicit various immunologic and metabolic 
functions which aid the host defense system against invading antigens. Cytokines produced 
by macrophages have both immunologic and metabolic function, whereas cytokines 
produced by T-helper cells tend to have immune stimulatory effects (Balkwill and Burke, 
1989). 
The steps involved in antigen presentation and the subsequent production of cytokines 
are depicted in Figure 1. As reviewed by Arai et al. (1990), the first step in this process 
is the recognition and processing of antigen by macrophages. The antigen is processed and 
brought to the cell surface. During this process, a myriad of cytokines are produced 
including IL-1, TNF-2, TNF-B and IL-6. These monokines act on various tissues such as 
hypothalamic, liver, skeletal muscle, bone, and adipose to elicit various metabolic processes. 
The antigen which is brought to the cell surface is presented to a resting T-helper cells. 
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Upon recognition of antigen and stimulation by IL-1, the resting T-helper cell undergoes a 
series of processes whereby it becomes an activated T-helper cell. In turn, a mature T-
helper cell produces a myriad of lymphokines which act on a variety of immune cells 
including granulocytes, NK cells, T suppressor, cytotoxic cells and B lymphocytes. These 
lymphokines trigger the activation of these cells in order to mount on an immune response. 
The term cytokine refers to a group of peptides which unlike hormones, do not 
originate from a specific endocrine gland but act in an autocrine, paracrine and/or endocrine 
fashion to mediate body homeostasis and immune function. Examples of cytokines include 
the interleukins (i.e. IL-1, IL-2); tumors necrosis factor (TNF-alpha, TNF-beta) and the 
Activated 
Macrophage 
Antigen 
Activated T-helper cell 
Figure 1. Mechanisms involved in cytokine production. 
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interferons (i.e IFN-alpha, IFN-beta). Cytokines are classified based on the cell type from 
which they originate. Leukocytic cytokines are cytokines produced by cells or tissues of 
the immune system and are prominent regulators of both immunologic and metabolic 
activities. Leukocytic cytokines are further subdivided into lymphokines (derived from 
lymphocytes) and monokines (derived from macrophages). Monokines tend to have 
systemic, hormone like roles, whereas lymphokines tend to act at a local level (Balkwill and 
Burke, 1989). 
Perhaps the most important function of the cytokines is to aid in the mounting of an 
immune response in the face of an antigen challenge. It is believed the IL-1 released from 
macrophages is the first cytokine produced in the cytokine cascade associated with the 
mounting of an immune response (Dinarello, 1984). IL-1, released by macrophages during 
the presentation of antigen to lymphocytes, results in B and T-cell maturation (Gillis and 
Mizel, 1981; Falkoff et al., 1983), production of bone marrows hematopoietic cells 
(Mochizuki et al., 1987), enhanced natural killer cell activity (Dempsey et al., 1982) and 
production of other cytokine (i.e. IL-2, IFN-alpha) production (Dinarello, 1984). In turn, 
the release of these cytokines further potentiates the immune response. 
In addition to their potent immunoregulatory activities, cytokines also have potent 
metabolic activities. Although the immunoregulatory activities of the cytokines are 
important in overall animal survival, their ability to regulate metabolic activities plays an 
important role determining growth characteristics (i.e. rate, efficiency, and composition of 
tissue deposition). Thus, the remaining portion of the discussion on cytokines will center 
on the metabolic activities of the cytokines. 
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Although the functional activities for different cytokines have been described, it's 
difficult to determine the molecular activities of specific cytokines because of the 
experimental methods utilized in these smdies and the similarity in function between various 
cytokines,. For example, many of the studies designed to investigate cellular events 
associated with a specific cytokine have utilized crude or partially purified preparations of 
monokines thereby making it difficult to associate specific cellular events with a particular 
cytokine. Recently three rodent cytokines, IL-1, TNF, and IL-6 have been sequenced and 
recombinantly synthesized. Because these cytokines have pronounced metabolic activities, 
the discussion of the molecular biology of cytokines will focus on these cytokines. 
There are two classes of IL-1 molecules known as IL-1 alpha and IL-1 beta, each 
encoded by a single gene. Although they have low sequence homology, both IL-1 alpha and 
IL beta are equipotent in most in-vitro assay systems (Rupp et al., 1986) and as such are 
considered to have similar activities. IL-1 is produced by a wide variety of cells of the 
leukocytic cell lineage including epithelial cells (Luger et al., 1981), chondrocytes (Le et 
al., 1987) leukocytes, (Acres et al., 1987), and natural killer cells (Lindemann et al., 1988). 
Although IL-1 is produced by a wide variety of cell types, macrophages seem to be the 
major source of IL-1 because of their ability to translocate IL-1 across their cell membranes 
(Giri et al., 1985). Secreted porcine IL-1 alpha is a 270 amino acid peptide which exhibits 
90%, 82% and 75% similarity with bovine, human and murine IL-1 alpha, respectively 
(Maliszewski et al., 1990). 
To date, receptors for porcine IL-1 alpha and IL-1 beta have not been sequenced. 
Based on porcine IL-1 alphas' homology with human and murine IL-alpha, their receptors 
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would be expected to have similar structures and function. Even though there is limited 
homology between IL-1 alpha and IL-1 beta, it seems that their receptors are identical based 
on their ability to completely block the binding of each other (Chin et al., 1987). The IL-1 
receptor seems to be 557 amino acids in length with 3 extracellular domains which have 
significant homology with the immunoglobulin super family (Sims et al., 1988). The 
cytosolic portion does not seem to have serine or tyrosine kinase activity. The IL-1 receptor 
(IL-IR) seems to be found on most cell types and IL-1 bound to IL-IR seems to be 
internalized (Mizel et al., 1987). Bound IL-1 seems to become associated with the cell 
nucleus and this binding may be important in the transcription of IL-1 regulated genes 
(Mizel et al., 1987). 
The mode of signal transduction by IL-1 is less well understood, but IL-1 does not 
seem to increase either kinase or adenylate cyclase activity. IL-1 release does increase the 
transcription of cycloxygenase and in mm increase the activity of phospholipase A, and the 
production of prostaglandin E; (Dinarello, 1988). 
There are two classes of TNF molecules, TNF-alpha and TNF-beta, each encoded 
by a single gene. They have 30% sequence homology and it seems that TNF alpha acts in 
a hormone-like manner, whereas TNF-beta tends to have autocrine effects. TNF-alpha is 
produced mostly by macrophages, but is also produced by other cells including B and T 
lymphocytes (Perez et al., 1990). TNF-beta is a product of activated T cells. 
Human TNF is a 233 amino acid peptide which is proteolytically cleaved to a 17,000 
dalton active form (Perez et al., 1990.) To date, porcine TNF has not been sequenced. 
TNF and IL-1 are similar in both physical properties and function. 
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There are two TNF receptors and each are composed of a hydrophobic signal peptide 
with an extracellular domain that has sequence homology with the CD^,, receptor family 
(Howard et al., 1991). TNF binds with equal affinity to either receptor and maximal cellular 
responses occur when less than 10% of the total receptor is occupied. The receptors are 
found on a variety of metabolically important tissues including adipose, liver and muscle, 
(Tracey and Cerami, 1993). The manner whereby TNF elicits its cellular effects is not 
clear. It does seem that TNF can alter gene expression (Andrews et al., 1990) and induce 
tyrosine and serine kinases (Hohmann et al., 1990.) 
IL-6 is synthesized by stimulated T-cells. IL-6 has a molecular weight of 26,000 
daltons and has little sequence homology with IL-1 or TNF (Klasing, 1988). IL-6 release 
seems to be mediated by TNF and IL-1 release (Tosato and Jones, 1990). Little information 
is available on signal transduction mechanisms of IL-6, but it does seem that IL-6 inhibits 
cAMP production (Rasmussen et al., 1991). To date, pig IL-6 or pig IL-6 receptor 
sequences have not been determined. 
Impact of Cytokines on Metabolic Processes 
Body temperature regulation and food intake 
The febrile response and anorexia are two classical symptoms of sickness behavior 
associated with the immune response. Both responses have potential deleterious effects on 
animal growth but aid in mounting a immune response. 
Increased body temperature is associated with typical sickness behavior. In order 
to better understand the mechanisms whereby cytokines increase body temperature, it is 
necessary to understand the various physiological states of body temperature. Snell and 
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Atkins (1968) suggested the following physiological states of body temperature; 1) 
Normothermia - where body temperature set point and actual body temperature coincide; 
2) Hypothermia - where set point may or may not be normal but body temperature is below 
set point; 3) Hyperthermia - where set point may or may not be normal but temperature is 
above set point due to disease or environmental temperature; and 4) Febrile - were body 
set point is raised. 
Cytokines contribute to both hyperthermic and febrile states. Cytokines induce 
hyperthermia by increasing metabolic activities (i.e. liver protein synthesis, protein 
degradation) in the body. Cytokines also induce the febrile response by acting on the 
neuroendocrine system. Cytokines (i.e. IL-1, IL-6) have been demonstrated to act on 
circumventricular areas of the brain to cause the production of prostaglandins (PGE) from 
the series (PGEj) via the metabolism of arachidonic acid (Hashimato et al., 1988). PGR 
then diffuses into the preoptic and anterior areas of the hypothalamus (Crestani, 1991). 
PGE^ induces fever by decreasing the firing rate of warm sensitive neurons (Shibata and 
Blatteis, 1988). The animal responds by increasing body temperature to maintain its level 
of neuronal activity. This proposed mechanism is supported by evidence that indomethacin 
injection either intraperitoneally or intracentroventrically inhibits this response in birds 
(Johnson et al., 1993) and in pigs (Johnson and von Borrell, 1994). Indomethacin blocks 
PGE2 production from arachidonic acid by inhibiting cyclooxygenase activity. 
Fever is metabolically expensive to the animal. For every 1" C rise in body 
temperarnre, resting energy expenditure is increased by 10 - 18% (Beisel, 1977). Why 
would the body respond in an metabolically inefficient manner? It seems that an increase 
37 
in body temperature benefits the immune system by aiding in the immune response. 
Specifically, increased body temperature: 1) enhances macrophage migration and lysis 
activity (Nahas et al., 1991); 2) increases anti-viral and anti-tumor activity of interferons 
(Yerushalmi et al., 1982); 3) increases T-cell proliferation (Gupta and Agarwal, 1980); and 
4) has a synergistic effect with reduced serum Fe in retarding bacterial growth (Kluger and 
Rothenburg, 1979). 
Anorexia is another classical sickness behavior and it also seems to be mediated by 
cytokines. Intraperitoneal (IP) injections of recombinant IL-1 reduces feed intake by 40% 
in rats for a period of 6 days (Mrosovsky et al., 1989). The mechanisms associated with 
the decrease in feed intake have been demonstrated to be: 1) corticotropin releasing hormone 
(CRH) mediated, 2) IL-8 mediated and, 3) colecystokinin (CCK) mediated. 
IL-1 and IL-6 injected IP induce CRH release in rodents (Navarra et al., 1991). The 
mechanism associated with CRH release via IL-1 or IL-6 administration is believed to be 
PGE mediated via the ability of IL-1 and IL-6 to stimulate arachidonic acid metabolism 
(Katsuura et al., 1990). CRH release (Navarra et al., 1991) and anorexia associated with 
LPS injection (Johnson et al., 1993) are blocked with pretreatment with indomethacin. 
adding support to this proposed mechanism. In turn CRH, injections into the hypothalamus 
have been demonstrated to induce anorexia in pigs (Parrot, 1990). 
IL-1 and IL-6 also may induce anorexia by inducing the production of other 
cytokines within the brain. IL-1 has been demonstrated to induce IL-8 synthesis (Baggiolini 
and Lewis, 1992). IL-8 injections into the hypothalamus have in mm induce anorexia by 
direct action on the lateral hypothalamus (Plata-Salaman and Borkoski, 1993). IL-8 does 
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not appear to mediate its effects via PGE's as pretreatment with indomethacin does not 
block its effect. 
In addition to PGE and IL-8 effects, IL-1 may induce anorexia by inducing CCK 
release. CCK is a peptide which reduces feed intake and gastric emptying in rats (Della-
Ferra, 1990), through CCK receptor stimulation of centers in the brain which control 
feeding behavior via action on the vagus nerve (Crawley et al., 1984). Intraperitoneal 
injection of IL-1 results in decreased feed intake and increased CCK levels in rodents (Duan 
and McCarthy, 1993). Pretreatment with L364 (a CCK antagonist) blocks approximately 
40% of the total decrease, indicating that at least a portion of the anorexia associated with 
IL-1 release is due to increased CCK release (Duan and McCarthy, 1993). 
Again, it seems paradoxical that animals would decrease feed intake at a time when 
the metabolic rate is increasing. The decrease in feed intake seems to aid in the immune 
response by decreasing nutrients available for bacterial growth. Also, this anorexia may be 
associated with an attempt by the body to shift body priorities away from growth and toward 
support of the immune system. 
Endocrine regulation of growth processes 
Animal growth is controlled by a myriad of factors. The growth of an animal is 
regulated by interactions between its potential for growth (determined by genetic potential 
and development stage), functional demands placed upon it, and the availability of nutrients. 
Therefore, as the impact of cytokines on the endocrine system is discussed, both the 
mechanistic role of hormones on growth (i.e. a single hormones influences on protein 
synthesis or degradation) and the interactive effects of hormonal influences will be 
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evaluated. In the following sections the mechanistic view of hormonal regulation, potential 
cytokine influences, and the interactive effects of hormonal and cytokine influences on 
growth processes are discussed. 
Somatotropin Somatotropin (ST) and growth hormone (GH) are synonyms for a 22 K Da 
polypeptide synthesized and secreted by the anterior pimitary gland. Plasma ST levels are 
positively correlated with increased lean tissue growth in pigs (Arbona et al., 1988), cattle 
(Grigsby and Trenkle, 1986) and poultry (Williams and Leelereg., 1986). Exogenous 
administration of ST increases protein accretion and decrease lipid accretion in pigs 
(Campbell et al., 1988b). ST release from the anterior pituitary is controlled by 
somatotropin releasing factor (SRF) and somatostatin (SMT). SRF is a 44 amino acid 
peptide released by the hypothalamus which increases ST release (Rivier et al., 1982). 
SMT is a 14 amino acid peptide released by the hypothalamus which inhibits ST release 
(Brazeau et al., 1974). SMT also inhibits the secretion of thyroid stimulating hormone 
(TSH) (Vale et al., 1974), insulin, and glucagon (Koerker et al., 1974). 
ST mediates its effect through a tyrosine-kinase receptor belonging to the ST-
prolactin (Pro) family (Carter-Su et al., 1989). Receptors for ST have been found in liver, 
heart, kidney, intestine lung, skeletal muscle, and pancreas tissues (Gluckman and Breier, 
1989). 
Cytokines have been demonstrated to directly and indirectly influence ST secretion. 
Administration of IL-1 has been demonstrated to increase SMT release and decrease ST 
release in-vitro (Hanegger et al., 1991). Cytokines also may indirectly reduce ST release 
by their actions on the thymus. Cytokines (IL-1, IL-6) increase corticotropin releasing 
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hormone (CRH) from the hypothalamus (Navarra et al., 1991) which in turn increases 
ACTH release from the pituitary. Elevated ACTH levels result in increased glucocorticoid 
release from the adrenal glands and induce thymus atrophy (Kelly, 1988). It has been 
demonstrated that pathogen infected pigs have lighter thymus gland weight indicative of 
thymus atrophy compared with pigs derived from specific pathogen free herds (Harris et al., 
1990). Decreased thymic function would potentially influence ST release because hormones 
produced in the thymus influence hormone release by the hypothalamus. Specifically, 
thymosin alpha-1 decreases SMT release from the hypothalamus (Milenkovic et al., 1992) 
and thymosin fraction 5 increases SRF release from the hypothalamus (Badamchian et al., 
1991). The net effect of increased thymus function would then appear to be an increase in 
ST release, whereas thymus atrophy would potentially decrease ST release. 
Chronic immune system activation influences ST release in humans and pigs 
(Farthing et al., 1981; Ghoshal et al.,1991). Children with inflammatory bowel disease 
have impaired ST release compared with normal children (Farthing et al., 1981). Pigs 
infected with atrophic rhinitis have temporal decreases in ST release and impaired growth 
rates compared with specific-pathogen free (SPF) pigs (Ghoshal et al., 1991). Thus, 
because of the influence of ST on lean growth processes and the deleterious influence of 
cytokines on ST release it could be hypothesized that cytokine release, or immune system 
activation, could negatively influence lean growth processes. Because ST seems to mediate 
its influences through insulin-like growth factor-1 (IGF-1) and/or IGF binding proteins 
(IGFBP), it is necessary to evaluate the potential influence of cytokines on IGF and IGFBP 
release. 
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Insulin like growth factors and insulin like growth factor bindin" proteins Insulin-like 
growth factors (IGF) I and II are 70 and 67 amino acid single chain proteins, respectively 
which are involved in mediating the effects of ST as well as directly influencing various 
aspects of lipid and protein metabolism. IGF-I and IGF-II share 70% structural homology 
with each other and 40% structural homology to insulin (Rinderknecht and Humbel. 1978). 
ST increases serum IGF-1 concentrations (Baxter, 1988). Liver is the primary site 
of IGF-1 synthesis ( > 50; Steele and Elasser, 1989), although IGF-1 can be produced in 
the kidney, heart, lung, brain, adipose, and skeletal muscle (D' Ercole et al., ^.984). Thus, 
the mechanism whereby IGF-1 elicits its local effects may be in either a paracrine or an 
autocrine fashion. Specifically, ST may act on the liver to produce IGF-1 which in turn acts 
in a paracrine fashion to elicit responses in muscle tissue. Conversely, ST (or other IGF-1 
mediators) may act in a autocrine fashion whereby it stimulates muscle cell production of 
IGF-1 which in mm acts locally to influence muscle cell metabolism. 
Although, ST is the primary determinant of circulating IGF-1 levels, both hormonal 
and nutritional factors may influence IGF-1 levels. Insulin deficiency (D' Ercole et al., 
1984) and dietary energy and protein deficiency (Elasser et al., 1989) reduce IGF-1 levels. 
IGF-1 elicits its responses in various tissues through binding to the type I IGF 
receptor. This receptor shares 84% homology with the insulin receptor and seems to show 
tyrosine kinase activity (Czech et al., 1983). 
In addition to mediating the growth promoting effects of GH, IGF-1 influences other 
aspects of metabolism. Because of its strucmral homology to insulin, the metabolic effects 
of insulin and IGF-1 are similar. Specifically, IGF-1 stimulates glucose transport and 
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glycolysis in muscle (Kaplowitz et al., 1984), stimulates amino acid uptake in muscle 
(Nishimoto et al., 1987), and stimulates protein synthesis and inhibits protein degradation 
in muscle (Parkes et al., 1986). Thus, the net effect of IGF-1 is a mitogenic effect, 
particularly in muscle. IGF-1 also influences muscle tissue by stimulating differentiation 
of satellite cells (Allen and Boxhorn, 1989). 
Insulin like growth factor binding proteins (IGFBP) influence the activity of IGF-1 
in addition to ST. Six forms of IGFBP have been characterized and their DNA's cloned 
(McCusker and Clemmons et al., 1992). IGFBP have been shown to have both stimulatory 
and inhibitory effects on IGF-1 dependent on cell type and IGFBP concentration. It is clear 
however that IGFB can alter IGF-1 activity either by changing circulating and/or tissue 
levels of IGF-1 (Drop et al., 1991). 
Cytokines alter both IGF- 1 and IGFBP levels in plasma and in specific tissues. 
TNF-alpha increases fibroblast IGFBP-3 concentrations and decrease fibroblast IGF-1 
mitogenic activity. IGF-1 levels are also depressed in pigs after parasitic infection (Prickett 
et al., 1992). Injection of rodents with LPS reduces both plasma ST and IGF-1 
concentrations and also tissue IGF-1 concentrations in the liver, skeletal muscle and the 
pituitary (Fan et al., 1994). The decrease in muscle IGF-1 levels seem to be independent 
of ST levels because although ST levels return to near normal levels within 24 hours post-
challenge, muscle IGF-1 levels remain suppressed 48 hours post-challenge (Fan et al., 
1994). The decrease in muscle IGF-1 seem to be associated with an increase in IGFBP-1 
levels. The authors also demonstrated in-vitro that TNF and IL-1 decreased muscle IGF-1 
and increase IGFBP levels. Wiseman et al. (1994) reported that pigs reared via a medicated 
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early weaning system and thus low antigenic challenge had 30 % greater IGF-1 level at 7 
weeks of age compared with conventionally weaned controls exposed to high antigenic 
stimulation. 
Based on these data, cytokines would be hypothesized to adversely influence growth, 
especially muscle tissue growth. 
Insulin, thyroid hormones and glucocorticoid hormones Produced in the pancreas, 
insulin is a hormone generally considered to have anabolic effects on protein, lipid and 
glycogen metabolism. Insulin stimulates protein synthesis by stimulating translational 
efficiency (Preedy and Garlick, 1986) and stimulates amino acid incorporation into muscle 
protein (Garlick et al., 1983). 
Interleukin-1 initially increases insulin release, but continual exposure of the islet 
cells of the pancreas to IL-1 reduces basal levels of insulin release and impairs glucose 
stimulated insulin release (Sandler et al., 1987). Furthermore, IL-1 seems to elicit a state 
of insulin resistance in muscle (Klasing and Johnstone, 1991). 
The absence of the thyroid hormones (T4: 3,5,3[,5, - tetraiodothyronine; and T,: 
3,5,3, triiodothyronine) as well as excessive levels of these hormones have detrimental 
effects on growth. Thyroid hormones act on receptors located in the cell nucleus (Apriletti 
et al., 1988). The binding of thyroid hormones to these receptors initiates the expression 
of gene products which mediate the effects of the thyroid hormones (Apriletti et al., 1988). 
Thyroid hormones are necessary for normal muscle growth as rats thyroidectomized 
al birth show reduced muscle rates compared with controls (Legrand, 1986). Thyroid 
hormones stimulate both protein synthesis (Brown and Millward, 1983) and degradation 
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(Millward et al., 1982). In hyperthyroid animals, the increase in degradation far exceeds 
the increase in synthesis thus muscle wasting occurs. 
Children infected with acute respiratory infection have lower serum levels of T, and 
higher levels of IL-6 compared with normal children (Hashimoto et al., 1994). Serum T, 
concentrations were positively correlated and serum IL-6 concentrations negatively 
correlated with height and weight gain in these children. 
Glucocorticoid hormones are produced by the adrenal glands and play an important 
role in the ability of an animal to respond to stress or injury. Glucocorticoid hormones bind 
to receptors on DNA and regulate the transcription of genes (Burnstein and Cidlowski, 
1989). Glucocorticoid hormones have a catabolic effect on muscle. Primarily, 
glucocorticoids decrease protein synthesis by decreasing the number of ribosomes 
transcribing RNA (Millward et al., 1985). Glucocorticoid hormones also have a catabolic 
effect on adipose tissue by initiating lipolysis (Lacesae et al., 1988). 
IL-1 and IL-6 mediate CRH release from the hypothalamus (Navarra et al., 1991). 
CRH in turn induces ACTH release from the anterior pituitary which in turn results in 
glucocorticoid release from the adrenal glands. Thus, cytokines interact with various 
hormones to result in a net catabolic effect, especially on muscle tissue. 
Skeletal muscle synthesis and degradation 
The overall net effect of cytokine release associated with an immune response seems 
to be a decrease in skeletal muscle tissue accretion. Yang et al. (1983) demonstrated that 
IL-1 administration increased nitrogen excretion in the urine by 30% and Flores et al. 
(1989) demonstrated that IL-1 and TNF induced a negative nitrogen balance, both indicating 
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a lowering of whole body protein accretion. Chronic immune challenge with sheep red 
blood cells and LPS results in a decrease in carcass moisture indicative of increased carcass 
fatness and decreased carcass muscle (Klasing et al., 1987). 
These alterations in whole body protein and skeletal muscle metabolism seem to be 
associated with a decrease in protein synthesis and an increase in protein degradation. 
Chicks infected with cicidia have decreased fractional rates of skeletal muscle protein 
synthesis compared with uninfected chicks (Symons and Jones, 1977). Newcastle disease 
and infectious bronchitis vaccination result in decreased skeletal muscle protein synthesis 
and decreased protein accretion (Hentges et al., 1984). 
Both the decrease in skeletal muscle protein synthesis and increase in skeletal muscle 
protein degradation are mediated by cytokines. The effects on degradation seem to be a 
direct effect whereas the effects on synthesis appear to be mediated via glucocorticoids. 
Incubation of skeletal muscle tissue with IL-1 results in an increase in protein degradation 
with no effect on protein synthesis (Klasing et al., 1987). This increase in protein 
degradation is most likely associated with IL-1 induced transcription of cycloxegenase and 
thus increased PGE2 production. PGE2 fuses with lysosomes to form autophagic vessels 
which degrade intracellular proteins (Goll et al., 1989). Cytokines may also mediate protein 
degradation via an increase in calcium dependent proteases through the actions of PGE2 
(Goldberg et al., 1984a). Calpain activities are increased and calpastatin activities decreased 
in response to LPS injection and these responses are inhibited with aspirin treatment, an 
inhibitor of PGE function, further indicating that cytokines mediate muscle proteases 
(Chavis et al., 1994). 
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Althougli the increase in protein degradation seems to be a direct effect of cytokines, 
decreases in protein synthesis associated with cytokine release seems to be an indirect effect. 
Both IL-1 and TNF have been demonstrated in-vitro not to influence protein synthesis 
(Klasing et al., 1987; Tracey and Cerami 1993). However, administration of crude IL-1 
preparations in-vivo results in decreased rates of translational activity as indicated by 
decreased rates of synthesis per unit of RNA (Jepson et al., 1986), decreased number of 
ribosomes translating mRNA (Klasing and Austic 1984) and decreased expression of mRNA 
for myofibrillar proteins (Pong et al., 1989). These in vivo results seem to be a result of 
IL-1 induced corticosterone release (Klasing et al., 1987). Additionally, the anabolic effect 
of insulin on skeletal muscle is abrogated by IL-1 indicating that IL-1 induces a state of 
insulin resistance in skeletal muscle (Klasing and Johnstone, 1991). Furthermore, amino 
acid uptake is reduced in muscle in response to IL-1 and TNF release (Hummel et al., 
1988). 
Cytokines also influence the ability of skeletal muscle to recruit new DNA to support 
growth. TNF blocks in vitro differentiation and fusion of human satellite cells taken from 
juvenile muscle cells (Miller et al., 1988). TNF blocks the expression of myosin heavy 
chain and alpha skeletal actin in myoblasts but not in fully differentiated myotubes. 
Further evidence for the deleterious effect of cytokines on skeletal muscle growth 
is provided by the work of (Zamir et al., 1994) with IL-IR antagonist. The authors 
demonstrated that injection of rodents with IL-1 resulted in a 50 % increase in 3-methyl 
histidine excretion, an indicator of skeletal muscle degradation. This effect was blocked 
with pretreatment IL-IR antagonist, indicating the Il-l has direct influence on inducing 
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skeletal muscle degradation. 
The influence of cytokines on protein synthetic and degradative activities seems to 
be dependent on tissue and muscle fiber type. Fractional protein synthesis and the 
efficiency of protein synthesis (mg of protein sythesized daily/mg of RNA) are decreased 
in skeletal muscle (gastrocnemius) but are increased in liver and heart in response to IL-1 
or turpentine injection (Ballmer et al., 1991). In addition to differential effects due to tissue 
type, the actions of cytokines may also be dependent on muscle fiber types. Protein 
synthesis is reduced and protein degradation increased by cytokines in muscles made up of 
predominantly fast twitch fibers but neither trait is influenced in muscles made up of slow 
twitch fibers (Vary and Kimball, 1992). 
The increase in protein synthesis in liver most likely is associated with the increased 
production of proteins associated with the acute phase response. The differential effects on 
skeletal muscle tissue fiber types are consistent with the findings of Baillie and Garlick 
(1991) who demonstrated that gastrocnemius muscle (mixed fiber type muscle) exhibited a 
loss in the efficiency of protein synthesis in response to a nutritional stress (fasting); 
whereas in soleus muscle (composed of slow twitch fibers), efficiency of protein synthesis 
was not influenced. Because pigs which are selected for increased lean growth rate have 
a greater proportion of white relative to red muscle fibers compared with fatter genetic 
strains (Rahelic and Puac, 1981), the influence of cytokines on skeletal muscle tissue are 
potentially more deleterious in leaner genetic strains of pigs. 
Lipid metabolism and adipose tissue synthesis and degradation 
Hyperlipidemia is associated with an immune response. This hyperlipidemia appears 
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to be associated with a decrease in adipocyte tissue lipase activity and thus lipopoprotein 
clearance by adipose tissue and an increase in the rate of fatty acid synthesis by the liver. 
It seems that this circulating supply of fatty acids is utilized to fuel increased liver activity 
and that cytokine stimulated adipose tissue is not capable of utilizing fatty acids for 
deposition. However, glucose utilization seems to be unaffected or even enhanced in the 
presence of cytokines and glucose. 
Both IL-1 and TNF decrease lipoprotein lipase (LPL) activity in adipose tissue (Fried 
et al., 1993). This decrease in LPL activity seems to be associated with a decrease in 
transcription of LPL and thus levels of the enzyme. No differences in LPL mRNA are seen 
in response to IL-1 of TNF (Fried et al., 1993). In contrast to adipose tissue, LPL activity 
in the liver (Semb et al., 1987) and the stomach and small intestine is increased (Argiles et 
al., 1989) due to cytokine stimulation. In addition to increase fatty acid uptake in liver, 
TNF increases fatty acid synthesis by increasing hepatic levels of citrate which in turn 
results in an increase in acetyl-coenzyme A carboxylase and fatty acid synthetase (Feingold 
et al., 1989). This increase in fatty acid uptake and fatty acid synthesis results in the 
increase in the accumulation of lipid in the liver of rodents treated with IL-1 (Feingold et 
al., 1989). 
Studies on adipose tissue metabolism in response to cytokines yield conflicting 
results. Early studies with crude monokine preparations in rodents indicated that fatty acid 
synthesis was decreased via inhibition of acetyl-coA carboxylase and fatty acid synthetase 
(Pekala et al., 1983) and lipolysis was increased due to an increase in hormone sensitive 
lipase activity (Patton et al., 1986). However more recent studies with recombinantly 
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produced cytokines have not consistently substantiated these findings. 
In two studies, IL-1 had no influence on fatty acid synthesis (Argiles et al., 1989; 
Price et al, 1986). LPS has actually increased lipogenesis in isolated adipocytes 
(Butterwirth and Griffith, 1989). In order to more accurately assess the influence of an 
immune response and thus cytokines on adipose tissue metabolism, it is necessary to assess 
changes over extended periods of times in animals subjected to a chronic immune challenge. 
Rats injected with TNF alpha for a period of 8 days have 38% more body fat than pair-fed 
controls indicating that cytokines may acmally increase lipid accumulation (Tracey et al., 
1988). This hypothesis is supported by evidence that IL-I actually enhances glucose 
transport into adipose cells (Welsh et al., 1990), thereby increasing substrate available for 
lipogenesis. 
Bone growth and resorption 
The influence of cytokines on bone growth in vitro seems to be catabolic; however 
few studies are present on the in vivo effect of immune system activation on bone growth. 
The mechanisms whereby cytokines deleteriously influence bone growth are: 1) mediated 
through alterations in hormone concentrations, 2) mediated through alterations in PGE 
levels, and 3) direct effect on bone tissue. Because both ST and IGF-1 stimulate bone 
growth and cytokines decrease the concentrations of these hormones, it could be inferred 
that these alterations would negatively influence bone growth. However, little evidence 
supports this mechanistic view directly and the focus of this discussion will be on PGE 
mediated alterations. 
As discussed in previous sections, PGE^ production is stimulated by cytokine action 
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on the enzyme cycloxygenase via its action on arachidonic acid. PGE2 increases cartilage 
growth by stimulating chondrocyte proliferation and bone resorption by stimulating 
osteoclast proliferation (O'Keefe et al., 1992). Evidence for direct cytokine action on bone 
consists of a Pasteurella multocida induced bone resorption in vitro (Felix et al., 1992) and 
IL-1 induced bone resorption in-vitro (Konig et al., 1988). The mechanism whereby IL-1 
stimulates bone resorption is through an increase in osteoclast number (Garret and Mundy, 
1989) and an up regulation in the expression of integrin subunits necessary for osteoclastic 
attachment to the bone matrix (Dedhar, 1991). IL-1 also decreases osteoblast proliferation 
(Ohmori et al., 1988). The net effect seems to be a net increase in bone resorption as Ca 
and alkaline phosphatase levels are increased in response to II-1 injection (Cochrin and 
Abernathy, 1988). 
Thus, in vitro, it would seem that long bone growth is decreased in response to 
cytokines; however little in vivo evidence is available. Children with leukemia have a 
reduction in long bone growth compared with normal children (Shinohara et al., 1991) 
although nutritional factors and chemotherapy confounds these results. It has yet to be 
demonstrated the net effect of chronic immune system activation on long bone growth or 
long bone characteristics (i.e. bone strength, density etc.). Moreover, it has yet to be 
elucidated if low levels of cytokines may alter bone growth, because it does seem that 
minimal amounts of IL-1 are required for normal osteoblast function (Rath et al., 1988). 
Liver protein and lipid synthesis 
In contrast to the catabolic influence of cytokines on muscle and bone tissue, 
cytokines have an anabolic effect on liver tissue. This anabolic effect results in an increase 
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in the production of both proteins and fatty acids which aid in support of the immune 
system. 
Cytokine (IL-1 and TNF) injections increase hepatic triglyceride synthesis iri rodents 
(Feingold and Grunfeld, 1986) and the secretion of these triglycerides contributes to the 
hyperlipidemia associated with the acute phase response (Feingold and GrunfelJ, 1986). 
This rise in triglyceride synthesis is due to an increase in the hepatic levels of citrate which 
is an allosteric activator of the rate limiting enzyme acetyl-coenzyme A carboxy lase and a 
decrease in the allosteric inhibitor fatty acid acyl-COA (Feingold et al., 1989"/. It seems 
that the fatty acids are utilized to fuel specific metabolic processes because the rate of LPL 
activity during an immune challenge is either enhanced, unaffected, or reduc(;d dependent 
upon tissue type. LPL activity is increased in the liver (Semb et al., 1987).. stomach and 
small intestine (Argiles et al., 1989) unaffected in the heart, lung or kidney , (Semb et al., 
1987) and decreased in adipose tissue (Fried et al, 1993) muscle, and r.iammary gland 
(Argiles et al., 1989). These data indicate that cytokines decrease the ut ilization of fatty 
acids not involved in essential processes (i.e. maintenance vs. growth pn icesses). 
In addition to altering lipid metabolism in the liver, cytokines alte ,• protein synthetic 
activity. IL-1, IL-6, and TNF have been demonstrated to increase the fractional rates of 
protein synthesis in the liver (Ballmer et al., 1993; Geiger et al., 198 S; and Klasing and 
Austic, 1984). The responses can also be mediated by LPS and turp entine (Klasing and 
Austic, 1984; Ballmer et al., 1993). The net effect of the enhanced p irotein synthesis is a 
net increase in hepatic protein accretion and an increase in hepatic pr otein release into the 
circulation (Geiger et al., 1988). The proteins released by the liver a re involved in a wide 
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variety of functions during an immune response and tlie functions are discussed in the 
following sections. 
Acute phase protein is a term given to a class of proteins which are produced by the 
liver in response to an immune challenge. Their release seems to be induced by various 
cytokines. There are several major acute phase proteins that have been investigated. The 
following sections discuss the general characteristics, half-life and proposed functions of 
these proteins. 
C-reactive protein (CRP) CRP is a protein comprised of five identical subunits with a 
molecular weight of 21,000 daltons (Liu et al., 1982). Approximately 10 % of the protein 
is comprised of sulfur amino acids (Liu et al., 1982). The function of CRP hasn't been 
completely elucidated, but CRP is involved in complement by binding to various ligand 
(Berman et al, 1986) and CRP enhances phagocytosis and lysis ability of macrophages 
(Mold et al., 1982). In pigs, normal serum concentrations are approximately 9.0 mg/L 
(Buerger et al., 1992) but levels as high as 120 mg/L in pigs injected with turpentine and 
60 to 87 mg/L in febrile animals have been reported (Burger et al., 1992). In rodents, the 
half-life of CRP appears is 3 to 7 days (Cheladurai et al., 1983) but in pigs elevated 
concentrations remain for approximately 6 days post turpentine injection (Buerger et al., 
1992). 
Serum Amyloid P-Component (SAP) This acute phase protein is similar in size and 
structure to CRP (Baltz et al., 1982). SAP is produced by hepatocyte and IL-1 is a 
mediator of synthesis (Le and Mortensen, 1986). SAP functions in enhancing bactericidal 
activity of macrophages and complement mediated phagocytosis (Wright et al., 1983). 
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Normal serum concentrations have not been established in pigs, however values of 20-30 
ug/ml are seen in mice (Mortensen et al., 1983). These levels increase to 170-200 ug/ml 
in response to endotoxin and there seems to be genetic strain and/or age effects (Mortenson 
et al., 1983). 
Serum Amvloid A (SAA) SAA is a single polypeptide chain with a molecular weight of 
approximately 12,000 daltons (Benditt et al., 1982). SAA is produced by the liver and 
shows a dose dependent increase in response to IL-1 injections (Ramadori et al., 1985). 
The function of SAA has not been elucidated; however, in mice serum concentrations 
increase from normal values of 40 ug/ml to 4000 ug/ml in response to E. coli challenge 
(McAdamand and Sipe, 1976). Initial studies with pigs have shown it not to be a significant 
acute phase protein (Gruys et al., 1994); however, SAA is elevated in horses during 
inflammatory disease (Pepys et al., 1989) and in cattle in response to endotoxin or shipping 
fever (Horadagoda et al., 1993). 
Alpha 2 Macroglobulin (MAC) MAC is a glycoprotein comprised of 10 % carbohydrate 
with a MW of 100,000 daltons (Gauthier and Mouray, 1976). MAC is produced by the 
liver and IL-1 induces its release (Mauer et al., 1985). It functions to bind serum proteases 
and plays a role in inhibiting the activity of these proteases (Barrett and Starkey, 1973). 
Normal levels in rodents are approximately 50 mg/ml, but higher concentrations are found 
in fetal and pregnant rats (Van Gool et al., 1978). Levels increase by as much as 10 times 
normal levels within 40 hours post challenge and levels decrease in 7 to 8 days after 
stimulus is removed (Van Gool et al., 1978). 
Alpha-1 Antitrypsin (AAT) AAT is a single polypeptide glycoprotein similar in structure 
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to MAC with a large carbohydrate component (Mega et al., 1980). Synthesis of this protein 
is induced by TNF (Carlson and Stenflo, 1982). AAT functions to inhibit serine protease 
activity. Normal concentrations in pig serum are approximately .14 mg/ml and levels 
increase to .42 mg/ml in response to turpentine injection (Lampreave et al., 1994). Levels 
remain elevated in pigs for approximately 10 days post challenge (Lampreave et al., 1994) 
and a half life of 6 days has been demonstrated in humans (Carrell et al., 1982). 
Alpha-1 Acid Glvcoprotein (AGP) AGP is a glycoprotein with a MW of approximately 
400,000 daltons (Schmidt et al., 1975). AGP is comprised of approximately 45 % 
carbohydrate (Schmidt et al., 1975). AGP is synthesized by the liver (Courtoy et al., 1981) 
and elevated serum concentrations are seen in response to IL-1 injection (Woloski et al., 
1985). The increase in synthesis is associated with an increase in mRNA due to increased 
gene transcription (Birch and Schreiber. 1986). Normal concentrations range from 400 to 
1000 ug/ml in pigs with normal concentrations being higher at weaning (1000 ug/ml; 28 d 
of age) and lower at market weight (400 ug/ml, 160 d of age; Itoh et al., 1992). In 
response to turpentine injections, serum concentrations of AGP increase from 400 ug/ml up 
to 800 ug/ml in 4 days and 1000 ug/ml in 10 days (Lampreave et al., 1994). Specific 
Pathogen Free pigs have 3 fold (500 vs 1500 ug/ml) lower levels of AGP compared with 
pigs infected with actinobacillus pleuropneumonia and atrophic rhinitis (Itoh et al., 1992). 
Serum half-life of AGP has been demonstrated to be 5.5 days in humans; however, in pigs 
elevated concentrations remain 10 d post challenge (Lampreave et al., 1994). The function 
of AGP has not been clearly elucidated but AGP does seem to aid in the inflammatory 
response by binding platelet activating factor and may play a role in mediating its activity 
(McNamara et al.. 1986). 
Ceuroplasmin Ceuroplasmin is a glycoprotein consisting of 8 to 9 % carbohydrate with 
a MW of 135,000 daltons and binding 6 atoms of Cu per molecule (Poulik and Weiss, 
1975). Ceuroplasmin is produced by the liver where it incorporates Cu. IL-1 induces 
ceuroplasmin release (Barber and Cousins, 1988). Thus, IL-1 controls the coordinated rise 
in serum Cu associated with the acute phase response. Serum Cu has been reported to 
potentiate the immune response by increasing antibody formation and macrophage activation 
(Kojima et al., 1986). Normal ranges for ceuroplasmin are 20 mg/dl in sheep (Pfeffer et 
al., 1993) and 30 mg/dl in humans (Cox, 1966). Sheep challenged with yeast injection 
show three fold increases in ceuroplasmin with 3 days post challenge and levels stay 
elevated for 65 days although body weight gain and feed intake reuirn to normal within 15 
to 20 days post challenge (Pfeffer et al., 1993). 
Fibrinogen (FB) FB is a component of compliment and is classified as an acute phase 
protein because it increases in concentration in response to inflammation. FB is synthesized 
by the liver and IL-1, endotoxin (Kampschmidt et al., 1982) and glucocortiocoids have been 
demonstrated to stimulate its release (Jeejeebhoy et al., 1972). The main function of 
fibrinogen is to provide substrate for production of fibrinogen. In sheep challenged with 
yeast, serum FB levels increase from 2 mg/ml to 10 mg/ml and levels stay elevated for 25 
days (Pfeffer et al., 1993). 
Haptoglobulin (HP) HP is an acute phase protein which increases in serum in response to 
an inflammatory challenge in pigs (Lampreave et al., 1994) and sheep (Pfeffer et al., 1993). 
The function of haptoglobulin has not been elucidated. In pigs, turpentine challenge elevates 
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normal serum concentrations from 2 to 6 mg/ml within 48 hours post-challenge with levels 
returning to normal levels within 6 days (Lampreave et al. 1994). Sheep show a four-fold 
increase in serum HP within 2 days post-challenge and levels decrease to normal levels 
within 30 days post-challenge (Pfeffer et al., 1993). 
Metallothionein Metallothionein synthesis is increased by the liver in response to IL-1 
injections in vitro (Klasing, 1984). IL-1 seems to directly influence metallothionein gene 
expression in liver cells (Karin et al., 1985). Metallothionein binds 7 g atoms of Zn per 
mol and draws Zn away from circulating pools and sequesters it in the liver. 
Lactoferrin and Transferrin IL-1 and TNF stimulate the release of lactoferrin from 
granulocytes, inducing hypoferremia (Goldblum et al., 1987). Lactoferrin removes Fe from 
transferrin and the Fe-lactoferrin is recognized by a hepatocyte receptor and internalized. 
This sequesters Fe in the liver and may slow the proliferation of Fe-requiring bacteria and 
protozoa. Additionally, serum transferrin levels are decreased in pigs in response to 
turpentine injection (Lampreave et al., 1994), thus adding to the IL-1 induced hypoferremia. 
Thus, there are several proteins associated with the acute phase response and these proteins 
play a wide variety of roles in aiding in the immune response. 
Nutrient Needs of the Immune System (Energy and Protein) 
In contrast to energy and protein requirements for specific rates of tissue growth, 
specific requirements of energy and protein for immune function have not been established. 
Part of the difficulty in determining specific nutrient requirements for immune function is 
the lack of the establishment of key response criteria. For example, in the case of humoral 
immunity, immune responses are measured by specific titers to antibodies or circulating 
57 
levels of specific classes of immunoglobulins (i.e. IgG, IgA, IgM). However, if the 
nutritional treatments influence blood volume or turnover of immunoglobins in the blood, 
then assessment of humoral competence is difficult to assess. Moreover, extremely low 
levels of IgG are required before immune response is compromised (Kelly and Easter, 1987) 
indicating that high levels of specific antibodies or increased specificity of antibodies do not 
necessarily correlate closely with an animal's ability to maintain homeostasis following an 
antigen challenge. 
As reviewed by Chandra (1992), severe and prolonged energy and protein 
malnutrition results in decreased immune responsiveness in humans, as children with 
protein-energy malnourishment have reduced lymphocyte number and mitogenic response, 
decreased humoral response, and decreased bactericidal capacity of neutrophils. Smythe et 
al (1971) reported increased thymus atrophy and decreased lymphocyte numbers in children 
with Kwashikor. Sheffy and Williams (1982) reponed that severity of impairment of 
immunological responses parallels severity of protein or calorie restriction in children. 
Protein restriction seems to decrease cytokine (IL-1) levels in human (Bell and Hoffman -
Goeitz, 1983) and rats (Bradley and Kauffman, 1988). Also, there is decreased acute phase 
protein synthesis associated with IL-1 injection in protein deficient rabbits (Bell and 
Hoffman - Goeitz, 1983). Energy restriction does not influence IL-1 production in humans 
(Bell and Hoffman - Goeitz, 1983). It is important to note that in the studies mentioned, 
there were severe energy and protein deficiencies accompanied by weight loss or severely 
retarded growth over a period of years as in children with PEM or Kwashikar. 
Under normal production conditions in which pigs are reared, it is not likely th it 
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either protein or energy would be limiting for normal immune function. In fact, severe 
protein restriction for extended periods of time does not impair immune function. Feeding 
of a 9% crude protein diet during gestation does not influence the ability of the newborn pig 
to synthesize antibodies nor does it influence pig serum levels of IgG, IgA, or IgM derived 
from sow colostrum compared with the feeding of an 18% crude protein diet (Haye et al., 
1981). Severe protein restriction does not impair immune function in young (4 week old) 
growing pigs as pigs fed a diet deficient in protein for a period of 5 weeks had significant 
quantities of IgG at the end of the feeding period (McGilliuary, 1967). 
Interaction Between Immune System Activation and Amino Acid 
Needs for Growing Pigs 
As discussed in the previous sections, activation of the immune system results in 
metabolic alterations which potentially reduce growth processes, especially muscle 
deposition, in pigs and in turn potentially influences nutrient needs for support of tissue 
growth. Acute activation of the immune system via lipopolysaccharide (LPS) challenge 
decreases growth rate, efficiency of feed utilization, and lysine and methionine requirements 
in growing chicks (Klasing and Barnes, 1988). Similar responses have been demonstrated 
for growth and the efficiency of feed utilization in pigs but not for alterations in protein 
requirements (Van Heugten et al., 1994). 
Although these relationships have been reported in short term non-pathogenic 
models, it is difficult to extrapolate the data to field situations. In modern production 
systems, activation of the immune system is more prolonged and chronic in nature due to 
pathogenic antigen exposure. Also, it is difficult to compare a non-pathogenic model such 
as LPS injection with pathogenic antigens commonly present in swine herds. It may be 
more appropriate to characterize immune system activation in field situations as a series of 
continual antigenic challenges resulting in a chronic activation of the immune system. This 
chronic activation of the immune system would alter metabolism in a manner which skeletal 
muscle accretion would be chronically lowered resulting in alterations of amino acids needs. 
Table 3 is an example of how lysine needs may be altered in two situations where the level 
of chronic immune system activation is either low or high. The estimated reductions in 
body growth and feed intake in high IS pigs are based on results demonstrated in pigs due 
to acute LPS administration (Van Heugten et al., 1994). The hypothesized depressions in 
body protein and fat accretion in high IS pigs are based on in vitro changes in skeletal 
muscle synthesis and degradation and in vivo changes in body composition seen in chicks 
injected with IL-1 (Klasing and Austic, 1984a; Klasing and Barnes, 1988). Both lysine 
needs for maintenance (Reeds et al., 1994) and the efficiency of lysine utilization for muscle 
tissue accretion (Klasing and Barnes, 1988) are assumed to be unaffected by IS activation. 
The digestibility of dietary lysine is assumed to be greater in low IS pigs based on results 
from digestibility studies with germ-free and conventionally reared chicks (Furuse et al., 
1991). From the table, it can be hypothesized that dietary lysine needs both in terms of 
intake and grams/day will be decreased during activation of the immune system. 
In addition to the fact that the quantity of dietary lysine needed to optimize pig 
growth may be altered due to immune system activation, the ideal dietary profile of amino 
acids relative to lysine may also be altered. As discussed in previous sections, sulfur amino 
acids needs relative to lysine may be increased due to increased acute phase protein 
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Table 3. Estimated Dietary Needs of Pigs with Low or High Levels of Immune System 
Activation 
IS Activation 
Item Low High 
Mean body weight (kg) 35 35 
Nutrient accretion (g/d) 
Protein 
Fat 
Ash 
180 
150 
32 
100 
110 
16 
Daily lysine needs'* 
Maintenance (.042g/kg^^)'' 
Growth (6.8 % of body protein) 
.60 
12.24 
.60 
6.80 
Biological lysine needs (g) 
Utilization of digestible lysine" .70 .70 
Digestible lysine (g) 
Digestibility of dietary lysine'* 
18.30 
.84 
0.60 
.82 
Dietary lysine (g) 21.7 12.9 
Estimated feed intake"-" 
Lysine needed (% of diet) 
1.76 
1.23 
1.55 
.83 
^Assumptions: Barrows with a medium to high genetic capacity for lean tissue growth 
housed in a warm thermal environment, and are allowed to consume a fortified, corn 
soybean meal diet ad-libitum. Assumptions for maintenance needs for lysine, utilization of 
lysine, and lysine in protein are based on relationships discussed previously 
•Tvlaintenance needs for lysine not assumed to be altered for increased acute phase proteins 
(Reeds et al., 1994) 
•^Utilization of lysine assumed not to be altered due to IS activation (Klasing and Barnes, 
1988) 
''Digestibility of lysine assumed to be increased in pigs with a low level of IS activation 
based on comparison of germ-free and conventionally reared chicks (Furuse et al., 1991) 
'^Estimate of feed intake, kg/d = 112 g/kg BW^^/d for pig with a low IS status (ARC, 
1981). High IS pigs assumed a 12% lower food intake (Klasing, 1987). 
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synthesis (Reeds et al., 1994), lower feed intalce relative to maintenance (Wang and Fuller, 
1990) and increased lymphocyte activity (Tsiagbe et al., 1987b). 
Methods to Assess Immune System Status 
As discussed in the previous section, alterations in immune system activity 
potentially alters muscle growth and in turn nutrient needs in pigs. As such, in order for 
nutritionist to more adequately formulate diets, it becomes necessary to assess level of 
immune system activity in pigs. In contrast to more traditional approaches of assessing 
immune function (i.e. T or B lymphocyte function in response to specific mitogens) per se, 
it is more important to determine what level of activity the immune system is functioning 
at in order to assess what influence it has on metabolic functions. 
Cluster of determination antigens 
Cluster of determination (CD) antigens are membrane associated molecules which 
are utilized to distinguish different lineages or maturational stages of lymphocytes via the 
use of monoclonal antibodies specific for the molecule (Pescovitz et al., 1984). Although 
the CD nomenclamre was originally developed for humans, monoclonal antibodies and 
similar nomenclamre has been adopted for pigs. 
Two CD antigens which potentially serve a role as indicators of immune system 
activity in pigs are CD4 and CDS. CD4 antigens are found on T-lymphocytes which 
recognize antigen in association with class-II MHC molecules and these cells are referred 
to as T-helper cells (Matis, 1990). CDS antigens are found on T lymphocytes which 
recognize class-I MHC molecules and they are involved in tolerance in mice and in the 
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release of immunosuppressive factors (Batchelor et al., 1989). Therefore, these are referred 
to as T-cytotoxic,suppressor cells (Matis. 1990). T-helper cells are activated by various 
immune cells in association with foreign antigens and once activated release cytokines which 
potentiate both cellular and humoral immunity (Tonegawa, 1985). T-helper cells are also 
involved in mediating antibody production by B-cells (Marrack and Kapler, 1986). In 
contrast, T-cytotoxic,suppressor cells do not release cytokines, are activated by cytokines 
released from T-helper cells, and play a role in elimination of non-self cells (Marrack and 
Kappler, 1986). Thus, because of their differential functions, differences in the absolute 
percentages and/or relative percentages of CD4 and CD8 positive lymphocytes could serve 
as an indicator of level of immune system activity. 
Differing percentages of CD4 to CDS positive lymphocytes have been reported in 
the literamre for pigs. Reported CD4:CD8 ratios in peripheral blood range from .19 
(Becker and Misfeldt, 1993) to .60 (Pescovitz et al., 1985) to 1.2 (Jonjic et al, 1987). It 
is difficult to interpret these data because little emphasis was placed on the description of 
the condition in which the animals were reared. Also, differences in percentages of 
identified surface antigens will vary among genetically different animals, antibodies used, 
and analytical techniques utilized to seperate lymphocytes (Becker and Misfeldt, 1993). The 
ratios reported are unique to pigs as ratios reported are unique to pigs as humans have 
normal ratios of approximately 2.0 (Pescovitz et al., 1984). 
Various immunological and physiological factors may potentially influence the 
proportion of these cell types and the relative ratios of the two surface cell antigens. 
Infection of sheep with blue tongue virus and infection of chicks with coccidiosis has been 
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demonstrated to increase CD4 positive lymphocytes and lymphocyte CD4:CD8 ratio 
(Barratt-Boyes et al., 1992; Lillehoj, 1994). Thyroidectomized chicks have higher levels 
of CD4 positive lymphocytes and CD4:CD8 ratios than sham operated controls (Johnson et 
al., 1993). These responses are inhibited with Tj treatment and are postulated to be due to 
depressed thymic hormone release. Because children with chronic respiratory infection have 
lower serum levels of Tj compared with normal children and thymic function is impaired 
due to chronic activation of the immune system (Kelly, 1988), increased CD4 positive cells 
and increased CD4;CD8 ratios may be associated with chronic infection in animals. 
Additionally, stress has been implicated to increase CD4:CD8 ratios in animals. Dairy 
cattle have higher CD4:CD8 ratios during early lactation (1.81) than during late lactation 
(1.18) (Park et al., 1992). Also pigs subjected to shipping stress demonstrated a trend 
toward higher CD4:CD8 ratios than non-stressed pigs (McGlone et al., 1993). 
Acute Phase Proteins 
As discussed in previous sections, acute phase proteins (ACP) are a group of mainly 
glycoproteins whose hepatic production is increased in response to cytokine release. Acute 
phase proteins serve many roles in the body but mostly function to potentiate the immune 
response via altering mineral metabolism, promoting immunoglobulin production, and tissue 
repair. Thus, ACP could possibly serve as reliable indicators of level of immune system 
activity. The "ideal" ACP as a monitor of an animals level of IS activation would fit the 
following response criteria: 1) negligible basal values or basal values that are largely 
independent of animal age or genetic makeup; 2) increases to very high values in response 
to mediators which induce cytokine production; 3) the level of response is quantitatively 
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associated with shifts in tissue accretion mediated by cytokine release; 4) values decrease 
quickly if stimulation of the immune system is removed; and 5) a secondary infection should 
result in an increase in the values of the ACP. 
Several groups have investigated the relationship between ACP's and various 
pathogenic and non-pathogenic activators of the immune system. Increased serum 
concentrations of haptoglobin are associated with atrophic rhinitis lesions (Eurell et al., 
1990) and actinobacillus infection in swine (Hail et al., 1992) and with respiratory infection 
in cattle (Skinner and Roberts, 1994). Serum acute amyloid concentrations increase in cows 
challenged with endotoxin or pneumonia (Boosman et al., 1989) however serum 
concentrations did not rise in challenged pigs (Gruys et al., 1994). Serum C-reactive 
protein concentrations rise in association with infection and fever in pigs (Burger et al., 
1992). Serum alpha-1- acid glycoprotein concentrations have been demonstrated to rise in 
response to bacterial challenge in cattle (Walker et al., 1994) and yeast challenge in pigs 
(Lampreave et al., 1994). 
Although many investigators have investigated the relationship between acute phase 
proteins and various pathogenic and non-pathogenic activators of the immune system, little 
information is available on the relationship between acute phase proteins and animal growth. 
Pfeffer et al. (1993) demonstrated that serum concentrations of ceruloplasmin, fibrinogen, 
and haptoglobin increased in sheep challenged with yeast and this increase correlated well 
with growth rate. Perhaps the most quantitative study relating acute phase proteins and 
production criteria in pigs is that of Itoh et al. (1992). Serum concentrations of serum 
alpha-1 acylglycoprotein were higher in conventionally reared pigs infected with 
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mycoplasma hyopneumonia and actino bascillus plueropneumoniae than in Specific Pathogen 
Free (SPF) pigs. Furthermore, SPF pigs had greater rates of body growth as they required 
25 days less to reach a market weight of 110 kg than conventionnaly reared pigs, indicating 
that serum alpha-1 acylglycoprotein concentrations may likely serve as a reliable indicator 
increased immunologic activity associated antigenic stimulation of the immune system as 
well as a reliable indicator of alterations in body growth associated with increased 
immunologic activity. 
Summary 
Acute activation of the immune system via non-pathogenic antigen challenge results 
in a reduction in the rate and efficiency of growth in animals. These responses are due in 
part to the release of cytokines such as interleukin-1 and tumor necrosis factor. These 
cytokines have been demonstrated to induce anorexia, decrease skeletal muscle synthesis, 
increase skeletal muscle degradation and increase bone resorption. Thus, the effect of 
cytokine release due to activation of the immune system appears to be deleterious on 
growth, especially muscle tissue growth. However, the impact of chronic activation of the 
immune system due to environmental antigen challenge on growth is not known. 
Specifically, the impact of chronic immune system activation on the rate, efficiency, and 
composition of growth has not been quantified. Moreover, the impact of chronic immune 
system activation on nutrient needs for tissue growth or the utilization of nutrients for 
metabolic processes has not been evaluated. It is hypothesized that minimizing activation 
of the immune system will increase the rate and efficiency of growth, increase proteinaceous 
tissue growth and influence nutrient needs as a result of alterations in proteinaceous tissue 
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growth. The studies presented in this dissertation were designed to determine the impact 
of chronic immune system activation on the rate, efficiency, and composition of growth and 
nutrient needs of pigs. 
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CHAPTER 3. THE IMPACT OF IMMUNE SYSTEM ACTIVATION ON THE RATE, 
EFFICIENCY, AND COMPOSITION OF BODY GROWTH, PARTIAL EFFICIENCY 
OF LYSINE AND ENERGY UTILIZATION, AND LYSINE NEEDS OF PIGS FED 
FROM 6 TO 27 KG' 
A paper to be published in the Journal of Animal Science 
N.H. Williams*, T.S. Stahly^ '^, and D.R. Zimmerman' 
Abstract 
The intluence of a low and high level of chronic immune system (IS) activation on 
growth and dietary nutrient needs of pigs was evaluated. The low and high IS pigs were 
created respectively, by either physically isolating from or continuously exposing pigs of 
a single genetic strain and geographical site of origin to major vectors of environmental 
antigen transmission. In each IS group, four littermate barrows in each of six litters were 
allotted at 25 ± 2 d of age to one of four dietary amino acid regimens (.60. .90, 1.20, 
1.50% dietary lysine, L). Dietary L concentrations were achieved by altering the ratio of 
corn to soybean meal resulting in L being the first limiting amino acid in each diet. Pigs 
were individually-penned in facilities maintained at 25.6 ± 2 "C and allowed to consume 
feed ad-libitum from 6.2 to 26.5 kg BW. Based on the differences in serological antibody 
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titers, lymphocyte CD4;CD8 ratios, and serum alpha-1 acylglycoprotein concentrations, low 
and high levels of IS activation were established and maintained during the study. 
Minimizing the level of chronic IS activation resulted in greater feed intakes (P< .09), body 
growth rates (P<.01), gain:feed ratios (P<.01), body leanness (protein:fat, P<.01) and 
apparent N digestibility (P< .01) and retention (P< . 10). The level of IS activation did not 
influence the partial efficiency of L utilization for body N retention or the partial efficiency 
of energy utilization for body protein and fat accretion. To allow their greater capacity for 
body growth and N retention to be expressed, the low IS pigs required higher L 
concentrations and daily L intakes than high IS pigs. 
Key words: Pigs, Lysine, Immune System, Body Composition, Nitrogen Retention 
Introduction 
Exposure of animals to pathogenic (i.e. bacteria, viral) or non-pathogenic (i.e. 
endotoxin) antigens results in cytokine release (Klasing, 1988). Cytokines such as 
interleukin-1 (IL-1) and mmor necrosis factor (TNF) activate the immune system (Dinarello, 
1984) and alter metabolic processes in animals (Klasing, 1988). Metabolically, cytokine 
(IL-1, TNF) administration induces anorexia (Mrosovsky et al., 1989), depresses protein 
synthesis (Jepson et aL, 1986), and stimulate protein degradation (Klasing el al., 1987) in 
skeletal muscle. Similarly, acute activation of the immune system via administration of non­
pathogenic antigens results in lower voluntary feed intake, body growth rates, and efficiency 
of feed utilization in chicks (Klasing et al.. 1987) and in pigs (van Heughten et al., 1994). 
An acute non-pathogenic antigen challenge also alters dietary lysine and methionine 
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concentrations needed to maximize rate and efficiency of growth in chicks (Klasing and 
Barnes, 1988). However, the impact of chronic immune system activation resulting from 
exposure to environmental antigens on the rate, efficiency, and composition of growth and 
dietary amino acid needs of pigs has not been evaluated. Furthermore, the impact of 
chronic immune system activation on the efficiency of utilization of dietary L and ME for 
body protein and energy accretion has not been determined. 
The present suidy was conducted to determine the impact of level of chronic immune 
system activation on rate, efficiency and composition of body growth, efficiency of 
utilization of dietary L and ME for body protein and energy accretion and dietary L needed 
to optimize these criteria in pigs fed from 6 to 27 kg BW. 
Materials and Methods 
Treatments. Experimental treatments consisted of a low and high level of chronic immune 
system (IS) activation and four dietary amino acid regimens (.60, .90, 1.20, or 1.50% 
lysine, L). Low and high levels of IS activation were created by employing rearing schemes 
that resulted in pigs experiencing a low and high level of continuous exposure to 
environmental (pathogenic and non-pathogenic) antigens. Dietary regimens consisted of 
corn, soybean meal, dried whey, dried skim milk mixmres in which the dietary L 
concentrations were achieved by altering the ratio of corn to soybean meal. 
Animals. Six sets of five littermate barrows were utilized. All pigs were derived from a 
single genetic strain (York x Landrace dam and Hampshire x Duroc sire) and geographical 
site of origin. Lean (muscle with 10 % fat) growth potential of the genetic strain used was 
estimated to be .30 to .35 kg/d from 20 to 110 kg BW. Lean growth potential was 
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estimated using NPPC (1983) equations, and growth rates, tenth rib backfat, and 
longissimus muscle area data previously collected on the strain at our research station. The 
herd of origin from which the pigs were derived possessed antibody titers iox Actino bacillus 
pleuropneumoniae (APP), Mycoplasma hyopneumoniae (MYCO), Swine influenza virus 
(SIV), and Transmissible gastroenteritis (TGE) virus which indicated that bacterial and viral 
pathogens were present. 
Animal Care. Pigs were individually penned in .36 x 1 m solid sided pens with woven wire 
flooring in rooms maintained between 23.8 and 26.6"C with minimal ventilation rates of 
.07 cmm's per pig. Each pig was allowed to consume feed and water ad-libitum from a 
single hole stainless steel feeder and individual nipple waterer, respectively. Pig weights, 
feed consumption, and feed wastage were determined at 4-d intervals throughout the 
duration of the trial. Total feces and urine were collected from each pig during three 4-d 
periods when the weight of the pig during the 4 d period was 9.6 (± .8), 17.5 (± 1.0), and 
25.3 (+ 1.0) kg by placing stainless steel collection trays with screens underneath the pigs' 
pen. Pigs were killed at 26.3 (± 2.3) d by intracardial administration of sodium 
penabarbatol (1 mg/kg BW) for subsequent determination of body nutrient content. A fifth 
pig in each litter was killed at the initiation of the study (26 d of age) for determination of 
initial body composition. 
Development of IS Activation. Two management schemes were utilized to develop pigs with 
a low and high level of chronic immune system activation. The low IS pigs were developed 
using a medicated early-weaning (MEW) scheme. This rearing scheme minimizes disease 
transmission by enhancing the development of passive immunity in neonatal pigs and by 
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physically isolating pigs from major vectors of antigen transmission (Harris, 1988). In this 
scheme, sows from which pigs were derived were vaccinated at 6 and 2 wk before 
farrowing for diseases which had previously been identified to exist in the herd of origin. 
These vaccinations included the following: Mycoplasma hyopneumoniae bacterin (Respifend 
™, Solvay, Mendota Heights, MN.); Bordetella bronchiseptica (Rhinobac 3, NOBL, Sioux 
Center, lA); Hemophiluspleuropneumoniae bacterin (Pneumosuis III, Pfizer Animal Health, 
Lenexa, PA); and transmissible gastroenteritis, Clostridium perfringens type C, Escherichia 
coli bacterin toxoid (Scourshield D, Pfizer Animal Health, Lenexa, PA.). Sows were 
farrowed in sanitized (steam power washed, disinfected with Bioguard-PFD 5; Bio-Lab, 
Inc., Decatur, GA.) farrowing rooms. Neonatal pigs were treated i.m. with L5 mg/kg BW 
of ceftiofur (Naxcel, UpJohn, Kalamazoo, MI) and 22.7 mg/kg BW enrofloxacin (Baytril, 
Miles Ag Division, Shawnee Mission, KS) at 1,3, 5, 8 and 11 days of age. Pigs were 
treated at weaning with 1.5 mg/kg BW ceftiofur, 22.7 mg/kg BW enrofloxacin, and with.5 
mg/kg BW of ivermectin (Ivomec ™, Merck AgVet, Rahway, NJ). Pigs were weaned at 
12 (range of 10 to 14) days of age while they still possessed passive antibodies derived from 
their dam's colostrum. At weaning, pigs were placed in a sanitized facility that was 
physically isolated from major vectors of antigen transmission. Pigs were allowed to 
consume a milk based diet (modified Day 13 [no antimicrobial agents or oat products], 
Merricks, Inc.; Union Center, WI) ad-libitum until 19 days of age. 
High IS pigs were derived via a conventional rearing scheme. Specifically, sows 
were not vaccinated for prevalent antigens present in the herd of origin, sows were farrowed 
in a non-sanitized farrowing room, pigs did not receive injectable antibiotics unless they 
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exhibited clinical signs of illness, and pigs were weaned at an average age of 19 (range of 
18 to 21) days in order to increase the likelihood of antigen transfer from the sow to the 
neonate pig. Pigs were weaned into a non-sanitized (unit not power washed after a previous 
4 wk occupation of the room by 6 to 15 kg pigs derived from the herd of origin) facility 
located at the site of sow origin. During the experiment, groups of 7 wk old pigs from 
another nursery unit at the site of origin were brought into the room at the start of the 
experiment and at 3 wk intervals during the trial to aid in maintenance of a chronic level 
of antigen exposure. 
Pigs in both the low and high IS groups were allowed to consume the 1.50% L 
experimental diet ad-libitum from 19 to 25 d of age. 
Kxperimental Diets. Dietary amino acid regimens consisted of corn, dehulled soybean meal, 
spray dried whey, dried skim milk mixtures, with added minerals and vitamins (Table 1). 
The dietary lysine levels were achieved by altering the ratio of corn to soybean meal in the 
basal mixture. The diets were fortified with vitamins at levels which met a minimum of 
350% and minerals which met a minimum of 200% of NRC (1988) estimated requirements 
for 5 to 10 kg pigs. Diets were formulated to meet a minimum of 110% of the ideal ratio 
of essential (Chung and Baker, 1992) and non-essential (Wang and Fuller, 1989) amino 
acids relative to L. Synthetic DL-methionine was added to the 1.20 and 1.50% dietary 
lysine diets to meet minimal methionine - cysteine levels. Single sources of corn, dehulled 
soybean meal, dried whey, and dried skim milk were used throughout the trial to minimize 
variation in nutrient content and potential ingredient toxin levels. Each ingredient source 
was sub-sampled and analyzed for protein and amino acid content. The analyzed amino acid 
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contents of the ingredients were used to formulate the experimental diets. 
Sample Collection and Analysis. N concentration in ingredients, urine and feces were 
determined for calculation of apparent nitrogen digestibility and nitrogen retention. 
Ingredient sub-samples were ground through a 1-mm screen for chemical analysis. Urine 
was collected into 4-L bottles containing 25 mL each of concentrated hydrochloric acid 
(HCl) and toluene as preservatives. A 10% aliquot was retained and stored at -10" C until 
it was analyzed for N. Feces were collected and preserved in 1 N HCl. At the end of the 
collection, fecal collections were weighed and freeze-dried to determine DM content. Dried 
samples were allowed to air-equilibrate, ground similarly to diet samples, and analyzed for 
N content. Nitrogen content of diet, feces and urine samples was determined by the 
Kjeldahl procedure (AOAC, 1990). 
Dry matter, N, ether extractable lipid, and ash content were determined on the whole 
bodies of pigs killed at the initiation (12 pigs) and completion of the trial. Pigs were killed 
via lethal sodium penabarbatol injection (1 mg/kg BW) and the pigs whole body including 
gut contents were then frozen at -20" C for subsequent analyses. Whole bodies were then 
ground in dry ice through a 2.54 cm die, mixed to ensure homogeneity of sample and 
reground through a .95 cm die. Two 500 g samples were collected and frozen at -20" C. 
Ground whole pig samples were then freeze dried to determine DM content. Dried samples 
were allowed to air-equilibrate, ground through a 1 mm screen and then analyzed for 
Kjeldahl nitrogen, ether extractable lipid and ash in triplicate according to AOAC (1990) 
procedures. 
Whole body nutrient accretion rates were calculated based on a comparative slaughter 
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technique. Because body nutrient content of low and high IS pigs killed at the initiation of 
the experiment did not differ, initial nutrient content of pigs in both IS groups was estimated 
based on initial BW of the experimental animals and average body nutrient content 
(expressed as a percentage of BW) of the initial pigs killed at 26 d of age (Table 2). 
For amino acid analyses, ingredients were ground through a 1 cm die and hydrolyzed 
in 6 N HCL for 20 h under N2 at 105" C. Amino acids were separated (Gehrke et al., 
1985) with an ion-exchange column (3-mm x 250-mm lithium gradient, Pickering 
Laboratories, Mountain View, CA.) and detected by fluorometry after post column reaction 
with o-phthaladehyde (Pickering Laboratories) and analyzed by HPLC (Shimazdv LC-6A, 
Columbia, MD). Tryptophan and methionine-cystine were not analyzed. 
For determination of immune status, each pig was bled via an orbital sinus on d 1 
and d 4 of each of the three N collection periods. Serum were separated by centrifugation 
and stored at -20" C until analyzed. Whole blood aliquoits were stored on ice and then 
processed within 5 h of collection. 
Whole blood samples were collected for flow cytometry analysis of lymphocyte 
populations. Aliquots of 10 /xL of whole blood from each pig were incubated for 30 min 
at 4" C with 30 /iL of either mouse anti-pig CD4 (T-helper lymphocytes), mouse anti-pig 
CDS (cytotoxic-suppressor lymphocytes), or PBS (auto sample). Specificity of these 
monoclonal antibodies has been previously described (Pescovitz et al., 1984). All 
monoclonal antibodies were diluted 1 to 100 mg/mL in PBS. Dilutions were based on 
previously determined optimal dilutions. After labeling with the primary antibody, cells 
were washed twice with 100 ^L of PBS. CD4 and CDS samples were then incubated with 
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100 (1:100) of goat anti-mouse fluorescein isothiocyanate (Sigma Chemical, St. Louis, 
MO.) for 30 min at 4" C. Samples were washed twice with 100 juL of PBS and then red 
cells were lysed with 100 juL (1:25) of Immunolyse (Coulter, Hialeah, FL) and fixed with 
10 /iL formaldehyde fixative (Coulter, Hialeah, FL). Cells were then resuspended in 100 
^L PBS. Control samples were incubated only with the second fluorescein labeled antibody 
to determine background fluorescence and autofluoresence. Samples were analyzed for 
fluorescence using a 15 Ar laser, 488 nm flow cytometer (Coulter Epics, Hialeah, FL). 
Windows for each animal were set using its own control to exclude autofluorescence. Auto 
fluorescent cells were excluded from analysis by gating. Less than 2% of cells showed 
autofluorescence. 
Two 1 mL serum samples were submitted to the Iowa State University Diagnostic 
Laboratory and analyzed for serum concentrations of antibody titers for: APP, SIV, TGE 
according to APHIS (1981) procedures and for MYCO by procedures outlined by Slavick 
and Switzer (1972). 
Serum samples also were analyzed for alpha-1 acylglycoprotein (AGP) concentrations 
utilizing a radial immuno-diffusion assay. Aliquots of 5 jxL of serum (diluted 1:1 with PBS) 
were pipetted into agar plates containing antibody specific to porcine AGP (Development 
Technologies International, Inc., St. Federick, MD). Plates were incubated for 48 h at 
37"C. Samples were analyzed by measuring the precipitin ring diameter in the agar utilizing 
a logarithmic scale. A standard curve developed from purified porcine AGP was developed 
and utilized to determine serum concentrations. The validity and repeatability of the assay 
has been reported by Tamura et al. (1989). 
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Statistical Analyses. Data were analyzed as a split plot design (Steel and Torrie, 1980) 
using the General Linear Model of SAS (1994). Immune status (IS) was considered the 
main plot and was tested by an error term of replicate within IS. Dietary L was considered 
the subplot and the IS x L interaction was tested with the residual (replicate x L [IS]) mean 
square term. Orthogonal comparisons were made to test for L linear and quadratic effects 
(Steel and Torrie, 1980). Changes in surface cell antigens and serum AGP concentrations 
over different stages of the pigs' growth (average body weight [ABW]) were analyzed as 
a repeated measure within the split-plot design. 
Single slope and two-slope, broken-line regression models (Robbins, 1986) were used 
to estimate inflection points of dietary lysine intakes needed for maximum body growth rate, 
gain:feed ratio and N retention at ABW of 9.5, 17.5, and 25 kg. To estimate the partial 
efficiency of dietary L utilization for N retention, the following linear regression model was 
utilized; 
y = a + b(x,) 
were y = daily N retention, g-d '-(BW, kg-^^)"' a = residual error term and Xi = (daily 
digestible L intake, g/d minus daily L need for maintenance, g-d"'-(BW, kg^-^)"'). Dietary 
digestible L concentrations were determined using coefficients described by Knabe (1991). 
Daily L need for maintenance was assumed to be .042 g/kg BW^^ (Stahly, 1990). N 
retention data from the high IS, 1.50 % dietary L treatment group were excluded from this 
analysis because body N retention was maximized by 1.20% dietary L and L intakes above 
that required for maximal protein growth negatively influence the efficiency of use of 
digestible L efficiency (Chiba et al., 1991). To estimate the partial energetic efficiency for 
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body protein and energy retention and daily energy maintenance needs of the pigs the 
following multiple regression model was utilized: 
y = a + b,(x,) 4- b^ix;) 
were y = daily ME intake (kcal/BW,kg^^), a = daily maintenance needs kcal/kg b, 
= partial energetic efficiency of protein gain (Kp), x, = daily energy retained as protein 
(kcal/BW, kg ") b; = partial energetic efficiency of lipid gain (K,), and X2 daily energy 
retained as lipid (kcal/BW, kg^^). The energy contents of retained body protein and lipid 
were assumed to be 5.76 and 9.5 kcal, respectively (ARC, 1981). The ME contents of the 
diets were estimated based on NRC (1988) values for the respective feed ingredients used. 
Data from the high IS, 1.50 % dietary L treatment group were excluded from the analysis 
because the dietary L intakes of pigs receiving this dietary regimen exceeded the animals 
daily needs at each stage of growth evaluated and excess intakes of protein have been 
demonstrated to decrease ME utilization (NRC, 1988). Variance procedures using pooled 
sums of squares and pooled degrees of freedom from the two independent regressions were 
used to test for differences in efficiencies (slopes) of utilization of dietary L and energy 
(ME) for body N retention and body protein and fat accretion between high and low IS 
groups (Steele and Torrie, 1980). 
One pig was removed from the low IS, 1.20% dietary lysine treatment group due 
to physical injury. One pig was removed from the high IS, 1.20% dietary lysine treatment 
group due to poor growth caused by proliferative enteritis. Least squares means are 
reported. Probability values less than .15 are reported as significant. 
107 
Results 
IS Effects. Low IS pigs exhibited colostrally-derived antibodies at the initiation of the study 
(6.2 kg BW) for APP, MYCO, SIV, and TGE (Table 3) but at 26.5 kg did not posses 
antibody titers for any of the antigens evaluated. High IS pigs did not possess colostral 
antibody titers at 6.2 kg BW but did possess positive titers for APP, MYCO, SIV and TGE 
at 26.5 kg BW. Pigs in the low IS group had fewer CD4 positive T-lymphocytes, more 
CDS positive T-lymphocytes, and lower CD4:CD8 ratios than high IS pigs at 9.5, 17.5, and 
25 kg BW and these responses were independent of dietary L (Table 3). Low IS pigs also 
had lower serum AGP concentrations than high IS pigs and the magnitude of the difference 
increased as the adequacy of the dietary amino acid regimen improved (Table 4). 
After a 6 day adjustment period (19 to 26 d of age) pigs were placed on their 
experimental diets at 6.2 ( + .9 kg) and were killed at an average weight of 26.5 (± 2.3 kg; 
Table 5). Over the duration of the trial, pigs in the low IS group consumed more feed and 
lysine, gained body weight faster and accrued more body weight per unit of feed than pigs 
in the high IS group (Table 5). Pigs in the low IS group also produced bodies with more 
protein and water, and less lipid than high IS pigs (Table 6). Body ash content was similar 
between the two IS groups (Table 6). Because of their greater body growth rate and body 
protein content, low IS pigs accrued body protein faster than high IS pigs. Pigs in the low 
IS group also accrued body lipid faster than high IS pigs; however, lipid accretion as a 
proportion of total body weight gain was lower in low IS pigs as indicated by their greater 
protein accretion to lipid deposition ratio. Estimates of dietary ME needed for maintenance 
and the energetic efficiency of ME utilization for body protein (kp) or fat (kf) accretion 
108 
were not altered by IS status in animals consuming L equivalent to or below their daily 
needs (Table 7). Maintenance energy (ME) needs for the low and high IS pigs were 
estimated to be 102 and 115 kcal/kg BW", respectively. The values of kp in the low and 
high IS pigs were estimated to be .47 and .49 and the values for kf were estimated to be .67 
and .70, respectively. 
Lysine Effects and Interactions. Dietary L concentration did not influence the percentages 
of CD4 or CDS positive lymphocytes or CD4"^:CD8^ ratio, thus data presented in Table 3 
are pooled across dietary L concentrations. Serum AGP concentrations decreased as dietary 
L concentrations increased (Table 4) with the magnimde of the decrease being greater in the 
low IS versus the high IS group. Serum AGP concentrations seemed to decrease until the 
dietary L concentration needed to maximize body growth within an IS group was reached. 
Over the duration of the study (6.2 to 25.6 kg BW). dietary L concentration did not 
alter daily feed intake (Table 5), although there was a tendency toward lower feed intakes 
with increased dietary L concentration in the low IS group. This tendency likely is due to 
the lower final pig weights in the .60% dietary L, low IS treatment (Table 5). 
As would be expected, increasing dietary L concentration resulted in a concomitant 
linear increase in daily L intake (Table 5). Over the duration of the study, daily body gain 
and gain:feed ratios increased as dietary L concentrations increased in both IS groups (Table 
5). However, the low IS pigs responded to higher dietary L concentrations than high IS 
pigs, resulting in IS x L quadratic interactions. Both body growth rate and the efficiency 
of feed utilization were maximized bv a dietarv L concentration of 1.50% and dailv L intake 
of 14.7 g in low IS pigs compared with a value of 1.20% and 8.8 g, respectively in high 
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IS pigs. 
Body protein and body water content in pigs at 26.5 kg BW increased and body lipid 
content decreased as dietary L concentration increased (Table 6). The daily accretion rate 
of body protein in pigs fed from 6.2 to 26.5 kg BW and the proportion of the body gain that 
was protein (protein;lipid) also increased, but the daily accretion rate of lipid decreased as 
dietary L concentrations were elevated (Table 6). The low IS pigs required higher dietary 
L concentrations (1.50%) and greater daily L intakes (14.7 g) to optimize these criteria than 
high IS pigs (1.20% and 8.8 g). 
Responses by Stage of Growth (Pig Weight). As the pig's BW increased from 9.5 to 17.5 
and then to 25 kg (Tables 8, 9, and 10), feed and L intakes, body weight gains, and N 
retention increased and gain:feed ratios decreased. At a BW of 9.5 kg, pigs in the low IS 
group consumed more feed and lysine, gained body weight faster and accrued more body 
weight per unit of feed than pigs in the high IS group (Table 8). Low IS pigs also 
consumed more dietary N, had a greater apparent N digestibility and retained more N daily 
than pigs in the high IS group during the 9.5 kg ABW growth phase (Table 8). 
Furthermore, the gross efficiency of L utilization for nitrogen retention (N 
retained/digestible lysine intake) was greater in the low IS pigs when the data were pooled 
across dietary L concentrations. At 17.5 and 25 kg BW the low IS pigs also exhibited 
greater body weight gain, efficiency of feed utilization, and apparent nitrogen digestibility 
and retention (Tables 9 and 10). The gross efficiency of digestible L utilization was greater 
in the low IS pigs during the 17.5 kg (Table 9) but not during the 25 kg growth phase 
(Table 10). 
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Daily feed intake during the three stages of growth (9.5, 17.5, and 25 kg, ABW) in 
which the 4 d N balances were determined was not influenced by dietary L concentration 
(Tables 8, 9, and 10). As expected, daily L and N intakes increased linearly in both IS 
groups during each of the 3 stages of growth evaluated as dietary L concentration increased. 
Daily body gain, efficiency of feed utilization and daily N retention also increased during 
each of the three stages of growth as dietary L concentrations increased. However, these 
responses to increasing dietary L were dependent on the pig's IS status as low IS pigs 
required higher dietary L concentrations and daily L intakes than high IS pigs to maximize 
these response criteria at each stage of growth. The differential response between IS groups 
to increasing dietary L concentration was linear for daily gain, gain:feed, and N retention 
during the 9.5 kg ABW stage of growth (Table 8) with L concentrations equal to or greater 
than 1.50% required to maximize the rate and efficiency of growth in low IS pigs compared 
with 1.20% in high IS pigs. Break point analysis of inflection points yielded estimates of 
daily L requirements of > 8.1 g in the low IS pigs and 6.2 g in the high IS pigs to 
maximize growth rate, gain:feed, and N retention at 9.5 kg BW (Table 11). Because a 
plateau in daily gain, gainifeed, and N retention was not demonstrated in low IS pigs at 9.5 
kg BW, more specific estimates of the L requirement for the low IS pigs can not be 
quantified. The differential response in daily body gain, gain:feed, and N retention between 
IS groups due to increasing dietary L concentration was quadratic during the 17.5 and 25 
kg growth phases except for N retention at 17.5 kg which was linear (Tables 9 and 10). 
At 17.5 and 25 kg BW, pigs in the low IS group required dietary L concentrations of 1.50% 
or greater and 1.2, respectively to maximize these criteria compared with 1.20% and .90% 
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in high IS pigs. Estimates of daily L intakes required to maximize daily body gain, 
gain:feed, and N retention in the low IS pigs were equal to or greater than 15.2 g at 17.5 
kg ABW and 19.3 to 20.6 g at 25 kg ABW compared with estimated daily L needs of the 
high IS pigs of 12.6 to 13.2 g at 17.5 kg ABW and 15.9 to 16.7 g at 25 kg ABW (Table 
11). 
Apparent digestibility of dietary N also increased linearly as dietary L concentrations 
increased during each of the three stages of growth evaluated (Tables 8, 9, and 10) and the 
response was independent of the IS status of the pigs. 
The calculated gross efficiency of utilization of digestible dietary L for accretion of 
nitrogenous compounds in the body decreased (Tables 8, 9, and 10) with increasing dietary 
L concentration during each of the N balance periods and the magnitude of response to 
dietary L was dependent on IS group (Tables 8 and 9) during the 9.5 and 17.5 kg stages of 
growth. This differential response to increasing dietary L concentration between IS groups 
was due to the dramatic decrease in the gross efficiency once the daily L intakes needed for 
optimal growth and N retention were achieved. Excess intakes of dietary L were consumed 
by the high IS pigs at 9.5 and 17.5 kg and by both low and high IS pigs at 25.5 kg ABW. 
Similar trends for reductions in the efficiency of lysine utilization for protein deposition 
once maximal protein accretion rates were met have been demonstrated in young pigs by 
Chiba et al. (1991). Therefore, a more meaningful evaluation of the partial efficiency of 
digestible L utilization for N retention consists of evaluating only the dietary treatment 
groups in which dietary L intakes were at or belov/ levels needed to maximize daily N 
retention in each IS group during each stage of growth. Using these treatment groups, g 
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N retained daily were regressed on g of digestible L consumed daily over maintenance needs 
(Table 12). The grams of N retained per gram of digestible L intake over maintenance were 
1.55, 1.79, and 1.45 g/d at 9.5, 17.5, and 25 kg ABW in the low IS pigs and 1.70, 1.67, 
and 1.61 g/d at 9.5, 17.5, and 25 kg ABW in the high IS pigs. Based on statistical analysis 
of the change in N retention per unit of L consumed (slope b) at each body weight, the 
partial efficiency of digestible L utilization was similar between the low and high IS groups 
at each stage of growth. 
Discussion 
Based on antibody titers for pathogenic antigens, T-lymphocyte CD4:CD8 ratio, and 
serum alpha-1 acylglycoprotein concentrations, two levels of chronic IS activation were 
created and maintained throughout the study. The presence of antibody titers for specific 
antigens indicates that an animal either possess colostral antibodies (i.e. 6 kg BW) or that 
an animal has been exposed to and mounted an immune response (i.e. activation of both the 
humoral and cellular components of the immune system) to a specific antigen (i.e. 27 kg 
BW). The minimal level of IS activation in the low IS pigs likely was achieved via the 
elimination of pathogenic antigens that were present in the herd of origin and by minimizing 
the pigs exposure to other major antigen vectors. The findings that pathogenic antigens 
present in the herd of origin were eliminated via the use of a MEW rearing scheme are in 
agreement with the results of Harris (1988). 
The elimination of pathogenic antigens quantified in this experiment was associated 
with a reduction in the number of CD4 positive T-lymphocytes, an increase in the number 
of CDS positive T-lymphocytes, and a reduction in the CD4:CD8 ratio in low IS pigs. CD4 
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antigens recognize antigen presented by class-II MHC molecules and are referred to as T-
helper cells (Matis, 1990). CD4 positive T-lymphocytes are activated by various immune 
cells (i.e. macrophages) which present foreign antigens. Once activated, the CD4 positive 
T-lymphocytes release cytokines which potentiate both cellular and humoral immunity 
(Tonegawa, 1985). In contrast, CDS positive T-lymphocytes recognize antigen presented 
by class-I MHC molecules, CDS positive T-lymphocytes do not release cytokines upon 
activation (Marrick and Kapler, 19S6), but rather they have been demonstrated to release 
immunosuppressive factors (Batchelor et al., 1989). Thus, CDS positive T-lymphocytes are 
referred to as T-cytotoxic, suppressor cells (Matis, 1990). Various factors (i.e. infection, 
stress) associated with IS activation influence the number of CD4 and CDS positive T-
lymphocytes. In chicks, coccidia infection (Lillehoj, 1994) and thyroidectomy (Johnson et 
al., 1992) increase CD4 positive T-lymphocytes and CD4/CDS ratios. Chronic respiratory 
infection in children is associated with low circulating levels of thyroid hormones 
(Hashimoto et al., 1994). Factors such as the onset of lactation (Park et al., 1992) and 
animal shipment (McGlone et al., 1993) that contribute to a physiological stress associated 
with glucocorticoid release also result in greater CD4:CDS ratios. Two cytokines (IL-1 and 
IL-8) involved in the immune response stimulate glucoconicoid release via stimulation of 
corticotrophin releasing hormone release from the hypothalamus (Navarra et al., 1991). 
Furthermore, physiological stress has been associated with thymus atrophy (Kelly, 1988) 
and pigs reared in MEW schemes with minimal antigenic challenge have larger thymus 
glands than pigs reared via conventional schemes (Harris et al., 1990). Because the thymus 
is a major site of T-cell differentiation, changes in thymic function due to thymic atrophy 
114 
might result in changes in CD4:CD8 ratio. Taken collectively, these data indicate that 
chronic exposure to initiators of the immune system would shift CD4:CD8 ratio via cytokine 
and endocrine mediators in a fashion similar to that observed in the present study. 
The low IS pigs also possessed lower concentrations of acute phase proteins (i.e. 
AGP) which are a class of proteins produced by the liver in response to infection or 
inflammation (Klasing, 1988). Specifically, AGP is a glycoprotein with a MW of 
approximately 400,000 daltons and is comprised of approximately 45 % carbohydrate 
(Schmidt et al, 1975). AGP is synthesized by the liver during an immune response 
(Courtoy et al., 1981) and IL-1 induces its release (Woloski et al., 1985). Serum 
concentrations of AGP also have been reported to be lower in specific pathogen free pigs 
which received minimal antigen challenge compared with conventionally reared pigs which 
were infected with Mycoplasma hyopneumoniae and Actinobacilliis pleuropneumoniae and 
required an additional 20 days to reach market weight (Itoh et al., 1992). 
The greater feed intake, body growth rate, efficiency of feed utilization, and 
proteinaceous tissue content of low IS pigs are likely due to lower cytokine release and 
associated endocrine changes resulting from a lower chronic level of immune system 
activation. IL-1 administration reduces food intake by 40% in rats (Mrosovsky et al., 
1989). This reduction in voluntary feed intake due to IL-1 release is associated with 
induction of CRH release (Navara et al., 1990) and induction of IL-8 release which serves 
as a potent stimulant of the lateral hypothalamus (Plata-Salaman and Borkoski, 1993). This 
cytokine induced reduction in feed intake accounts for a portion of the reduction in growth 
rate and efficiency of feed utilization in antigen challenged animals. However, other 
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metabolic shifts mediated by cytokines also play a role as lipopolysaccharide administration 
in chicks reduced body gains and gain:feed ratios by 17.1 and 17.0%, respectively, 
compared with those of pair-fed controls (Klasing et al., 1987). These metabolic shifts 
include increased skeletal muscle protein degradation (Klasing and Austic 1984). decreased 
skeletal muscle protein synthesis (Jepson et al., 1986). increased liver and heart protein 
synthesis (Ballmer et al.. 1991) and increased bone resorption (Cochran and Abernathy. 
1988). Cytokines mediate these alterations in skeletal muscle protein synthesis and 
degradation by decreasing the release of anabolic hormones such as somatotropin (Hannegar 
et al.. 1991) and IGF-1 (Fan et al.. 1994), increasing catabolic (glucocorticoid) hormone 
release (Navarra et al., 1990), and by direct inhibition of the muscle proteolytic inhibitor 
calpastatin (Chavis et al., 1994). Furthermore, thymic atrophy associated with cytokine 
release may result in decreased somatotropin release as the thymic peptide thymosin alpha-1 
decreases somatostatin release from the hypothalamus (Milenkovic et al., 1992) and the 
thymic peptide thymosin fraction 5 increases somatostatin releasing factor release from the 
hypothalamus (Badamchian et al., 1991). These observations are supported by the findings 
of Zamir et al., (1994) which demonstrated that pre-treatment of rats with IL-1 receptor 
antagonist prevented skeletal muscle catabolism resulting from IL-1 administration or sepsis 
resulting from cecum rupture. These data indicate that both pathogenic and non-pathogenic 
initiators of the immune system will influence body muscle accretion. Based on these 
relationships, minimizing chronic immune system activation by minimizing exposure to 
antigens should result in beneficial alterations in skeletal muscle protein accretion. In turn, 
these changes should allow low IS pigs to accrue more body protein and to produce bodies 
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with a higher proportion of protein relative to fat similar to the results observed in the 
current study. Environmental and non-pathogenic antigen challenge has also been reported 
to increase cytokine release and decrease the rate and efficiency of growth. Chicks reared 
in sanitary environments exhibit lower circulating levels of IL-1 than those reared in 
unsanitary environments where antigen exposure is high (Roura et al., 1991). Chicks reared 
in germ free environments grow faster than chicks raised conventionally or exposed to 
normal bacterial flora (Lev and Forbes, 1959). Pigs reared via a MEW versus a 
conventional rearing scheme have been reported to grow faster, require less feed per unit 
of gain and possess higher serum concentrations of IGF-1 (Wiseman et al., 1994). Acute 
activation of the immune system via administration of lipopolysaccharide, a component of 
the cell wall of gram negative bacteria which is a potent stimulant of macrophages that 
produce IL-1 and TNF upon activation (Feldmann and Male, 1989), reduces feed intake, 
body growth rate, and efficiency of feed utilization in chicks (Klasing and Barnes, 1988) and 
pigs (van Heughten et al., 1994). 
As expected, the greater capacity of the low IS pigs to accrue body protein resulted 
in these pigs requiring greater dietary L concentrations and greater daily L intakes to 
express their maximum rate of protein accretion compared with that of high IS pigs. Over 
the duration of the trial, daily body protein accretion was maximized and daily lipid 
accretion minimized by dietary L concentrations of 1.50% and daily L intakes of 14.7 g in 
the low IS group compared with 1.20% and 8.8 g in the high IS group. Because of 
increases in the rate of body protein accretion and increases in voluntary nutrient intake as 
the pig marnres, it is more appropriate to evaluate dietary L needs for maximal N retention 
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at specific body weights. In the present study, the low IS pigs required a higher dietar\' 
concentration and intake of L to maximize daily gain, gain:feed, and N retention at 9.5, 
17.5, and 25 kg BW than high IS pigs. The dietary L concentration required to maximize 
N retention in the low IS pigs are .35 to .15 percentage units greater than requirements 
defined by NRC (1988) for pigs weighing 5 to 10 and 10 to 20 kg, respectively whereas 
requirements for high IS pigs are comparable to NRC (1988) recommendations. 
Furthermore, the low IS pigs required 3 to 8 g more daily L intake than requirements 
defined by NRC (1988) for 5 to 10 and 10 to 20 kg pigs. In addition to requiring greater 
dietary L concentrations and daily L intakes to maximize apparent body N retention, low 
IS pigs retained more daily N when dietary L concentrations were below those which 
maximized apparent daily N retention in both IS groups. This response is due to the greater 
feed and L intakes of low IS pigs, with the increased L intake being able to support a 
greater rate of daily body N retention. 
The apparent digestibility of dietary N was improved by minimizing the level of IS 
activation. It is hypothesized that dietary L digestibility also was improved. The greater 
N digestibility in the low IS pigs is in agreement with observations by Hale and Stewart 
(1979) and Hale et al. (1981, 1985) that minimizing the level of parasitic infection in pigs 
results in greater apparent N digestibility. Also, antimicrobial agents decrease intestinal 
wall weight and thickness and increase apparent absorption of nutrients possibly via the 
reduction of pathogenic organisms which produce toxins that damage intestinal tissue 
(Taylor. 1957). The lower levels of pathogenic antigens present in low IS pigs may have 
resulted in the improvements in apparent N digestibility due to decreased intestinal wall 
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damage. However, the greater nutrient intakes of the low IS pigs likely contributed in part 
to the improved N digestibility by reducing the amount of endogenous N excreted relative 
to undigested dietary N. 
Based on statistical analysis of the change in body N retention per unit of digestible 
L consumed (slope b) at each body weight, the partial efficiency of utilization of digestible 
L was similar between the low and high IS groups at each stage of growth indicating that 
the increased rates of proteinaceous tissue growth observed in this study were due to an 
increase in the pigs capacity to deposit protein and not due to a change in the efficiency of 
L utilization. The finding that the efficiency of digestible L utilization was unaltered due 
to IS activation is contrary to the work of van Heugten et al. (1994) in which utilization of 
total dietary protein for body weight gain was depressed by LPS administration. However, 
the dietary protein levels fed in that study were in excess of the pig's needs and because 
protein intakes were more excessive in LPS treated pigs, the differences in the efficiency 
of protein utilization reported may have been due to a reduction in efficiency associated with 
excess protein intake. Assuming that retained body proteins contained 16% N, 1 g of 
digestible dietary L supported between 9.1 and 11 g of protein gain in low IS pigs and 
between 10.1 and 10.6 g of protein gain in high IS pigs. These values compare with 
literature estimates ranging from 6.1 g of protein/g digestible L intake (Chiba et al, 1991), 
to 14.7 g protein/ g digestible L intake (Fuller et al., 1989). The efficiencies reponed by 
Chiba et al. (1991) likely are low because some of the dietary L levels which were fed were 
above the animals requirement. Furthermore, the dietary L levels were evaluated over a 
wide weight range (20 to 50 kg) which did not account for a reduction in dietary L needs 
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of pigs at heavier body weights due to shifts in the composition of tissue growth at different 
stages of the pig's development. The efficiency reported by Fuller et al. (1989) may be a 
more suitable comparison to that reported in the present study, as the efficiency of L 
utilization was determined using a N balance technique and a wide range of dietary L 
intakes at or below the pig's requirement were evaluated. However, the pigs utilized in the 
experiment of Fuller et al. (1989) were heavier (41 to 57 kg BW) than those in the present 
study (6 to 27 kg BW) and responses to dietary regimens were determined over a relatively 
large period of body growth (3 wk). The values reported in the present smdy may be more 
appropriate because the experimental design allowed for the determination of the efficiency 
of L utilization for proteinaceous tissue growth over narrow weight ranges at specific stages 
of the pigs development. Assuming a L content in body protein of 6.5% (Campbell et al., 
1985), the efficiency of utilization of digestible L for body lysine deposition ranges from 
.59 to .72 for low IS pigs and from .65 to .69 for high IS pigs. These values compare 
favorably with literamre estimates ranging from .51 (Krick et al., 1993) to .75 (Batterham 
et al., 1990) although the latter values were determined with heavier weight pigs fed over 
a wider weight range. 
The energetic cost of body maintenance and body protein (kp) and fat (kf) accretion 
were similar among the two IS groups. Estimates of ME maintenance needs compare 
favorably with literature estimates (110 kcal/kg BW'' ARC, 1981). The estimates of kp 
and kf in the present study were slightly lower than estimates (kp = .54; kf=.74) reported 
by ARC (1981). The lower partial efficiencies reported in this study may be a result of 
decreased efficiency of ME utilization associated with over feeding of protein (NRC, 1988) 
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This reduction in ME utilization due to excess dietary protein consumption is associated with 
the failure to retain the energy associated with the excretion of excess N as well as with 
higher rates of protein uimover and therefore higher rates of heat production related to 
protein catabolism and N excretion (Reeds et al., 1981; Adeola and Young, 1989). 
Based on these data, low IS pigs require greater dietary L intakes because of their 
greater capacity for body protein accretion not due to changes in efficiency of use of 
digested amino acids or ME for body protein deposition. The fact that dietary L needs 
expressed as a percentage of the diet increased in low IS pigs is because the dietary amino 
acids needed for body protein accretion are increased more (40.1%) than that of dietary 
energy (19.7%) needed for body protein and fat accretion. 
Implications 
Technologies that minimize chronic activation of the pigs immune system by 
minimizing the animals exposure to antigens enhance the rate and efficiency of growth, 
increase carcass leanness, and alter dietary amino acid needs of pigs. It is biologically and 
economically desirable to match nutritional inputs with the pigs biological capacity for 
proteinaceous tissue growth as defined by the animal's IS status. 
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Table 1. Composition of experimental diets (as-fed basis). 
Ingredient 
Dietary lysine, % 
.60 .90 1.20 1.50 
Yellow corn, ground 67.60 57.24 46.85 36.41 
Soybean meal, dehulled 3.99 14.53 25.08 35.64 
DL-methionine, 99% - - .01 .07 
Spray-dried whey 20.00 20.00 20.00 20.00 
Dried skim milk 5.00 5.00 5.00 5.00 
Dicalcium phosphate 2.17 1.94 1.71 1.48 
Ground limestone .44 .49 .55 .60 
Salt, iodized .25 .25 .25 .25 
Vitamin-trace mineral mix" ,55 .55 .55 .55 
Total 100.00 100.00 100.00 100.00 
Analyzed composition'', % 
Crude protein 12.0 16.2 20.4 24.7 
Amino acid 
Lysine .60 .90 1.20 1.50 
Threonine .58 .74 .90 1.06 
Leucine 1.35 1.61 1.87 2.13 
Isoleucine .59 .77 .96 1.15 
Valine .67 .88 1.09 1.30 
Histidine .31 .41 .50 .60 
Arginine .56 .90 1.25 1.59 
Calculated composition 
Tryptophan, % .16 .23 .29 .35 
Methionine -t- cystine, % .50 .61 .72 .88 
Calcium, % .90 .90 .90 .90 
Phosphorus, % .80 .80 .80 .80 
ME, kcal/kg 3,169 3,169 3,175 3,179 
^'Provided the following per kg of diet: 140 mg of Fe, 120 mg of Zn, 48 mg of Mn, 14 
mg of Cu, .80 mg of I, .30 mg of Se, 2,205 lU of Vit A, 551 lU of Vit D3, 26.0 lU of 
Vit E, 1.50 mg of Vit K (as menadione dimethylpyrimidinol bisulfate), 6.3 mg of 
riboflavin, 16.8 mg of panothenic acid, 28.5 mg of niacin, 55.0 jug of Vit B,,, .03 mg of 
biotin, .17 mg folacin, 250 mg choline, .82 mg of pyridoxine, .56 mg thiamine, and 167 
mg ethoxyquin. 
''Analyzed values based on analysis of corn, dehulled soybean meal, dried whey, and dried 
skim milk sources used. 
"Values based on NRC (1988) estimated nutrient composition of the ingredients used. 
128 
Table 2. Impact of immune system (IS) activation on initial body and nutrient 
contentof pigs at 6 kg BVV." 
IS activation P < 
Item Low High CV IS 
Pig weight, kg 6.2 5.7 28.2 .65 
Body nutrient content, % of BW 
Protein 15.6 15.2 10.4 .74 
Water 74.1 73.3 28.2 .65 
Lipid 6.3 7.9 22.9 .19 
"Five pigs per IS group. 
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Table 3. Impact of immune system (IS) activation on sereological titers for prevalent 
antigens and CD4 and CDS positive lymphocytes in pigs at average body weights 
(ABW) of 9.5, 17.5, and 25 kg." 
IS Average body weight, kg P < 
Item Activation 9.5 17.5 25 CV IS ABW ISxABW 
Serological titers 
APP, MYCO 
SIV, TGE 
Low 
High 
-f- ND'' 
ND'' -f-
Antigen receptors, 
CD/ 
% of total 
Low 
High 
peripheral blood 
22.9 17.6 
42.9 45.5 
lymphocytes 
21.8 28.0 
46.8 
.01 .69 .22 
CD/ Low 
High 
38.9 
22.4 
32.4 
26.0 
35.6 
25.2 
29.9 .01 .83 .22 
CD/CD« Low 
High 
.62 
2.20 
.84 
1.97 
.66 
2.01 
56.8 .01 .63 .72 
"Twenty-three individually-penned pigs per IS group. Data pooled across dietary L 
concentration. Least squares means reported. 
''Not determined. 
Table 4. Impact of iininiinc system (IS) activation and dietary lysine (L) regimen on serum alpha-1 acylglycoprotein 
(AGP) concentrations in pigs at average body weights (ABVV) of 9.5, 17.5, and 25 kg." 
F'ig P_< 
ABW, IS Dietary lysine, % ISx Lx ISxLx 
Criterion kg Activation .60 .90 1.20 1.50 CV, % IS L ISxL ABW ABW ABW ABW 
Serum AGP, ug/ml 
9.5 Low 1146 1283 1022 992 36.1 .01 .01 .05 .46 .01 .01 .01 
Higii 1449 1463 1531 1554 
17.5 Low 1907 1514 495 530 
High 1722 1780 1189 1476 
25 Low 1952 784 452 457 
High 2140 1618 787 1059 
•'Five or six individually penned pigs per IS activation - dietary L ABW treatment group. Least squares means reported. 
Table 5. Impact of iiiunime system (IS) activation and dietary lysine (L) regimen on feed intake, body weight gain 
and gain;feed ratio of pigs fed from 6 to 27 kg B\V." 
IS Dietary lysine, % P< 
Criterion Activation .60 .90 1.20 1.50 CV IS LL'' LQ'' ISxLL'- ISxLQ' 
Pig weight, kg 
Initial Low 
High 
6.6 
5.7 
6.7 
6.0 
6.3 
6.1 
6.2 
5.8 
14.7 .31 .37 .84 .94 .67 
Final Low 
High 
25.0 
24.5 
26.9 
27.3 
27.7 
27.7 
27.6 
26.6 
8.6 .63 .27 .98 .74 .49 
Growth performance 
Daily feed, g 
of pigs fed 
Low 
High 
from 6.2 
896 
889 
to 26.5 
1025 
954 
kg BW 
1052 
889 
1002 
911 
9.3 .09 .23 .04 .15 .21 
Daily L, g Low 
High 
5.11 
4.18 
9.33 
6.92 
12.21 
8.78 
14.73 
11.48 
7.7 .04 .04 .18 .01 .21 
Daily gain, g Low 
High 
400 
357 
556 
495 
644 
510 
663 
504 
8.8 .01 .01 .21 .95 .01 
Gain/feed, g/kg Low 
High 
445 
395 
544 
522 
613 
581 
662 
565 
7.3 .01 .01 .59 .16 .07 
"Five or six individually penned pigs per IS activation -L treatment group. LS means reported. 
''Linear lysine (LL) and quadratic lysine (LQ) effects. 
Table 6. Impact of iminime system (IS) activation and dietary lysine (L) regimen on body nutrient content and 
accretion rates of pigs fed from 6 to 27 kg." 
IS Dietary lysine, % P < 
Criterion Activation .60 .90 1.20 1.50 CV IS LL'> LQ'' ISxLL'' ISxLQ' 
Body nutrient content at 26.5 kg BW 
Protein, % Low 12.92 14.37 15.70 16.40 6.4 .14 .01 .87 .83 .07 
High 12.21 13.94 15.82 15.72 
Water, % Low 59.82 64.67 67.61 69.11 2.3 .14 .01 .79 .23 .05 
High 59.36 64.36 67.10 67.63 
Lipid, % Low 21.48 15.46 11.95 10.85 7.3 .08 .01 .27 .75 .01 
High 22.72 15.57 11.98 12.28 
Ash, % Low 3.26 2.92 2.74 2.59 17.4 .79 .06 .19 .15 .47 
High 3.05 2.65 2.71 2.94 
Body nutrient accretion rates from 6.2 to 26.5 kg BW 
Protein, g/d Low 47.6 77.8 100.7 110.8 9.8 .01 .01 .27 .55 .01 
High 40.3 67.3 80.3 79.4 
Water Low 220.1 343.4 424.8 449.9 9.3 .01 .01 .15 .42 .01 
High 200.7 310.6 339.4 336.0 
Lipid, g/d Low 106.6 101.7 86.4 79.3 13.6 .10 .08 .57 .87 .05 
High 97.3 90.0 69.0 71.0 
Protein: lip id" Low .46 .77 1.17 1.41 11.7 .09 .01 .28 .01 .03 
High .41 .76 1.15 1.13 
"Five or six individually penned pigs per IS aetivation-L treatment group. LS means reported. 
''Linear lysine (LL) and quadratic lysine (LQ) effects. 
Trotein deposited/per unit of body lipid deposited. 
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Table 7. Impact of immune system (IS) activation on energetic maintenance 
needs (a) and the partial efficiency (b) of utilization of metabolizable energy for 
body protein (Kp) and fat (Kf) accretion in pigs fed from 6 to 27 kg BW." '' 
IS pj < 
Activation a (SE) b,(SE)^ b:(SE)'' R- a b, b: 
Low 102 (48) 2.11 (.33) 1.49(.31) .68 .54 .61 .82 
High 115 (39) 2.03 (.54) 1.42(.33) .72 
•'Seventeen individually-penned pigs in the high IS group and twenty-three 
individually-penned pigs in the low IS group included in the analysis. 
''Model: y = a+ b,(x,) + bilx,) where y = daily metabolizable energy intake 
(Mcal/BW.kg^^), a= ME for rnaintenance(kcal/BW, kg^^), b,= kcal of ME required 
to deposit a kcal of protein energy, x, = daily protein energy gain (kcal/ BW, kg "'^), 
b2 = kcal of ME required to deposit a kcal of lipid energy, and x, = daily lipid 
energy gain (kcal/BW, kg "). 
''Standard error of estimate in parenthesis. 
''Probability values for low vs high IS. 
Table 8. Impact of immune system (IS) activation and dietary lysine (L) regimen on rate and efficiency of pig gain 
and N utilization in pigs at an average body weight (ABVV) of 9.5 kg." 
Criterion 
IS Dietarv Ivsine. % 
CV 
P< 
Activation .60 .90 1.20 1.50 is^- LU' LQ'' ISxLU' ISxLQ'' 
Pig weight, kg Low 8.8 9.5 9.0 9.2 8.0 .12 .22 .26 .17 .22 
High 9.7 9.5 10.2 10.6 
Growth performance 
Daily feed, g Low 656 726 651 645 15.2 .01 .96 .45 .40 .52 
High 556 572 575 590 
Daily L, g Low 3.15 5.37 6.47 8.12 13.4 .01 .01 .25 .22 .93 
High 2.71 4.19 5.72 7.44 
Daily gain, g Low 180 364 451 543 27.6 .05 .01 .05 .05 .54 
High 156 300 408 396 
Gain:feed, g/kg Low 275 488 685 839 25.5 .06 .01 .52 .12 .20 
H igh 294 535 711 659 
Nitrogen utilization 
Inlake, g/d Low 12.61 18.82 20.66 25.49 13.7 .01 .01 .38 .91 .42 
H igh 10.75 15.04 18.55 23.34 
Digestibility, % Low 84.49 86.13 86.82 87.82 2.1 .04 .01 .22 .92 .44 
High 82.68 83.94 86.36 85.21 
Retained, g/d Low 6.30 9.83 11.16 13.86 18.7 .01 .01 .55 .05 .21 
High 4.85 7.46 9.84 9.13 
L utilization" Low 1.99 1.84 1.72 1.70 7.6 .01 .79 .01 .01 .01 
High 1.84 1.76 1.73 1.23 
"Five or six individually penned pigs per IS activation-L treatment group. LS means reported. 
''Linear lysine (LL) and quadratic lysine (LQ) effects. 
'^N retained, g/d per g of daily digestible L intake. 
Table 9. Impact of imimine system (IS) activation and dietary lysine (L) regimen on rate and efficiency of pig gain 
and N balance in pigs at an average body weight (ABW) of 17.5 kg." 
Criterion 
IS Dietary ly: sine, % 
CV 
P < 
Activation .60 .90 1.20 1.50 IS LL" LQ" ISxLL" IsxLQ" 
Pig weight, kg Low 17.3 17.9 16.9 18.1 5.9 .54 .71 .33 .85 .36 
High 17.0 17.7 17.3 17.4 
Growth performance 
Daily feed, g Low 1120 1262 1217 1203 15.1 .72 .49 .83 .30 .80 
High 1198 1252 1158 1121 
L intake, g/d Low 5.38 9.22 12.13 15.16 13.7 .33 .01 .25 .22 .92 
High 5.74 9.20 11.40 14.12 
Daily gain, g Low 560 686 706 782 18.1 .01 .01 .11 .47 .09 
High 459 607 643 631 
Gainifeed, g/kg Low 507 544 581 652 13.0 .03 .01 .48 .67 .11 
High 389 487 561 550 
Nitrogen utilization 
Intake, g/d Low 21.54 32.68 39.95 47.57 13.8 .40 .01 .65 .23 .89 
High 22.96 32.28 37.64 44.30 
Digestibility, % Low 85.93 88.20 89.78 89.40 1.5 .04 .01 .01 .49 .92 
High 84.00 87.33 87.86 88.74 
Retained, g/d Low 10.06 16.23 21.08 26.56 23.5 .05 .01 .61 .04 .34 
High 10.32 15.95 19.01 18.83 
L utilization" Low 1.84 1.76 1.73 1.70 9.20 .01 .01 .14 .04 .07 
High 1.78 1.74 1.71 1.32 
"Five or six individually penned pigs per IS activation-L treatment group. LS means reported. 
''Linear lysine (LL) and quadratic lysine (LQ) effects. 
"N retained, g/d per g of daily digestible L intake. 
Table 10. Impact of immune system (IS) activation and dietary lysine (L) regimen on rate and efficiency of pig gain 
and N balance in pigs at an average body weight (ABW) of 25 kg." 
IS 
Criterion Activation 
Dietary ly sine, % 
CV 
P < 
.60 .90 1.20 1.50 IS'' LL'' LQ'' ISxLU' ISxLQ' 
Pig weight, kg Low 23.5 24.7 25.7 25.8 4.1 .01 .16 .72 .01 .45 
High 26.6 25.7 25.9 25.5 
Growtli performance 
Daily feed, g Low 1483 1505 1581 1526 9.0 .02 .24 .57 .22 .68 
High 1414 1344 1387 1310 
L intake, g/d Low 8.45 13.70 18.38 22.44 11.3 .01 .01 .71 .07 .94 
High 7.84 12.30 16.01 19.26 
Daily gain, g Low 554 788 939 897 14.6 .02 .01 .01 .24 .04 
High 618 672 706 696 
Gain;feed, g/kg Low 375 524 606 592 15.8 .08 .01 .02 .49 .02 
High 437 494 513 491 
Nitrogen utilization 
Intake, g/d Low 28.48 39.02 49.74 60.31 10.6 .04 .01 .48 .08 .93 
High 26.87 35.00 45.11 51.78 
Digestibility Low 84.39 87.32 88.94 89.30 2.1 .01 .01 .60 .17 .77 
High 83.09 85.63 86.59 85.87 
Retained, g/d Low 12.92 19.63 26.81 28.88 15.8 .13 .01 .54 .86 .09 
High 12.52 17.12 23.96 23.18 
L utilization'-' Low 1.80 1.76 1.71 1.48 7.6 .45 .01 .04 .45 .88 
High 1.79 1.71 1.64 1.40 
'Five or six individually penned pigs per IS activation-L treatment group. LS means reported. 
''Linear lysine (LL) and quadratic lysine (LQ) effects. 
"N retained, g/d per g of daily digestible L intake. 
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Table 11. Impact of Immune system (IS) activation on the daily lysine intakes 
(g/d + SE) required to maximize daily body gain (g/d), gain;feed (g/kg) and N 
retention (g/d) at average body weights (ABW) of 9.5, 17.5, and 25 kg." 
Pig IS Daily L intakes (g) required to maximize criterion 
ABW Activation Daily gain Gain; feed N retention 
9.5 Low iS.KND)'''" iS.KND) iS.KND) 
High 6.2 (.86)^ 6.1 (1.2) 6.6 (.33) 
17.5 Low ^15.2 (ND) ^15.2 (ND) ^15.2 (ND) 
High 12.6 (1.3) 13.2 (1.3) 13.2 (.97) 
25 Low 19.3 (1.2) 20.1 (.62) 20.6 (.72) 
High 15.9 (1.1) 16.7 (1.2) 16.5 (.98) 
Twenty-three individually penned pigs per IS activation group. 
''Values represent the daily L intakes of pigs consuming the 1.50% L diet because a 
plateau was not detected in the break point analysis. 
"Standard error not determined because a plateau was not detected in the break point 
analysis. 
''Standard error of estimate in parenthesis. 
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Table 12. Impact of immune system (IS) activation on the efficiency of utilization (b) 
of digestible L for body N retention in pigs at average body weights (ABW) of 9.5, 
17.5, and 25 kg." '' ' 
Pig IS P^< 
ABW Activation a (SE)' b (SE)' R- IS 
9.5 Low .24 (.08) 1.55 (.07) .95 .36 
High .04 (.07) 1.70 (.10) .96 
17.5 Low -.02 (.11) 1.79 (.09) .96 .49 
High .07 (.18) 1.67 (.08) .97 
25.0 Low .35 (.13) 1.45 (.11) .88 .45 
High .08 (.12) 1.61 (.14) ^91 
"Seventeen individually-penned pigs in the high IS group and twenty three individually-
penned pigs in the low IS group utilized for the analysis. 
''Model: y = a + b(x) where y = daily nitrogen retained, g/(BW,kg) ''^ a = residual 
error and x = (daily digestible lysine intake, g - (.042 g X BW, kg ''^ ))/(BW/kg) ''"\ 
"Standard error of estimate in parenthesis. 
''Probability values for b of low vs high IS group. 
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CHAPTER 4. IMPACT OF LEVEL OF IMMUNE SYSTEM ACTIVATION ON THE 
GROWTH AND DIETARY LYSINE 
NEEDS OF PIGS FED FROM 6 TO 112 KG'" 
A paper to be published in the Journal of Animal Science 
N. H. Williams\ T. S., Stahly"'-"' and D.R. Zimmerman"* 
Abstract 
The impact of a low and a high level of chronic immune system (IS) activation on 
the rate, efficiency, and composition of body growth and dietary lysine (L) needs of pigs 
fed from 6 to 112 kg body weight was evaluated. The low and high IS pigs were created, 
respectively, by physically isolating and continually exposing pigs from a single genetic 
strain and geographical site of origin to major vectors of environmental antigen 
transmission. In each IS group, five littermate barrows from each of seven litters were 
individually penned and randomly allotted to one of five dietary amino acid regimens (.6, 
.9, 1.20, 1.50, and 1.80% L from 6 to 27 kg BW and .45, .60, .75, .90, and 1.05% L 
from 27 to 112 kg BW). Dietary L concentrations were achieved by altering the ratio of 
com to soybean meal in the diets and diets were formulated such that L was the first 
'Research supponed in part by National Pork Producers Council, Des Moines, IA and 
Cennex/Land C Lakes Inc., Fort Dodge lA. 
-The authors acknowledge the assistance of Scott Swenson in the collection of data and Dr. 
Mike Wannemuehler for the donation of antibodies and technical assistance for CD4 and 
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'Present address, Cennex/Land O'Lakes Inc.. Fort Dodge lA, 50501. 
^Department of Animal Science, Iowa State University. 337 Kildee Hall, Ames, lA. 50010. 
^To whom correspondence should be addressed. 
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limiting amino acid. Low IS pigs possessed lower (P< .01) T-lymphocyte CD4:CD8 ratios 
and serum alpha-1 acylglycoprotein concentrations. Low IS pigs also consumed more 
(P< .01) feed, gained body weight faster (P< .01), required less (P< .01) feed per unit of 
gain and at 112 kg BW produced bodies with more (P < . 12) muscle and less (P < . 10) fatty 
tissue and offal than high IS pigs. To allow their elevated capacities for proteinaceous tissue 
to be expressed, low IS pigs required .15 to .30 percentage units greater dietary L 
concentrations and 2 to 5 g higher daily L intakes at each 14 kg BW increment from 6 to 
112 kg BW. 
Key words: Pigs, Lysine, Immune System, Muscle 
Introduction 
The body's defense system (i.e. immune system) functions to contain and/or 
eliminate antigens foreign to the body. In response to pathogenic and non-pathogenic 
antigens, mediators of an immune response (i.e. cytokines) are released by cells of the 
immune system (i.e. macrophages, T-lymphocytes). In turn, cytokines such as interleukin-1 
and tumor necrosis factor induce anorexia (Morosovsky et al., 1989), decrease skeletal 
muscle synthesis (Jepson et al., 1986) and increase skeletal muscle degradation (Klasing et 
al., 1987). In previous research by the authors (Williams et al., 1995), minimizing the level 
of chronic IS activation by minimizing pig exposure to major vectors of antigen transmission 
resulted in greater feed intakes and rates of proteinaceous tissue growth in immature pigs 
fed from 6 to 27 kg BW. In turn, greater dietary L intakes were required to allow the 
greater capacity of the low IS pigs for proteinaceous tissue growth to occur. However, the 
impact of chronic immune system activation on growth and nutrient needs of pigs during 
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later stages of development (27 to 112 kg BW) in which pigs may be less susceptible 
immunologically to pathogenic antigens (Cooper et al., 1968) and in which proteinaceous 
tissue accretion is less detrimentally effected by feed restriction (Campbell and Traverner, 
1988) has not been evaluated. Furthermore, the impact of IS activation on the distribution 
of nutrients into various body tissue has not been quantified. The objective of the present 
study was to determine the impact of level of chronic immune system activation on rate, 
efficiency, and composition of growth and the dietary L needs of pigs fed from 6 to 112 kg 
body weight. Materials and Methods 
Treatments. The experimental treatments consisted of two levels of chronic immune system 
activation (low or high) and five dietary amino acid regimens (.60, .90, 1.20, 1.50, and 
1.80% L from 6 to 27 kg BW and .45, .60, .75, .90, and 1.05% L from 27 to 112 kg 
BW). The low and high levels of IS activation were created and maintained by employing 
rearing schemes that minimized and maximized, respectively, the pigs exposure to 
pathogenic and non-pathogenic environmental antigens. The dietary regimens consisted of 
a basal ingredient mixture in which the dietary L concentrations were achieved by altering 
the ratio of corn to soybean meal in the diet. 
Animals. Seven sets of six littermate barrows were utilized. All pigs were derived from 
a single genetic strain (York x Landrace dam and Hampshire x Duroc sire) and geographical 
site of origin. The lean (muscle with 10 % fat) growth potential of the genetic strain was 
estimated to be .30 and .35 kg/d from 20 to 110 kg BW. The lean growth potential of the 
pigs was estimated from body growth rates, tenth rib backfat, and longissimus muscle area 
data (NPPC, 1983) previously collected on the strain at our station. The herd of origin of 
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the pigs used in this study possessed antibody titers for Actino bacillus pleuropneumoniae 
(APP), Mycoplasma hyopneumoniae (MYCO), Swine influenza virus (SIV), and 
Transmissible gastroenteritis (TGE) virus, which indicates that bacterial and viral pathogens 
were present. 
Animal Care. From 6 to 27 kg BW, pigs were individually penned in .36 x 1 m raised deck 
pens with woven wire flooring in rooms maintained at 23.8 to 26.6"C with minimum 
ventilation rates of .007 cmm's per pig. From 27 to 112 kg BW, pigs were individually 
penned in .6 x 2.3 m pens with either partially slatted concrete (low IS) or tri-bar (high IS) 
flooring in rooms maintained at 21.1 to 23.8"C with minimum ventilation rates of .014 
cmm's per pig. Pigs were allowed to consume feed and water ad libitum. Pigs were 
weighed and feed consumption and wastage was determined at 4 and 7 d intervals from 6 
to 27 and 27 to 112 kg BW, respectively. Upon reaching a weight of 112 ± 7.1 kg, pigs 
were removed from feed and water at 0630, transported 5 km to the Iowa State University 
Meats Laboratory at 0700, and electrically stunned and killed by exsanguination within 240 
min of arrival for determination of body composition. 
Pigs were bled via an orbital sinus at BW of 6 and 27 kg and at 28-d intervals 
throughout the 27 to 112 kg growth phase for determination of IS status via 
microflorometric determination of cluster of determination antigens and serum 
concentrations of the acute phase protein alpha-1 acylglycoprotein (AGP) as well as for 
serological monitoring for prevalent antigens at BW of 6, 27, and 112 kg. 
Development of IS Activation. Two management schemes were utilized to create pigs with 
a low and high level of chronic IS activation. A medicated early-weaning (MEW) scheme 
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was used to create pigs with a low level of antigen exposure and thus low level of IS 
activation. This rearing scheme minimizes disease transmission by enhancing the 
development of passive immunity in neonatal pigs and by physically isolating pigs from 
major vectors of antigen transmission (Harris, 1988). In this scheme, sows from which pigs 
were derived were vaccinated at 6 and 2 wk before farrowing for the prevalent antigens 
which had previously been identified to exist in the sow herd. The vaccinations included 
the following; Mycoplasma hyopneumoniae bacterin (Respifend Solvay, Mendota 
Heights, MN); Bordetella bronchiseptica (Rhinobac 3, NOBL, Sioux Center, lA); 
Hemophilus pleuropneiimoniae bacterin (Pneumosuis III, Pfizer Animal Health, Lebanon, 
PA) ; and transmissible gastroenteritis, Clostridium perfringens type C, Escherichia coli 
bacterin toxoid (Scourshield D, Pfizer Animal Health, Lebanon, PA). Sows were farrowed 
in sanitized (steam power washed, disinfected with Bioguard-PFD 5; Bio-Lab, Inc., 
Decatur, GA) farrowing rooms. Neonatal pigs were treated i.m. with L5 mg/kg BW of 
ceftiofur (Naxcel, Upjohn, Kalamezoo, MI) and 22.7 mg/kg BW of enrofloxacin (Baytril, 
Miles Ag Division, Shav/nee Mission, KS) at 1, 3, 5, 8, and 11 days of age. Pigs v/ere 
treated at weaning with 1.5 mg/kg ceftiofur, 22.7 mg/kg enrofloxacin, and .5 mg/kg BW 
of ivermectin (Ivomec™, Merck AgVet, Rahway, New Jersey). Pigs were weaned at 12 
(range of 10 to 14) d of age into a sanitized nursery facility physically isolated from major 
vectors of antigen transmission. Pigs received a milk based diet (modified Day 13 [no 
antimicrobial agents or oat products] Merricks, Inc.; Union Center, WI) ad libitum until 19 
d of age. Upon reaching a BW of 27 (± 2) kg, pigs were transported to a sanitized grower 
facility also physically isolated from major vectors of antigen transmission. 
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A conventional rearing scheme was used to create pigs with a high level of antigen 
exposure and thus high level of chronic IS activation. In this scheme, sows were not 
vaccinated, sows were farrowed in non-sanitized farrowing rooms, the neonatal pigs did not 
receive injectable antibiotics unless clinical signs of illness were present, and pigs were 
weaned at an average age of 19 d (17 to 20) to increase the likelihood of antigen transfer 
from the sow and/or environment to the neonatal pig. Pigs were weaned into a non-
sanitized nurser>' facility located at the site of sow origin. The unit had been previously 
occupied and was not power washed between pig groups. During the trial, the facility was 
co-occupied by 7 wk old non-experimental pigs derived from the base herd and additional 
pigs from a continuous flow nursery located at the site of the base herd were introduced into 
the room at 21 d intervals to increase the likelihood of antigen exposure in the experimental 
animals. This facility shared common air-spaces with the grower and finisher facilities 
located at the site of the base herd. Upon reaching a BW of 27 (± 2) kg pigs were 
transported to a grower facility at the site of the base herd. The facility had been previously 
occupied and was not power washed between pig groups. During the trial, the facility was 
co-occupied by 10 wk old pigs from the base herd and additional pigs from a continuous-
flow finisher located at the site of the base herd were introduced into the room at 21 d 
intervals throughout the remainder of the study to increase the likelihood of chronic antigen 
exposure in the experimental animals. Pigs in the low and high IS groups were allowed to 
consume the 1.80% L experimental diet ad libitum from 19 to 25 d of age. 
Experimental Diets. Dietary amino acid regimens consisted of corn, dehulled soybean meal, 
spray dried whey, skim milk mixtures, with added minerals and vitamins during the 6 to 
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27 kg growth phase (Table 1) and corn, dehulled soybean meal mixaires with added 
minerals and vitamins during the 27 to 112 kg growth phase (Table 2). The dietar}' L 
concentrations fed during the two growth phases were achieved by altering the ratio of corn 
to soybean meal in the 1.80 or 1.05% L basal diets, respectively. Dietary amino acid 
regimens were formulated based on pretrial chemical analysis of protein (N x 6.25; AOAC. 
1990) and amino acid concentrations (ion exchange chromatography after acid hydrolysis 
as described by Gehrke et al. 1985) of the single source corn, dehulled soybean meal, dried 
skim milk, and dried whey sources used in the trial. The diets were fortified with vitamins 
at levels which met a minimum of 350% and minerals which met a minimum of 200% of 
NRC (1988) estimated requirements for 5 to 10 kg pigs. Diets contained no antimicrobial 
agent. Diets were formulated to provide a minimum of 110% of the ideal ratio of amino 
acids relative to lysine as defined by Chung and Baker (1992). Synthetic DL-methionine 
was added to the 1.20, 1.50, and 1.80% dietary L diets to meet minimal dietary methionine 
+ cystine concentrations. To minimize variation in nutrient content and potential toxins, 
single sources of dehulled soybean meal, corn, dried whole whey, and dried skim milk were 
used throughout the trial. 
Sample Collection and Analysis. For determination of body composition, pigs were 
transported to the Iowa State University Meats Laboratory, BW recorded (post-transport 
weight), electrically smimed, and killed by exsanguination. The pigs were scalded at 68 "C 
for five and one-half minutes and then eviscerated. The following offal components were 
obtained within 45 minutes of exsanguination and weighed to the nearest gram: leaf fat, 
heart-lungs, liver, kidneys, gastrointestinal tract (with digesta), reproductive tract, jowl trim. 
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and the head (removed from the carcass at the atlas joint). The offal components were 
frozen (-20" C) for later chemical analysis. The offal components were ground (Buffalo 
Grinder, Buffalo, NY) in dry ice through a 1.9 cm die, mixed twice to ensure homogeneity 
and reground through a .64 cm die. Two 500 g samples were collected and frozen at -20" 
C. Ground viscera samples were freeze dried to a constant weight. Dry matter, ash, 
Kjeldahl nitrogen, and ether extractable lipid were determined in triplicate on each sample 
of offal according to AO AC (1990) procedures. 
The hot carcass was weighed 45 min after exsanguination and then chilled at TC. 
At 24 hr postmonem, standard carcass measurements of backfat thickness (midline at first 
rib, last rib, and last lumbar vertebrae, and 2.54 cm off midline at the tenth rib), and 
longissimus muscle area at the tenth rib were taken on the cold carcass. Carcass muscle 
(with 10 % fat) was estimated from hot carcass weight, tenth rib backfat and longissimus 
muscle area according to the NPPC (1983) formula. 
Cold carcass weights were recorded and then carcasses were split uniformly into 
right and left sides. The right side of the carcass was divided into six untrimmed wholesale 
cuts (ham, loin, shoulder, belly, ribs and jowl) and feet and tail (Romans et al., 1977). The 
wholesale cuts and feet and tail were frozen (-20"C) for later dissection. The frozen 
wholesale cuts and feet and tail were allowed to thaw at 2" C for 48 h followed by 15" C 
for 12 h and then each cut was physically separated into muscle, fatty tissue, skin, and bone 
components. All separable connective tissues were considered muscle. 
The separable tissue from each cut was weighed to the nearest gram. The muscle 
tissue from each cut was pooled and ground immediately after dissection through a .64 cm 
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die (Biro Model : 75424852 7.5 HP grinder, Marblehead, OH), mixed thrice to ensure 
homogeneity, and reground through a .32 cm die. Two 500 g samples were collected and 
frozen at -20"C. Chemical analysis of muscle samples was then determined using the same 
procedures as for viscera samples. 
Weight losses for each wholesale cut that occurred during the freezing and dissection 
processes were assumed to be moisture losses. Weights of separable muscle were corrected 
for water losses with the water loss being assigned to muscle for each wholesale cut. 
For determination of initial body composition, the sixth barrow in five litters per 
IS group were killed at the initiation of the experiment via intracardial injection of 1 mg of 
sodium penabarbatol/kg BW. Pigs were then exsanguinated and offal components of leaf 
fat, heart-lungs, liver, kidneys, gastrointestinal tract (withdigesta), and head (removed from 
the carcass at the atlas joint) were collected and weighed to the nearest gram. The hot 
carcass was weighed and then split into right and left halves. Offal and carcass components 
were frozen at -20''C for subsequent analysis. Offal components were then ground and 
chemically analyzed using the same procedures as for 112 kg pigs. The right side of the 
carcass was thawed, divided into wholesale cuts, and then physically separated into muscle, 
fatty tissue, skin, and bone components using the same procedures as for 112 kg pigs. 
Chemical composition of muscle samples was then determined using the same procedures 
as for viscera samples. Body tissue content of the initial pigs was similar among IS groups. 
Thus, initial body composition of the experimental pigs was estimated based on the body 
tissue and nutrient content of the initial pigs pooled across IS status expressed as a 
percentage of body weight. For estimation of body nutrient content and nutrient accretion 
148 
rates, literature values (Gnaedinger et al., 1963) were utilized to estimate the amount and 
nutrient (water, protein, lipid, and ash) composition of hair and blood and nutrient 
composition of separable bone, skin, and fatty tissue of the pigs killed at 6 and 112 kg BW. 
For determination of immune status, pigs were bled via an orbital sinus at 6 and 27 
kg and at 28-d intervals throughout the duration of the 27 to 112 kg growth phase. Serum 
was separated by centrifugation and stored within 24 h of collection at -20"C until it was 
analyzed. Whole blood aliquots were stored on dry ice until processed (within 5 h). Whole 
blood samples were collected for flow cytometry analysis of lymphocyte populations 
utilizing procedures described by Williams et al. (1995). Two 1 mL serum samples were 
submitted to the Iowa State University Diagnostic Laboratory for determination of antibody 
titers for APP, MYCO, SIV, TGE, using the serological assays defined by Williams et al. 
(1995) and for PRRS using an ELISA assay (PRRS ELISA Test Kit, Idexx Laboratories 
Inc., West Brook, ME.). Serum samples were utilized to determine serum alpha 1-
acylglycoprotein (AGP) concentrations using a radial immuno-diffusion assay (Development 
Technologies International, Inc., St. Frederick, MD) defined by Williams et al. (1995). 
Statistical analysis. Statistical analysis were performed by variance and covariance 
procedures appropriate for a split-plot design (Steele and Torrie, 1980) using the General 
Linear Model of SAS (1994). IS status was considered as the main plot and was tested by 
the error term of replicate within IS stams. Dietary L concentration (subplot) and the IS 
X L interaction were tested with the residual (replicate x dietary L [IS]) error term. Body 
weight was used as a covariate in the analysis of the carcass characteristics, offal, and 
separable tissue data. Lymphocyte surface cell antigen, serum AGP concentrations, body 
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weight gain, gain;feed, and daily L intake data over various stages of pig development were 
analyzed as a repeated measure. Effects of stage of development and two and three way 
interactions were tested with the error term of replicate and stage of development within IS 
status and dietary amino acid regimen. 
Dietary L requirements at various stages of the pig's development were estimated 
utilizing one or two slope broken-line regression analysis (Robbins, 1986) of daily body 
growth rates and gain:feed ratios during 4 or 7 d periods in the 6 to 27 kg and 27 to 112 
kg growth phases, respectively. Responses of each pig during 4 and 7 d periods were 
analyzed when pigs weighed (± 2.5 kg) 7, 13, 19, and 25 kg in the initial growth phase and 
when pigs weighed (± 7 kg) 32, 46, 60, 74, 88, and 102 kg in the second growth phase. 
Because a plateau was not reached in the analysis of daily gain of high IS pigs at a BW of 
102 kg, daily L requirement could not be estimated from break point analysis for this IS 
status - body weight group. Differences in estimated L requirements between IS groups at 
each of body weight were analyzed with a t-test for two independent samples (Steel and 
Torrie, 1980). The relationship between daily body weight gain and daily L intake at 
various stages of the pig's development (ABW) were developed utilizing multiple regression 
procedures. 
Three pigs in the low IS treatment group (1 - .90/.60; 1 - 1.20/.75; 1 - 1.50/.90% 
L) were removed from the experiment due to physical injury. In the high IS group, one pig 
(1.50/.90% L) was removed due to a gastric ulcer and two pigs (1 - .90/.60; 1 -1.20/.75% 
L) were removed due to poor growth caused by proliferative enteritis and mycoplasma 
hyopneumonia induced respiratory disease. Least squares means are reported. Probability 
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values less than .15 are considered significant. 
Results 
IS ejfects. Low IS pigs exhibited colostrally derived antibodies at the initiation of the study 
(6 kg BW) for APP, MYCO, SIV, and TGE but were free of all tested antigens at 27 and 
112 kg BW. High IS pigs did not possess colostral antibody titers for tested antigens at 6 
kg but did possess positive titers for APP, MYCO, SIV, TGE at 27 kg and 112 kg as well 
as PRRS at 112 kg. Low IS pigs had lower T-lymphocyte CD4:CD8 ratios than high IS 
pigs (Figure 1) and this response was consistent at each stage of growth monitored. The 
low CD4:CD8 ratio in low IS pigs was the result of a smaller number of CD4 positive cells 
and a greater number of CDS positive cells. Low IS pigs also had lower serum AGP 
concentrations than high IS pigs (Table 3) at each stage of growth although AGP 
concentrations declined in both groups as the pigs approached market weight. 
Initial body composition, defined as separable tissue content of the pigs body, did 
not differ between IS groups (Table 4). Therefore, data for initial body composition were 
pooled across IS status group in order to estimate initial body composition of the 
experimental animals placed on test. 
Low IS pigs were one kg heavier (P< .01, Table 5) at the initiation of the trial (4.6 
vs 6.1 kg) than high IS pigs, although pigs in both groups were started on test at similar 
ages (25 ± 2 d). As designed in the experimental procedures, body weights of pigs in the 
two IS groups did not differ at the diet change (27 kg) or at the termination of the study 
(112 kg). Low IS pigs consumed more feed, gained body weight faster and accrued more 
weight per unit of feed than high IS pigs during the 6 to 27, 27 to 112, and 6 to 112 kg 
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growth phases, respectively. 
Post-transport and hot carcass weights of low and high IS pigs did not differ between 
IS groups (Table 6). Carcasses of the low IS pigs had less backfat, larger longissimus 
muscle areas, and greater estimated carcass muscle content. Low IS pigs also had lighter 
organ and gastrointestinal tract weights, and less leaf fat than high IS pigs (Table 7). 
Separable tissue contents of pig carcasses also differed among the IS groups as low IS pigs 
had more separable muscle and skin tissue and less separable fatty and offal tissue (Table 
8). The separable muscle and offal tissues from low IS pigs also contained a higher 
proportion of protein and water and a lower proportion of fat than these tissue from high 
IS pigs. The relative proportion of the carcass in the untrimmed wholesale cuts of ham, 
loin, shoulder, and belly did not differ between IS groups (Table 9). The proportion of the 
carcass muscle in the wholesale cuts of ham, loin, and shoulder was unaffected by IS status, 
although low IS pigs had a greater proportion of carcass muscle in the belly (Table 10). 
The proportion of separable bone and skin tissue relative to muscle in pigs at 112 kg BW 
did not differ between IS groups but low IS pigs possessed less offal and fatty tissue relative 
to muscle than high IS pigs. 
Low IS pigs accrued more muscle, fat, bone, skin, and offal tissue daily than high 
IS pigs (Table 11). The low IS pigs also accrued more body protein, water and fat daily 
than high IS pigs. Furthermore, the low IS pigs deposited a greater proportion of body 
protein in muscle tissue and a lower proportion in offal tissue than the high IS pigs. 
Lysine effects and interactions. Lymphocyte CD4:CD8 ratios did not differ among dietary 
treatments, therefore data presented in Figure 1 are pooled across dietary L concentration. 
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Serum AGP concentrations decreased (Table 3) as dietary L concentration increased with 
the magnitude of the decrease becoming greater as pig matured, particularly in the low IS 
pigs. 
Pig body weights at 112 kg and post-transport weights differed among dietary L 
groups (Tables 5 and 6) as pigs in the .60/.45 dietary L treatment group were lighter at the 
termination of the study. Daily feed intake during the 27 to 112 kg and 6 to 112 kg growth 
phases also were influenced by dietary L concentrations (Table 5) as feed intakes were 
lower in the .60/.45% L treatment group. This decrease in feed intake likely is due to the 
lighter final pig weights of the .60/.45% L treatment group in both IS groups. As dietary 
L concentration increased, daily body growth rate and the efficiency of feed utilization 
increased (Table 5) during the 6 to 27, 27 to 112 and 6 to 112 kg growth phases, 
respectively in both IS groups. However, low IS pigs required greater dietary L 
concentrations to allow their greater capacities for rate and efficiency of body growth to be 
expressed during the 6 to 27, 27 to 112, and 6 to 112 kg growth phases. 
Both carcass traits and offal component weights also were influenced by dietary 
amino acid regimen. As dietary L concentration increased, tenth rib and average backfat 
were reduced, longissimus muscle area and estimated carcass muscle (Table 6) and liver and 
kidney weights were increased, while leaf fat weights were decreased (Table 7) in both IS 
groups. However, the low IS pigs required higher dietary L concentrations to maximize 
these shifts in carcass leanness and organ weights. Separable tissue content of the body also 
was influenced by dietary L concentration and IS status of the pigs. Increasing dietary L 
resulted in greater separable muscle and skin tissue content and lower fatty tissue (Table 8) 
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and offal content in pigs weighing 112 kg BW with a greater response occurring in low vs 
high IS pigs (Table 8). The protein and water content of the separable muscle and offal 
tissues were increased and fat content reduced as dietary L levels were increased. Again, 
the magnitude of the response to increasing dietary L was greater in low IS pigs. 
The relative proportion of carcass in the untrimmed wholesale cuts of ham, loin, and 
shoulder were not influenced by increasing dietary L concentration, although the relative 
proportion of the carcass in the belly tended to decrease with increasing L concentration 
(Table 9). The proportion of carcass muscle tissue present in each wholesale cut also was 
independent of dietary L concentration except that about 1% more of the total carcass 
muscle was deposited in the belly in pigs' fed the highest dietary L concentrations (Table 
10). The amount of separable offal and fatty tissue present relative to muscle tissue in pigs 
at 112 kg BW decreased and bone to muscle ratio increased as dietary L concentration 
increased with the magnitude of the response being greater in low IS pigs. Skin to muscle 
ratios were not altered by dietary regimen. 
Daily accretion rates of body tissues and nutrients were dependent on dietary L 
concentration as well as IS status of the pig. Daily body muscle, fatty, bone, skin, and offal 
accretion increased as dietary L concentration increased in both IS groups. However, the 
magnitude of the increase in proteinaceous carcass tissue (muscle, bone, and skin) accretion 
was greater in the low IS pigs. Similarly, body protein, water, and fat accretion increased 
as dietary L concentration increased and the magnitude of the increases in protein and water 
deposition were greater in the low IS pigs. 
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Response by stage of growth (Pig BW). Feed intake, body growth rate, gain:feed ratio and 
response to dietary amino acid regimen were dependent on the pig's stage of development 
(ABW) in each IS group (Table 12). Daily L intake and body growth rate increased 
curvilinearly and gain: feed ratios declined in both IS groups as ABW increased from 7 to 
102 kg. Dietary L concentrations needed to maximize BW gain and gain:feed ratios 
declined curvilinearly and daily L intakes needed to maximize these criteria increased 
curvilinearly as pigs grew from 7.5 to 102 kg BW, independent of the pig's IS status. Low 
IS pigs also required greater dietary L concentrations at each stage of growth to allow their 
greater rate and efficiency of growth to be expressed. Low IS pigs required 2 to 6 g more 
dietary L daily at each stage of growth to maximize daily gain and gain:feed compared with 
high IS pigs (Table 13). 
Discussion 
Based on antibody titers for pathogenic antigens, T-lymphocyte CD4:CD8 ratios, and 
serum alpha-1 acylglycoprotein concentrations, two levels of chronic IS activation were 
created and maintained throughout the study. The presence of antibody titers for specific 
antigens indicates that an animal either possessed colostral antibodies (i.e. 6 kg BW) or that 
an animal has been exposed to and mounted an immune response (i.e. activation of both the 
humoral and cellular components of the immune system) to a specific antigen (i.e. 27 kg 
and 112 kg BW). The reduction in the level of IS activation in the low IS pigs was 
achieved via the elimination of pathogenic antigens that were present in the herd of origin 
and by minimizing the pigs' exposure to other major antigen vectors. The findings that 
pathogenic antigens present in the herd of origin were eliminated via the use of a MEW 
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rearing scheme are in agreement with the results of Harris (1988) and Williams et al. 
(1995). 
The elimination of pathogenic antigens quantified in this experiment was associated 
with a reduction in the number of CD4 positive T-lymphocytes, an increase in the number 
of CDS positive T-lymphocytes, and a reduction in the CD4:CD8 ratio in low IS pigs. 
Similar results have been previously reported by the authors (Williams et al., 1995). A low 
T-lymphocyte CD4:CD8 ratio occurs in animals experiencing minimal exposure to initiators 
of the immune system (i.e pathogenic and non-pathogenic antigens and physiological stress) 
and is associated with minimal cytokine release and greater anabolic hormone concentrations 
(Williams et al., 1995). The lower serum AGP concentrations of low IS pigs also indicates 
that these animals experienced less exposure to initiators of the immune system than the high 
IS pigs. Similar findings were previously reported by the authors (Williams et al., 1995). 
Environmental and non-pathogenic antigen challenge has been reported to increase 
cytokine release and decrease the rate and efficiency of growth. Chicks reared in sanitary 
environments exhibit lower circulating levels of IL-1 than those reared in unsanitary 
environments where antigen stimulation is high (Roura et al., 1991) and pigs and chicks 
reared in sanitary environments have greater rate and efficiency of growth than pigs and 
chicks reared in unsanitary environments (Lev and Forbes, 1959; Williams et al., 1995; 
Wiseman et al., 1994). Acute activation of the immune system via administration of the 
non-pathogenic antigen lipopolysaccharide, a component of the cell wall of gram negative 
bacteria which has been demonstrated to be a potent stimulant of macrophages that produce 
IL-1 and TNF upon activation (Feldmann and Male, 1989), reduces feed intake, body 
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growth rate, and efficiency of feed utilization in chicks (Klasing and Barnes, 1988) and pigs 
(van Heugten et al., 1994). In the current study, the greater feed intakes, body growth 
rates, gain:feed ratios, proteinaceous tissue accretion rates, carcass muscle contents, and 
dietary L needs of low versus high IS pigs apparently are due to differences in cytokine 
release and associated endocrine changes among the two IS groups. IL-1 administration has 
been demonstrated to reduce food intake by 40% in rats (Mrosovsky et al., 1989). This 
reduction in voluntary feed intake due to IL-1 release is associated with induction of CRH 
release (Navarra et al., 1990) and induction of IL-8 release which serves as a potent 
stimulant of the lateral hypothalamus (Plata-Salaman and Borkoski, 1993). This cytokine 
induced reduction in feed intake accounts for a portion of the reduction in growth rate and 
efficiency of feed utilization in antigen challenged animals. However, other metabolic shifts 
mediated by cytokines also play a role as LPS administration in chicks reduced body weight 
gains and gain;feed ratios by 17.1 and 17.0%, respectively, compared with those of pair-fed 
controls (Klasing et al., 1987). These metabolic shifts include increased skeletal muscle 
protein degradation (Klasing and Austic, 1984), decreased skeletal muscle protein synthesis 
(Jepson et al., 1986), increased liver and heart protein synthesis (Ballmer et al., 1991) and 
increased bone resorption (Cochran and Abernathy, 1988). Cytokines mediate these 
alterations in skeletal muscle protein synthesis and degradation by decreasing the release of 
anabolic hormones such as somatotropin (Hannegar et al., 1991) and IGF-1 (Fan et al., 
1994), increasing catabolic (glucocorticoid) hormone release (Navarra et al., 1990), and by 
direct inhibition of the muscle proteolytic inhibitor calpastatin (Chavis et al., 1994). 
Furthermore, thymus atrophy associated with cytokine release may result in decreased 
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somatotropin release as the thymic peptide thymosin alpha-1 decreases somatostatin release 
from the hypothalamus (Milenkovic et al., 1992) and while thymic peptide thymosin fraction 
5 has been demonstrated to increase somatotropin releasing factor release from the 
hypothalamus (Badamchian et al., 1991). These observations are supponed by the findings 
of Zamir et al., (1994) who demonstrated that pre-treatment of rats with IL-1 receptor 
antagonist prevented skeletal muscle catabolism resulting from IL-1 administration or sepsis 
resulting from cecum rupture. Based on these relationships, minimizing chronic immune 
system activation by minimizing the pigs exposure to antigens would result in beneficial 
alterations in skeletal muscle protein accretion. In turn, these changes would allow low IS 
pigs to accrue proteinaceous tissue faster and to produce bodies with a higher proportion of 
proteinaceous tissue versus fatty tissue similar to that observed in the current study. 
The greater feed intakes of the low IS pigs in the current study only accounted for 
a ponion of the observed increase in proteinaceous tissue growth. Specifically, the low IS 
pigs consumed daily 36 kcal more ME/BW, kg^"' and accrued 27 and 30 g more body 
protein (117 vs 90 g) and fat (241 vs 211 g) respectively, than high IS pigs when animals 
in each IS group were consuming dietary amino acid intakes at or slightly above their daily 
needs (1.80/1.05; 1.50/.90% L regimens in low IS pigs and 1.50/.90; 1.20/.75% L 
regimens in high IS pigs). The greater dietary energy intake of the low IS pigs accounts 
for only a portion of their greater rates of body protein accretion. In pigs with moderate 
genetic capacities for protein accretion (6g-BW, kg^^"''d"'), the additional ME consumed by 
low IS pigs would be expected to result in only 10 additional grams of accrued protein and 
48 grams additional body fat accretion (Stahly 1986). The fact that protein accretion was 
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increased more in low IS pigs than projected based on their elevated ME intakes apparently 
is the result of the greater anabolic endocrine status of the low IS pigs (Harmegar et al., 
1991; Fan et al., 1994; Wiseman et al., 1994) and not due to greater partial efficiency of 
use of dietary ME for body protein and fat accretion (Williams et al., 1995). The increase 
in the amount of body protein accrued per unit of additional ME consumed also has been 
shown to become greater as the pigs biologic capacity for muscle tissue accretion increases 
due to genetic selection (Stably, 1986) and porcine somatotropin administration (Stahly, 
1990). Based on energetic costs of body protein and fat accretion of 10.5 and 12.8 kcal 
ME/g respectively, the greater than expected protein accretion (27 vs 10 g) in the low IS 
pig would lower the amount of additional ME available for fat accretion to levels sufficient 
to support only 34 g/d of additional fat which compares closely with 30 g acmally observed. 
Again, these data are in agreement with the findings that the partial efficiency of ME use 
for body protein and fat accretion are not altered due to IS activation (Williams et al., 
1995). 
The greater body weight growth rates and gain:feed ratios of the leaner, low IS pigs 
are in agreement with the findings that body weight gains and gross efficiency of feed 
utilization are improved as the animals lean tissue growth is enhanced via genetic selection 
(Stahly et al., 1989; Stahly et al., 1991) and administration of growth regulators (i.e. 
ractopamine and somatotropin; Stahly, 1990). However, the greater lean tissue accretion 
rates and higher carcass muscle content in the low IS pigs was associated with elevated 
voluntary feed intakes and body fat accretion rates. In contrast, the greater lean tissue 
accretion rates and body muscle content of genetically lean and somatotropin treated pigs 
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are associated with lower voluntar>' feed intakes and rates of body fat accretion (Stahly 
1990; Stahly et al., 1991). 
The greater tissue accretion capacities of the low IS pigs resulted in these pigs 
requiring a higher daily L intake than high IS pigs to allow this greater capacity to be 
expressed. The low IS pigs also require a higher concentration of dietary L to optimize 
their lean tissue growth because minimizing the level of chronic IS activation increased the 
pig's capacity for body protein accretion more (+23 %) than for its capacity for body 
energy retention ( + 13%) while the efficiency of use of digestible L for proteinaceous tissue 
accretion is similar among the two groups (Williams et al., 1995). The observations that 
dietary L needs, expressed as a percentage of the diet or grams per day, are increased as 
the pigs lean tissue growth rate and body protein mass (maintenance needs) are increased 
by minimizing the pigs chronic IS activation are similar to shifts in amino acid needs 
associated with greater lean tissue accretion rates resulting from genetic selection for lean 
tissue growth (Stahly et al., 1989; Stahly et al., 1991) and administration of somatotropin 
and ractopamine (Stahly 1990). Based on an assumed L content of body proteins of 7.0% 
(ARC, 1981) an assumed efficiency of utilization of digestible L for protein accretion of 
65% (ARC, 1981) and the observed protein accretion rates in the low and high IS pigs 
(receiving their respective optimal L regimens), the low IS pigs are estimated to need an 
additional daily intake of 2.9 g of digestible L and 3.5 g of dietary L over the duration of 
the trial than high IS pigs. 
The fact that low IS pigs deposited a greater proportion of their accrued body protein 
in L rich muscle protein than in offal proteins which have a lower proportion of L (ARC, 
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1981) may have contributed to the higher L requirements of the low IS pigs. Furthermore, 
the alterations in the distribution of accrued protein in body tissues between IS groups may 
influence the ideal ratio of amino acids relative to L because of differential patterns of 
amino acid composition among body tissues as well as those associated with maintenance 
functions (i.e. acute phase proteins) versus tissue growth (Reeds et al., 1994). 
As expected, feed intake, body weight growth rates, and gainrfeed ratios were 
dependent on the pigs stage of development. Daily feed intakes of both IS groups increased 
until pigs reached body weights of 74 to 88 kg and then plateaued. Daily body weight gains 
of low IS pigs receiving the optimal dietary L regimens increased from 566 g at 7 kg BW 
to about 980 to 998 g at 46 to 74 kg BW and then declined slightly to 956 g at 102 kg BW. 
Daily gains in the high IS pigs increased from 375 g at 7 kg BW to 830 to 870 g at 60 to 
102 kg BW. Gain:feed ratios in the low IS pigs declined quadratically from 965 to 297 as 
pigs grew from 7 to 102 kg BW and from 686 to 275 in the high IS pigs. The low IS pigs 
exhibited greater daily feed intakes, body weight gains, and gain;feed ratios at each stage 
of growth evaluated (Table 12). For example, the !ov,' IS pigs grew 90 to 190 g/d faster 
at the four BW evaluated from 7 to 25 kg BW and 106 to 242 g/d faster at the six BW 
evaluated from 32 to 102 kg. Because the patterns of voluntary feed intake and body tissue 
accretion are dependent on the pig stage of growth, the optimal dietary L regimen of pigs 
also shifts as the animal matures. In terms of tissue growth, proteinaceous tissue accretion 
increase rapidly during the early stage of growth, plateaus, and then declines as the animal 
approaches maturity (Shields et al., 1983) while fatty tissue accretion rates increase 
quadratically as the animal mamres with the largest increase occurring as the animals 
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approach market weight. Thus, in pigs allowed to consume feed ad libitum, dietary L 
requirements expressed as percentage of the diet decrease as the pig matures (Campbell and 
King, 1982; Stahly et al., 1991). In contrast, dietary L requirements expressed as daily 
intakes increase until the animals reaches the stage of development were peak rates of 
proteinaceous tissue occurs and the daily needs decline. Therefore, estimation of the dietary 
L needs of pigs during specific stages of development is more accurate than defining needs 
over a wide range of body growth. Based on the body weight gains and gain:feed ratios of 
pigs during 4 and 7 d periods when pigs weighed 7, 13, 19, 25, 32, 46, 60, 74, 88, and 102 
kg (Table 12). the low IS pigs required .3 to .6 and .15 percentage units higher dietary L 
concentrations than high IS pigs at each body weights between 7 to 25 and 32 to 102 kg 
BW, respectively. In animals receiving the dietary L concentrations that maximized daily 
gain and gain:feed ratio within each IS group, the low IS pigs consumed 2.6 to 6 g more 
L daily than the high IS pigs at the various BW evaluated. The daily L requirements 
estimated via break point analysis of body growth rates and gain:feed ratios at the various 
stages of BW growth are reported in Table 13. Based on these estimates, the low IS pigs 
required 2.2, 2.6, 3.1, 3.5, 3.1, 3.4, 5.2, 2.9, 3.1, and 3.8 more g of dietary L intake daily 
than high IS pigs at BW of 7, 13, 19, 25, 32, 46, 60, 74, 88, and 102 kg respectively. 
Based on these data, the influence of minimizing chronic IS activation on daily body weight 
gains as well as daily L needs was relatively constant as the pigs matured from 7 to 112 kg 
BW. These results indicate that the alterations in metabolic processes associated with 
chronic IS activation occurred even in the later stages of development when pigs potentially 
are less immunologically susceptible to pathogenic antigen challenge due to a more 
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developed immune system (Cooper et al., 1968) and are less susceptible to energy 
restriction due to lower rates of proteinaceous tissue growth (Cambell and Travener, 1988). 
The greater daily L intakes, rate and efficiency of growth, and estimated daily L 
requirements of low IS pigs during the 6 to 27 kg BW growth phase are consistent with 
previously demonstrated findings of the authors when a similar model was use to create 
different levels of chronic IS activation (Williams et al., 1995). At similar stages of body 
development (7 to 9 kg and 25 to 26 kg BW), pigs in the previous study exhibited slightly 
greater daily feed intakes, rate and efficiency of growth, and estimated daily L 
requirements. These differences may be because slightly lower levels of chronic IS 
activation existed in the initial study (Williams et al., 1995), even though similar 
management schemes as well as genetic strains and herd of origin were used in both studies 
to create the two IS activation groups. This hypothesis is supported by the fact that serum 
AGP concentrations in both IS groups were slightly lower in the initial study compared with 
the present suidy. 
As expected, dietary L regimens that provided amino acid intakes above that needed 
to meet the animals needs for lean tissue growth depressed body growth rate and gain:feed 
ratios. Since the low IS pigs possessed a greater capacity for proteinaceous tissue growth 
and thus dietary L needs, dietary amino acid intakes provided by the high dietary L regimen 
(i.e. 1.80/1.05% L) were less excessive in the low vs high IS pigs. Compared with daily 
gains of pigs receiving the optimal dietary L regimens at 32, 44, 60, 74, 88, and 102 kg 
BW, feeding the 1.05 % L regimen depressed daily gain by 0, 0, 0, 64, 23, and 94 g, 
respectively, in the low IS pigs and 4, 24, 99, 6, 156, and 207 g in the high IS pigs. 
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Similarly, feeding the 1.80/1.05% L regimen tended to depress the accretion rates of 
proteinaceous (muscle, bone, and skin) and fatty tissues less in the low versus high IS pigs. 
Base on these data, minimizing the level of chronic IS activation resulted in greater 
rate and efficiency of body weight growth, greater proteinaceous tissue growth, and carcass 
muscle tissue content. Because of the differential effects of IS activation on tissue growth 
and the differential nutrients requirements for the various tissues, dietary L needs were 
increased to a greater degree than dietary energy needs in the low IS pigs. These findings 
support previously reported work by the authors which demonstrated that minimizing IS 
activation increases the capacity of pigs to deposit proteinaceous tissue and in Uirn increases 
the animals dietary L needs (expressed as a percentage of the diet or grams/day) in order 
for this elevated capacity for proteinaceous tissue growth to be expressed. 
Implications 
Technologies that minimize the level of chronic IS activation in pigs enhance rate 
and efficiency of body weight growth and carcass leanness of pigs and alter their dietary 
amino acids needs at each stage of development from weaning to market weight. Therefore, 
the pig's level of chronic IS activation should be considered when defining nutrient 
requirements. 
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Table 1. Composition (%) of diets fed to pigs fed from 6 to 27 kg BW. 
Dietary lysine. % 
Ingredient .60 .90 1.20 1.50 1.80 
Yellow corn, ground 67.60 57.24 46.85 36.41 25.80 
Soybean meal, dehulled 3.99 14.53 25.08 35.41 46.20 
DL - methionine, 98.5% - - .01 .07 .18 
Whey, dried 20.00 20.00 20.00 20.00 20.00 
Skim milk, dried 5.00 5.00 5.00 5.00 5.00 
Dicalcium phosphate 2.17 1.94 1.71 1.71 1.38 
Ground limestone .44 .49 .55 .60 .64 
Salt, iodized .25 .25 .25 .25 .25 
Vitamin-trace mineral mix" .5? .55 .55 .55 .55 
Total 100.00 100.00 100.00 100.00 100.00 
Analyzed composition, 
Crude protein 12.0 16.2 20.4 24.7 28.9 
Amino acids 
Lysine .60 .90 1.20 1.50 1.80 
Threonine .58 .74 .90 1.06 1.23 
Arginine .56 .90 1.25 1.59 1.93 
Histidine .31 .41 .50 .60 .70 
Isoleucine .59 .77 .96 1.15 1.34 
Leucine 1.35 1.61 1.87 2.13 2.39 
Phenylalanine + tyrosine .94 1.28 1.62 1.97 2.34 
Valine .67 .88 1.09 1.30 1.52 
Calculated composition" 
Methionine + cystine, % .50 .61 .72 .89 1.08 
Tryptophan, % .16 .23 .29 .35 .40 
Calcium, % .90 .90 .90 .90 .90 
Phosphorus, % .80 .80 .80 .80 .80 
ME, kcal/kg 3,169 3,169 3,175 3,175 3,178 
••'Provided the following per kg of diet; 140 mg Fe, 120 mg Zn, 48 mg Mn, 14 mg Cu, 
.80 mg I, .30 mg Se, 2,205 lU Vit A, 551 lU Vit D,, 26.0 lU Vit E, 1.5 mg Vit K (as 
menadione dimethylpyrimidinal bisulfate), 6.3 mg riboflavin, 16.8 mg panathenic acid, 
28.5 mg niacin, 55.0 /ug Vit B,,, .03 mg biotin, .17 mg folacin, 250 mg choline, .82 mg 
pyridoxine, .56 mg of thiamine, 173 mg ethoxyquin. 
''Analyzed values determined from analysis of corn, soybean meal, whey, and dried skim 
milk sources used. 
"Values based on NRC (1988) estimated nutrient composition of the ingredients used. 
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Table 2. Composition (%) diets fed to pigs from 27 to 112 kg. 
Dietary lysine. % 
Ingredient, % .45 .60 .75 .90 1.05 
Yellow corn, ground 89.45 84.45 79.44 74.44 69.42 
Soybean meal, dehulled 7.07 12.15 17.23 22.31 27.39 
Dicalcium phosphate 2.08 1.98 1.88 1.78 1.69 
Ground limestone .57 .59 .62 .64 .67 
Salt, iodized .40 .40 .40 .40 .40 
Vitamin-trace mineral mix'' .43 .43 .43 .43 .43 
Total 100.00 100.00 100.00 100.00 100.00 
Analyzed composition, 
Crude protein 10.5 12.5 14.5 16.6 18.6 
Amino acid 
Lysine .45 .60 .75 .90 1.05 
Threonine .46 .53 .61 .69 .77 
Arginine .64 .81 .97 1.14 1.30 
Histidine .33 .37 .42 .47 .52 
Isoleucine .51 .60 .70 .79 .88 
Leucine 1.32 1.45 1.57 1.70 1.82 
Phenylalanine + tyrosine 1.04 1.21 1.37 1.54 1.70 
Valine .60 .71 .81 .91 1.01 
Calculated composition" 
Tryptophan, % .13 .16 .19 .22 .25 
Methionine + cysteine, % .44 .49 .54 .59 .64 
Calcium, % .70 .70 .70 .70 .70 
Phosphorus, % .65 .65 .65 .65 .65 
ME, kcal/kg 3,195 3,198 3,200 3,202 3,205 
"Provided the following per kg of diet; 140 mg Fe, 120 mg Zn, 48 mg Mn, 14 mg Cu, 
.80 mg I, .30 mg Se, 2,205 lUVit A, 551 lU Vit D3, 26.0 lU Vit E, 1.5 mg Vit K (as 
menadione dimetiiylpyrimidinal bisulfate), 6.3 mg riboflavin, 16.8 mg panathenic acid, 
28.5 mg niacin, 55.0 ng Vit 8,2, .03 mg biotin, .17 mg folacin, 250 mg choline, .82 mg 
pyridoxine, .56 mg thiamine, 173 mg ethoxyquin. 
''Analyzed values determined from analysis of corn and soybean meal sources feed. 
"Values based on NRC (1988) estimated nutrient composition of the ingredients used. 
Table 3. Impact of immune system (IS) activation and dietary lysine (L) concentration on serum alpha-I 
acylglycoprotein (AGP) concentrations of pigs at various periods (P) of development. ' 
Dietary lysine, % P < 
IS .60 .90 1.20 1.50 1.80 ISxP 
item Activation .45 .60 .75 .90 1.05 CV IS L ISxL P ISxP PxL xL 
Serum AGP (/^g/ml) 
Low 1 1173 947 1007 895 1149 47.7 .01 .01 .09 .01 .29 .09 .01 
High 1878 1875 1331 1070 1178 
Low 2 2947 1430 1047 793 535 
High 2410 1460 1773 1475 2258 
Low 3 1815 676 550 449 438 
High 3002 1124 749 840 753 
Low 4 1092 989 675 575 529 
High 1852 1076 941 1394 1033 
Low 5 1793 873 778 493 448 
High 3017 1232 756 1743 2355 
Low 6 1851 626 564 476 498 
High 2905 1044 727 1667 796 
Low 7 ND^ ND ND ND ND 
High 2761 919 721 612 667 
o 
reported. 
•"Periods 1 and 2 are measurements taken at BW of 6 and 27 kg, respectively. Periods 2-7 represent 28-day intervals 
throughout the 27 to 112 kg growth phase. 
'•"Values not determined. Low IS pigs marketed before period 7. 
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Table 4. Impact of immune system (IS) activation on initial body tissue and nutrient 
composition of pigs at 6 kg BW" 
IS activation IS 
Item Low High CV % P< 
Pig weight, kg 4.63 6.05 31.9 .23 
Body composition, % of body weight 
Muscle 30.0 30.1 13 .20 
Fatty tissue 5.4 5.3 23.2 .91 
Skin 7.0 6.8 15.0 .79 
Bone 15.6 18.1 11.2 .08 
Offal 37.3 34.8 31.3 .18 
Muscle composition, % 
Protein 15.7 16.2 14.3 .32 
Water 78.4 77.3 3.7 .59 
Lipid 4.4 4.4 25.0 .44 
Offal composition, % 
Protein 11.3 12.5 8.1 .19 
Water 79.0 78.0 3.6 .59 
Lipid 4.6 3.8 34.9 .44 
^ Five pigs per IS group. 
TabJe 5. Impact of immiiiie system (IS) activation and dietary lysine (L) concentration on feed intake body weight 
gain, and gain:feed ratios of pigs fed from 6 to 112 kg BVV." 
Dietary ly^ne, % P < 
IS Pig .60 .90 1.20 1.50 1.80 
item Activation BW .45 .60 .75 .90 1.05 CV IS L ISxL 
Pig weight, kg 
Feed, kg/d 
BW gain, kg/d 
Low 
High 
Low 
High 
Low 
High 
6 kg 
27 kg 
112 kg 
6.8 
5.7 
7.0 
5.6 
Low 6-27 kg 
High 
Low 27-112 kg 
High 
Low 6-112 kg 
High 
Low 6-27 kg 
High 
Low 27-112 kg 
High 
27.5 27.6 
24.8 27.0 
107.5 114.8 
102.9 114.1 
1.114 1.052 
.870 .927 
2.504 2.728 
2.110 2.520 
2.142 2.292 
1.790 2.067 
.476 .577 
.364 .478 
.657 .889 
.553 .793 
7.0 
5.4 
27.0 
27.0 
112.7 
114.8 
.990 
.907 
2.630 
2.557 
2.215 
2.095 
.652 
.531 
.951 
.778 
6.8 
6.0 
27.2 
25.7 
111.4 
114.5 
.977 
.863 
2.675 
2.389 
2.258 
2.018 
.677 
.476 
.928 
.749 
6.6 
5.4 
27.2 
26.0 
113.6 
110.8 
.968 
.883 
2.772 
2.355 
2.270 
1.993 
.624 
.491 
.961 
.703 
16.4 .01 .91 .90 
8.3 .22 .83 .67 
6.1 .88 .02 .77 
9.9 .01 .16 .20 
7.8 .01 .01 .35 
7.9 .01 .03 .52 
10.0 .01 .01 .12 
5.6 .01 .05 .01 
Table 5. (cont'd) 
Dietary lysine, % P < 
IS Pig .60 .90 1.20 1.50 1.80 
Item Activation BW .45 .60 .75 .90 1.05 CV IS L ISxL 
Daily body weight gain, kg (cont'd) 
Low 6-112 kg .614 .799 .864 .850 .857 6.8 .01 .01 .08 
High .503 .705 .720 .707 .668 
Low 6-27 kg .425 .550 .659 .696 .645 7.4 .01 .01 .01 
High .418 .518 .587 .550 .557 
Low 27-112 kg .264 .324 .362 .349 .347 6.9 .02 .01 .02 
High .263 .315 .310 .315 .297 
Low 6-112 kg .285 .349 .391 .378 .378 5.9 .02 .01 .03 
High .283 .342 .344 .352 .336 
''Six or seven individually-penned barrows per IS activation - dietary L concentration treatment group. Least squares 
means reported. 
Table 6. Impact of immune system (IS) activation and dietary lysine (L) concentration on carcass measurements 
from pigs at 112 B\V." 
Dietary lysine, % P < 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Post-transport pig weight, kg 
Low 105.0 110.1 108.2 108.6 109.4 6.4 .51 .01 .28 
High 98.4 112.2 113.2 113.3 109.7 
Hot carcass wieght, kg'' 
Low 79.7 80.5 81.6 80.6 80.5 1.9 .39 .83 .35 
High 79.7 80.4 79.1 79.6 79.5 
Backfat thickness, cm'' 
10th rib Low 3.84 3.37 2.52 2.48 2.79 12.0 .09 .01 .07 
High 3.45 3.56 2.92 2.97 3.05 
Avg Low 5.11 4.19 3.81 3.45 4.01 9.7 .07 .01 .14 
High 4.85 4.21 4.14 4.04 4.29 
Longissimus muscle area, cm- '' 
Low 25.23 37.78 35.23 38.38 36.45 8.1 .01 .01 .04 
High 24.44 30.52 31.87 31.81 32.65 
Estimated carcass muscle, %'' 
Low 48.06 52.05 54.94 56.79 55.52 3.4 .01 .01 .11 
High 47.43 50.96 52.84 52.68 52.90 
"Six or seven individually-penned barrows per IS activation - dietary lysine concentration treatment group. Least sqaures 
means reported. 
''Data adjusted by covariance for post-transport pig weight. 
Table 7. Impact of imimme system (IS) activation and dietary lysine (L) concentration offal component Heights in 
pigs at 112 kg BW." '" 
IS 
Item Activation 
Dietary lysine. % 
CV 
P < 
.60 
.45 
.90 
.60 
1.20 
.75 
1.50 
.90 
1.80 
1.05 IS L ISxL 
Organ weights, kg 
Liver Low 1.45 1.49 1.48 1.56 1.59 9.3 .01 .06 .48 
High 1.65 1.51 1.71 1.69 1.75 
Kidney Low .239 .294 .305 .335 .326 9.7 .59 .01 .21 
High .261 .259 .310 .352 .352 
Heart and Low 1.46 1.52 1.51 1.53 1.45 12.7 .01 .22 .28 
lungs High 1.67 1.61 1.90 1.94 1.77 
Leaf fat, kg Low 2.55 2.10 1.55 1.49 1.63 14.6 .07 .01 .14 
High 2.71 2.24 1.92 1.93 1.90 
Gastrointestinal Low 8.81 9.21 8.44 8.95 9.34 10.8 .02 .80 .26 
tract, kg High 9.10 9.40 10.31 9.52 9.68 
Reproductive Low .267 .266 .296 .248 .277 20.6 .31 .32 .55 
tract, kg High .308 .291 .276 .253 .333 
Head, kg Low 6.95 6.67 6.80 6.97 6.73 7.0 .46 .61 .95 
High 6.97 6.69 6.60 6.75 6.63 
Jowl trim, kg Low 1.34 2.47 1.19 .98 .97 85.6 .66 .35 .51 
High 1.04 1.35 1.49 1.19 1.16 
U\ 
"Six or seven individually-penned barrows per IS activation - dietary L treatment treatment group. Least squares means 
reported. 
''Data adjusted by covariance for post-transport pig weight. 
Table l i .  Impact of imiiuine system (IS) activation and dietary lysine (L) concentration on the amonnt of separable 
body tfssnes and the chemical composition of separal)le muscle and offal tissues in pigs at 112 kg BW." '" 
Dietary lysine, % P < 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Separable tissue, kg 
Muscle Low 34.82 39.55 43.16 45.34 44.25 5.4 .12 .01 .01 
High 36.45 39.45 42.02 42.37 42.20 
Fatty Low 32.39 28.35 24.11 20.05 22.60 9.7 .11 .01 .03 
High 30.84 27.99 23.80 23.70 24.12 
Bone Low 9.46 8.74 9.37 9.99 9.32 6.7 .36 .22 .35 
High 9.2! 9.32 9.63 9.60 9.41 
Skin Low 3.04 3.81 4.16 4.19 4.43 11.2 .07 .01 .38 
High 3.18 3.62 3.64 3.90 3.81 
Offal, kg Low 23.07 24.32 21.58 22.08 22.31 8.4 .01 .55 .19 
High 23.72 23.46 24.53 23.64 23.59 
Chemical composition of separable muscle, % 
Protein Low 19.1 19.5 19.5 20.4 20.1 7.2 .09 .12 .22 
High 18.6 19.5 19.6 18.9 19.7 
Water Low 65.0 66.5 67.7 68.3 67.8 3.3 .05 .04 .12 
High 65.4 66.2 66.5 67.3 67.7 
Table 8. (coat.') 
Dietary lysine. % P < 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Lipid Low 13.7 12.0 11.2 10.3 10.4 14.6 .05 .01 .48 
High 14.4 12.7 11.3 11.1 10.9 
Chemical composition of offal, % 
Protein Low 9.8 10.8 11.9 12.5 11.5 9.7 .02 .01 .54 
High 9.1  10.7 n.4 ! ! . [  11.6 
Water Low 52.0 55.9 58.5 60.1 58.4 3.4 .11 .01 .03 
High 54.3 55.5 57.4 56.6 57.2 
Lipid Low 31.8 26.5 24.1 21.4 23.7 10.0 .08 .01 .04 
High 28.8 27.4 25.2 26.0 25.6 
''Six or seven individually-penned barrows per IS activation 
reported. 
''Data adjusted by covariance for post transport pig weight. 
- dietary L concentration treatment group. Least squares means 
Table 9. Impact of immune system (IS) activation and dietary lysine (L) concentration on distribution! of 
wholesale cuts (ham, loin, shoulder, and belly) in pigs at 112 kg BW/ 
Dietary lysine. % P < 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Untrimmed wholesale cut weight / % of cold carcass weiglit 
Ham Low 23.6 24.2 24.8 25.1 24.1 3.6 .40 .41 .38 
High 24.0 24.0 24.9 25.4 25.3 
Loin Low 28.2 27.6 27.6 26.4 27.6 4.6 .51 .22 .67 
High 28.3 28.0 26.5 26.3 27.1 
Shoulder Low 23.1 22.8 22.8 24.1 23.5 4.4 .99 .30 .57 
High 24.8 25.7 25.5 25.9 25.3 
Belly Low 16.5 16.2 15.5 15.1 15.5 5.4 .79 .01 .99 
High 16.4 15.9 15.5 14.9 15.6 
^Six or seven individually-penned barrows per IS activation - dietary L concentration treatment group. Least squares means 
reported. 
''Data adjusted by covariance for post transport pig weight. 
Table 10. Impact of immune system (IS) activation and dietary lysine (L) concentration on distribution of muscle 
tissue in the carcass and proportion of seperable fatty, bone, skin, and offal tissues to muscle at 112 kg BW." 
Dietary lysine, % P_< 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Proportion of carcass muscle in each wholesale cut, % 
Ham Low 28.6 28.6 28.5 28.1 27.2 5.6 .31 .84 .74 
High 28.3 28.9 28.5 28.5 28.7 
Loin Low 26.0 25.7 26.2 25.9 27.0 4.9 .62 .54 .20 
High 26.1 26.9 25.3 25.5 26.0 
Shoulder Low 26.1 25.0 24.7 25.4 25.0 5.4 .49 .93 .38 
High 24.8 25.7 25.5 25.9 25.3 
Belly Low 10.8 11.4 12.5 12.6 12.5 9.9 .09 .09 .44 
High 11.3 11.3 11.6 11.3 12.1 
Proportion of body tissues relative to muscle, % of muscle 
Fatty: Low 93.2 72.4 54.9 46.6 52.0 15.3 .06 .01 .01 
muscle High 84.2 71.8 57.1 56.3 57.4 
Bone: Low 27.2 22.1 21.2 22.2 21.2 7.7 .27 .01 .23 
muscle High 25.4 23.9 23.1 22.9 22.3 
Skin; Low 8.7 9.6 9.4 9.2 10.0 12.9 .60 .79 .24 
muscle High 8.7 9.3 8.7 9.3 9.0 
Table 10. (coiit.') 
Dietary lysine. % P < 
Item 
IS 
Activation 
.60 
.45 
.90 1.20 1.50 
.60 .75 .90 
1.80 
1.05 CV IS L ISxL 
Offal: 
muscle 
Low 
High 
66.3 
65.6 
61.8 49.1 48.9 
60.1 58.8 56.3 
51.0 
55.9 
11.1 .01 .01 .24 
"•Six or seven individually-penned barrows per IS activation - dietary L concentration treatment group. Least squares means 
reported. 
•'Data adjusted by covariance for post transport pig weight. 
Table 11. Impact of immune system (IS) activation and dietary lysine (L) concentration on body tissue and nutrient 
accretion rates in pigs fed from 6 to 112 lig.'' 
Dietary lysine, % P < 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Tissue accretion, g/d 
Muscle Low 199 279 341 348 339 6.9 .01 .01 .01 
High 166 246 268 265 255 
Fatty Low 194 209 194 167 179 11.7 .01 .01 .67 
High 133 180 158 154 149 
Bone Low 50 57 67 72 66 7.5 .01 .01 .02 
High 40 55 58 56 53 
Skin Low 16 25 31 31 33 12.8 .01 .01 .02 SS 
High 14 21 22 23 22 
Offal Low 123 161 154 157 159 10.4 .01 .01 .44 
High 100 138 149 138 135 
Muscle gain: Low 89 123 154 155 150 7.3 .02 .01 .01 
feed (g/kg) High 93 122 132 136 129 
Nutrient accretion, g/d 
Protein Low 71 97 113 120 114 6.6 .01 .01 .01 
High 68 86 93 88 88 
Water Low 239 331 383 394 384 6.1 .01 .01 .01 
High 198 291 310 310 292 
Table 11. (cont.') 
Dietary lysine, % ^ P < 
IS .60 .90 1.20 1.50 1.80 
Item Activation .45 .60 .75 .90 1.05 CV IS L ISxL 
Lipid 
Muscle protein; 
offal protein 
Low 250 275 263 234 248 8.9 .01 .01 .74 
High 180 240 219 213 209 
Low 3.3 3.3 3.7 3.7 3.8 16.8 .02 .90 .47 
Higli 3.4 3.3 3.1 3.4 3.3 
"Six or seven individually-penned barrows per IS activation-dietary L concentration treatment group. Least sqaures means 
reported. 
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Table 12. Impact of iiiiiiuiiie sys tem (IS) activation and dietary lysine (L) concentration on L intake and the rate 
and efficiency of body growth of pigs at various average body weights (ABW) from 6 to 112 kg." '' 
- ^ • Dietary lysine, % P < 
ISx Lx fSxL 
Item Activation kg .45 .60 .75 .90 1.05 CV IS L ISxL ABW ABW ABW xABW 
Daily 
IS ABW, .60 .90 1.20 1.50 1.80 
intake, g , from 6-27 kg BW 
Low 7 4.0 5.6 6.9 8.6 10.7 
13 6.9 9.7 12.0 13.4 16.9 
19 8.1 11.7 15.5 16.9 19.5 
25 9.5 13.6 16.9 21.1 24.3 
High 7 3.1 5.1 6.7 7.8 10.2 
13 5.9 9.6 12.1 13.3 16.1 
19 7.4 11.8 14.4 15.7 18.6 
25 8.9 12.5 15.9 18.6 23.5 
Daily gain, g from 6-27 kg BW 
Low 7 300 374 484 527 566 
13 483 624 653 706 636 
19 554 685 757 742 717 
25 659 762 789 818 751 
High 7 237 321 375 322 334 
13 428 588 606 614 569 
19 524 657 655 615 627 
22.8 .12 .01 .45 .01 .18 .01 .93 
.21 .03 .78 
25 594 727 734 626 682 
Table 12. (cont.') 
Dietary lysine, % 
IS ABW, .60 .90 1.20 1.50 1.80 
item Activation kg .45 .60 .75 .90 1.05 
Gain:feed, g/kg from 6 to 27 kg BW 
Low 7 468 613 
13 421 580 
19 419 529 
25 419 509 
Higii 7 450 567 
13 421 548 
19 419 512 
25 403 542 
Daily L intake, g from 27 - 112 kg BW 
Low 32 7.4 11.5 
46 9.1 14.1 
60  11 .1  16 .1  
74 12.7 17.1 
88 13.6 18.4 
102 13.3 19.3 
32 6.3 10.3 
46 7.6 12.8 
60 9.7 15.5 
74 12.7 16.6 
88 15.9 17.4 
102 15.0 17.1 
835 958 963 
732 771 765 
627 667 578 
566 587 558 
686 627 572 
542 541 593 
571 566 569 
557 500 503 
14.5 16.3 18.5 
17.0 18.9 22.8 
18.8 22.2 29.6 
21.2 23.8 29.5 
23.4 29.0 32.7 
22.0 28.0 30.6 
12.9 15.6 17.9 
14.4 17.3 20.4 
18.1 21.1 24.3 
22.2 21.8 28.3 
21.3 24.5 26.7 
20.7 23.7 26.4 
P< 
ISx Lx ISxL 
CV IS L ISxL ABW ABW ABW xABW 
24.1 .01 .01 .01 .01 .29 .01 .24 
00 
32.8 .08 .01 .19 .01 .22 .01 .89 
Table 12. (cont.') 
Dietary lysine, % 
IS ABW, .60 .90 1.20 1.50 1.80 
Item Activation kg .45 .60 .75 .90 1.05 
Daily gain, g from 27 to 112 kg BW 
Low 
Low 
32 504 775 926 924 965 
46 563 807 928 938 980 
60 769 888 978 956 998 
74 796 974 985 913 921 
88 696 973 904 896 900 
102 697 956 912 877 862 
32 396 644 691 744 740 
46 412 724 717 738 714 
60 611 834 792 808 709 
74 737 815 807 719 809 
88 799 873 786 755 717 
102 841 850 805 665 643 
12 kg BW 
32 300 407 482 512 537 
46 288 361 449 432 456 
60 322 345 381 390 342 
74 321 328 339 350 330 
88 193 315 284 276 293 
102 236 297 291 273 279 
P< 
ISx Lx ISxL 
CV IS L ISxL ABW ABW ABW xABW 
36.1 .01 .01 .01 .01 .22 .01 .25 
29.8 .01 .01 .03 .01 .67 .01 .86 
Table 12. (cont.') 
Dietary lysine, % P < 
IS ABW, .60 .90 1.20 1.50 1.80 ISx Lx ISxL 
Item Activation kg .45 .60 .75 .90 1.05 CV IS L ISxL ABW ABW ABW xABW 
Gain:feecl, g/kg 27 - 112 kg BW 
32 286 371 418 434 416 
46 242 338 369 378 365 
60 236 321 325 333 302 
74 263 296 303 284 305 
88 253 300 258 278 284 
102 275 270 252 256 228 
"Six or seven individualiy-penned barrows per IS activation-dietary L concentration treatment group. Raw means 
reported. 
''Responses during 4 or 7 d intervals during which the ABW of the pigs were (+ 2.5 kg) 7, 13. 19, and 25 kg in the 6 to 
27 kg growth phase and were (+ 7 kg) 32, 46, 60, 74, 88, and 102 kg in the 27 to 112 kg growth phase. 
Table 13. Impact of immune system (IS) activation on estimated dietary lysine (L) intakes (g/d ± SE) required to 
maximize daily BW gain and gain:feed in pigs at various pig body weights (ABVV). 
IS Activation P'' < IS Activation P*" < 
ABW, kg Low IS High IS IS Low IS High IS IS 
Daily BW gain Gain:feed, 
6 to 27 leg'' 
7 7.8(.27)" 5.1(.23) .01 7.9(.16) 5.7(.22) .01 
13 12.1(.26) 9.8(.34) . 01 13.5(.40) 10.5(.22) .01 
19 15.5(.29) 12.0(.72) .10 16.8(.27) 14.2(.20) .01 
25 17.6(.35) 12.8(.35) .01 18.8(.26) 15.6(.24) .01 
27 to 112 kg" 
32 16.6(.27) 13.5(.27) .01 17.1(.25) 14.1(.22) .01 
46 I7.6(.40) 13.5(.28) .01 18.4(.59) 15.7(.26) .01 
60 20.0(.58) 15.5(.64) .10 21.9(.48) 16.1(.67) .03 
74 20.7(.41) 17.9(.48) .05 22.0(.41) 19.0(.13) .01 
88 18.2(.39) 15.1(.52) .05 19.9(.64) 16.8(.56) .10 
102 19.4(.61) 15.0(ND)f ND 19.3(.61) 16.1(ND)f ND 
"Six or seven individually penned barrows per IS activation - dietary L concentration treatment group. 
'T-test of low versus high level of IS activation. 
"Data from all pigs receiving dietary L concentrations of .60, .90, 1.20, 1.50, and 1.80% were included in the analysis. 
Data consisted of daily L intakes, daily gains, and gain:feed ratios over a 4 d period in which pig weights in the period 
were (+ 2.5 kg) 7, 13, 19, and 25 kg. 
''SE of estimated L requirement. 
"Data from all pigs receiving dietary L concentrations of .45, .60, .75, .90, and 1.05% were included in the analysis. 
Data consisted of daily L intakes, daily gains, and gain:feed ratios over a 7 d period in which pig weights in the period 
were (+ 7 kg) 32, 46, 60, 74, 88, and 102 kg. 
^Value based on L intake which numerically maximized BW gain and gain:feed ratio. Because a plateau was not reached 
in the break point analysis, a SE and probability value could not be determined. 
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CD4:CD8 RATIO 
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Figure 1. Impact of immune system (IS) activation on CD4:CD8 ratio in 6 to 112 kg pigs. 
Periods 1 and 2 refer to measurements taken at 6 and 27 kg BW and periods 3-7 refer to 
measurements taken at 28 d intervals throughout the duration of the 27 to 112 kg growth 
phase. Low IS pigs had lower CD4;CD8 ratios than high IS pigs (CV = 35.2%; P< .01). 
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CHAPTER 5. GENERAL SUMMARY 
Two experiments were conducted to determine the impact of immune system 
activation on the rate, efficiency, and composition of growth, the efficiency of nutrient 
utilization, and dietary lysine needs of growing pigs. 
In experiment one, forty-eight crossbred pigs were utilized to determine the impact 
of immune system (IS) activation (low and high) and dietary amino acid regimen (.60, .90, 
1.20, and 1.50 % total dietary lysine) on the rate, efficiency and composition of growth, 
apparent N digestibility and retention, the partial efficiency of dietary lysine and energy 
utilization, and dietary L intakes needed to maximize these response criteria in 6 to 27 kg 
barrows. Pigs with low IS activation had lower (P< .01) lymphocyte CD4:CD8 ratios and 
lower serum alpha 1 - acylglycoprotein concentrations than high IS pigs. Low IS pigs 
consumed more (P< .09) feed, gained (P< .01) body weight faster, accrued (P< .01) more 
body weight gain per unit of feed, and a higher (P< . 14) proportion of their body gain was 
protein, and a lower (P< .01) proportion was fat than high IS pigs. Low IS pigs also had 
greater apparent N digestibilities (P< .01) and retained more (P< .10) N than high, IS pigs. 
The partial efficiencies of L utilization for body N retention (g N retained per g of apparent 
digestible L intake) at body weights of 9.5, 17.5, and 25 kg of low IS pigs did not differ 
(P>.15) from those of high IS pigs. The partial efficiency of ME utilization for body 
protein and fat retention or daily energy needs for maintenance did not differ (P>.15) 
between IS groups. In order to achieve their greater rate and amount of proteinaceous tissue 
growth, low IS pigs had greater L needs (% of the diet, g/day). Minimizing IS activation 
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increased the rate and amount of proteinaceous tissue growth in 6 to 27 kg pigs and 
increased L needed in order to achieve this elevated growth. 
In the second experiment, a trial involving seventy crossbred barrows was conducted 
to determine the impact of level of immune system (IS) activation and dietary amino acid 
regimen on the rate, efficiency, and composition of body growth and dietary lysine (L) 
needs of 6 to 112 kg pigs. Low and high IS pigs were derived via medicated early weaning 
and conventional rearing schemes, respectively. Pigs were fed dietary L concentrations 
ranging from .60 to 1.80% in .30% increments from 6 to 27 kg and ranging from .45 to 
1.05% in .15% increments from 27 to 109 kg. Dietary L concentrations were achieved by 
altering the ratio of corn to soybean meal in the either the 1.8 or 1.05% dietary L basal 
diets and all diets were calculated to be first limiting in L. Pigs were penned individually 
and pig weight and feed consumption were determined at 4 and 7 d intervals from 6 to 27 
and 27 to 112 kg, respectively. A comparative slaughter technique was used to quantify 
body tissue content and accretion rates. Low IS pigs had lower (P<.01) T-lymphocyte 
CD4:CD8 ratios and lower (P<.01) serum alpha-1 acylglycoprotein concentrations than 
high IS pigs throughout the duration of the smdy. Low IS pigs consumed (P< .01) more 
feed, gained (P<.01) body weight faster and more (P<.01) efficiently, and produced 
carcasses with more (P < . 12) muscle and less (P < . 11) fatty tissue than high IS pigs at 109 
kg. To support their elevated capacities for proteinaceous tissue accretion, low IS pigs 
required .15 to .30 percentage units greater dietary L concentrations and 2 to 6 more g of 
daily L intake than the high IS pigs. Daily L needs and body growth rate of low IS pigs 
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were greater throughout pig development indicating that differences in IS activation 
remained consistent. Minimizing IS activation increases muscle tissue accretion capacity 
of pigs and as a result increases L needs in order to support this elevated rate of muscle 
tissue growth. 
Activation of the immune system alters body growth in growing pigs. Specifically, 
minimizing activation through the use of a management scheme which minimized pig 
exposure to pathogenic antigens resulted in increased feed intake, increased rate and 
efficiency of body growth, increased the amount of proteinaceous tissue growth, and 
influenced the distribution of proteinaceous tissue growth as a higher proportion of 
proteinaceous tissue growth was deposited in muscle tissue relative to offal tissue. Because 
of the increase in proteinaceous tissue growth, especially muscle tissue, L needs were 
increased (% of the diet, g/day) in pigs with minimal activation of the immune system. The 
changes in the amount and rate of proteinaceous tissue growth were not due to alterations 
in the efficiency of nutrient utilization as there were no differences in the efficiency of L 
utilization for proteinaceous tissue growth, the partial energetic efficiencies of protein and 
fat deposition, or in energy needs for maintenance. Implementation of management schemes 
which minimize immune system activation should increase the efficiency of pork production. 
Furthermore, level of immune system activation should be considered when formulating 
nutritional regimens for pigs. 
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APPENDIX A 
DISSECTION PROCEDURES 
1. The frozen wholesale cuts, feet and tail from the right carcass side were allowed to thaw 
at 2"C for 48 h followed by 15 "C for 12 h. 
2. The cuts were weighed to the nearest gram using a digital (Metier PG 32, Metier 
Instrument Corp., Highstown, NJ) scale. 
3. Each cut was individually seperated into muscle, fatty, bone, and skin tissue. 
a. Any connective tissue was considered muscle. 
4. The dissected tissues were weighed to the nearest gram using a digital (Metier PG 32, 
Metier Instrument Corp., Highstown, NJ.) scale 
5. The dissected muscle from each cut was pooled and ground immediately following 
dissection through a .64 cm die (Biro Model: 75424852 7.5 HP grinder, Marblehead, OH). 
Samples were then mixed thrice to ensure homogenity, and reground through a .32 cm die. 
6. Two 500 g samples were collected and stored at -20 "C for later chemical analysis. 
a. Samples analyzed for nitrogen (Kjeldahl), ether extract, moisture and ash (AOAC, 
1990). 
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APPENDIX B 
T LYMPHOCYTE DETERMC^ATION PROCEDURES 
1. 10 ml of whole blood was obtained from pigs via bleeding from and orbital sinus. 
2. Blood samples were stored on ice until processing. 
3. Blood samples were processed within five h of collection. 
4. Three aliquots of 10 fxL whole blood were pipetted into 96 well microtiter plates and 
incubated for 30 minutes at 4 "C with 30 juL of either mouse anti pig CD4 (T-helper 
lymphocytes), mouse anti-pig CDS (cytotoxic-suppressor lymphocytes) or pH 7.1 PBS (auto 
sample). Specificity of these monoclonal antibodies to CD4 and CDS antigens has been 
previously described (Pescovitz et al., 1984). 
5. All monoclonal antibodies were diluted 100 mg/ml in pH 7.1 PBS. Dilutions were based 
on previously determined optimal dilutions. 
6. Samples were then washed of excess antibody by the addition of 100 nL of PBS and 
centrifugation of the samples at 2200 g for 5 min. The washing step was repeated two 
times. 
7. CD4 and CDS samples were then incubated with 100 ixL (1.^00) of goat anti-mouse 
fluorescein isothiocynate (sigma Chemical, St. Louis, MO.) for 30 min at 4 "C. 
8. Auto samples were incubated only with the second fluorescein labeled antibody in order 
to determine background fluorescence and autofluoresence. 
9. Ceils were then washed with PBS using procedures previously described. 
10. Red blood cells were then lysed via the addition of 100 fiL of Immunolyse (Coulter, 
Hialeah, FL.). The lysing solution was diluted 1:25 with pH 7.1 PBS. 
11. Cells were resuspended with 100 /xL PBS and fixed with 10 juL formaldehyde fixative 
(Culter, Hialeah, FL.). 
12. Samples were then covered with aluminum foil to prevent damage from light until 
samples were read for fluorescence. Samples were read within 72 h of processing. 
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13. Samples were analyzed using a 15 Ar laser, 488 mn flow cytometer (Coulter Epics, 
Hialeah, FL.). Windows were set using its own auto sample to exclude autofluorescence 
from nonspecific binding of secondary antibody. Autofluorescent cells were excluded from 
analysis by gating. 
14. Less than 2% of cells showed autofluorescence. 
15. Reagents used, .5 M PBS (1 Liter). 
a. Na^HPOj (anhydrous) 59.64 g. 
b. Na2HP04 9.6 g ^ 
c. NaNj 1.0 g. 
d. brought to pH (7.1) with 5 N HCl or 5 N NAOH. 
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APPENDIX C 
SERUM AGP CONCENTRATION DETERMINATION PROCEDURES 
1. 10 mL of whole blood was collected from pigs via bleeding from an orbital sinus. 
2. Blood was collected into 12 ml plastic centrifuge tubes and allowed to clot for 20 h at 
1 "C. 
3. Blood was centrifuged at 2300 g for 20 minutes to obtain serum. 
4. 3 ml of serum was poured off into 6 ml polystyrene tubes and tubes were frozen at -20 
"C until processing. 
5. A porcine AGP kit (Development Technologies International, St. Federick, MA) was 
utilized to determine serum AGP concentrations. 
a. 5 /iL test samples (diluted 1:1 with .5 M PBS) were pipetted into individual wells 
on the microtiter test plate. 
b. Plates were covered with plastic lid, placed in a horizontal position, and incubated 
in a drying oven for 48 h at 37 "C. 
c. A standard curve was developed utilizing a serial dilution (250, 500, 750, and 
1000 juL) of purified porcine AGP included in the test kit. A separate standard curve 
was developed each day that the tests were ran. 
d. After the 48 h incubation period, test results were obtained by measuring the 
diameter of the precipitin ring formation between the AGP and AGP antibody 
incorporated in the microtiter plate agar. 
e. Data were log transformed in order to determine serum AGP concentrations. 
6. Reagents used, .5 M PBS (1 Liter). 
a. Na2HP04 (anhydrous) 59.64 g. 
b. Na2HP04 9.6 g 
c. NaNj 1.0 g. 
d. brought to pH (7.1) with 5 N HCl or 5 N NAOH. 
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APPENDIX D 
SIGNIFICANCE VALUES FOR SEROLOGICAL TESTS 
1. APP: titers > 8 considered significant. 
2. MYCO; titers > 8 considered significant. 
3. TGE virus: titers > 8 considered significant. 
4. SIV titers: > 10 considered significant. 
5. PRRS titer: > 8 considered significant. 
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APPENDIX E 
REPRESENTATIVE ANOVA TABLES 
Table El. Analysis of variance for a split plot model. 
Source of variation DF 
IS Status 1 
Replicate(IS Status)" 10 
Diet 3 
IS Status X Diet 3 
Diet X Replicate(IS Status)'' 30 
"Error term used to test significance of variance for IS status. 
''Error term used to test significance of variance for diet and IS status x diet. 
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Table E2. Analysis of variance for a repeated measure model. 
Source of variation DF 
IS Status 1 
Replicate(IS Status)" 10 
Diet 3 
IS Status X Diet 3 
Diet X Replicate(IS Status)'' 30 
ABW^ 2 
ABW X IS Status 2 
ABW X Diet 6 
ABW X IS Status x Diet 6 
ABW X Diet X Replicate(IS Status)'' 60 
"Error term used to test significance of variance for IS status. 
''Error term used to test significance of variance for diet and IS status x diet. 
'•Average body weight (9.5, 17.5, and 25 kg). 
''Error term used to test significance of variance for ABW, ABW x IS status, 
ABW X diet, and ABW x IS status x diet. 
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APPENDIX F 
LUNG LESION SCORES OF PIGS AT 112 KG (PAPER 2) 
Table Fl. Impact of immune system (IS) activation on lung lesion scores of pigs at 
112 kg BW. 
IS Activation 
Criteria Low High 
Lung lesion score, % of pigs 
Severe" 0 43.8 
Moderate"' 3.1 37.5 
Mild*^ 6.3 12.5 
Free'' 90.6 6.2 
"Lesions on more than 60% of the lung. 
''Lesions on between 30% and 60% of the lung. 
'^Lesions on between 1% and 30% of the lung. 
''Lesions not present on the lung. 
